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We are developing a systematic method for the design and synthesis of rigid 
macromolecular scaffolds capable of displaying chemical functionality in three dimensional 
space.  These scaffolds will enable the study of structure-function relationships in designed 
receptors, and to examine factors governing biological catalysis.  The scaffolds might also be 
used as tools for the construction of nanoscale devices.  The monomers used to synthesize the 
oligomeric scaffolds are orthogonally protected bis-amino acids.  These heterocyclic monomers 
are coupled through diketopiperazines to neighboring monomers.  The formation of two peptide 
bonds between adjacent monomers eliminates the rotational flexibility in the scaffold backbone, 
and results in unique spirocyclic fused ring structures that we have christened bis-peptides. 
We discuss the synthesis of the four stereoisomers of a bis-amino acid monomer derived 
from 4-hydroxyproline, as well as the development of procedures for fabricating bis-peptides 
from these monomers.  Combinations of all four “pro4” monomers were incorporated into 
oligomers of different lengths.  The solution conformation of six oligomers was determined by 
analysis of their 2D-NMR spectra and using computational modeling.  Based upon the 
conformational preferences of the monomers, two pentamer scaffold oligomers were designed to 
form distinguishable shapes: a molecular rod, and a curved shape.  We confirmed the design 
hypothesis by labeling the ends of these scaffolds with dansyl and naphthyl fluorophores; this 
allowed us to determine the approximate end to end distances by measuring the efficiency of 
fluorescence resonance energy transfer.  This result suggests that we can rationally design the 
physical properties of bis-peptides based upon the stereochemistry of their constituent 
monomers. 
We also discuss progress toward the synthesis of chiral molecular cavities from bis-
peptides and from assemblies of bis-peptides.  The resulting macrocyclic cavities may ultimately 
serve as receptors for designed sensors of small chiral organic molecules. 
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“…there are rules that determine the reaction of most life forms to emerging 
technologies: 
1. Anything that is in your world when you're born is normal and ordinary and is just a 
natural part of the way things work. 
2. Anything that's invented in the first third of your life-span is new and exciting and 
revolutionary and you can probably get a career in it. 
3. Anything invented once you are middle aged is against the natural order of things.” 
–– Douglas Adams 
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1.0  INTRODUCTION 
Proteins are complex molecular machines that position functional groups within three 
dimensional space.1  In part, this is how proteins achieve a remarkable variety of tasks; they are 
molecular motors, they process and transmit information, and catalyze chemical reactions.  A 
goal within molecular nanotechnology is to develop methods that allow rational design of 
molecules that begin to approach the capabilities of proteins.  A way to achieve this goal is to 
design synthetic molecular scaffolds as a framework for positioning functional groups with 
optical, magnetic, or chemical properties.2  The challenge is to develop efficient methods to 
prepare macromolecular scaffolds that are asymmetric and that have well-defined conformation 
and connectivity.3  The ability to fashion non-natural macromolecules that have designed tertiary 
structure and that precisely align chemical functionality in three dimensional space would be 
valuable for bio-mimetic and nanotechnology applications.4,5 
Synthetic chemistry provides the means to construct remarkably complex structures from 
covalent bonds.6  There are a number of natural products, such as brevetoxin B (Figure 1-1),7 
that are rigid, covalent, scaffold-like macromolecules.2  Brevetoxin B is a relatively large 
molecule.  It is nearly 1 kilodalton, nearly 2 nm from end to end, and has well-defined 
stereochemistry and structure.  Though it is possible to achieve the synthesis of molecules the 
size and complexity of brevetoxin, this represents neither a general nor an efficient approach 
toward the development of complex nanoscale systems.  The total synthesis of brevetoxin B 
required monumental effort over nearly a decade.8-10  Using the current array of traditional 
covalent bond forming tools, the synthesis of very large and complex molecules is costly, 
inefficient, and time consuming.11  A more straightforward approach for fabrication of non-
natural molecular scaffolds would be to assemble the desired structure from similar repeating 
units (building blocks).  This modular approach is more efficient, and diverse structures can be 
generated by simply incorporating different monomers.12 
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Figure 1-1: Brevetoxin B, a natural molecular scaffold 
 
We are developing a unique method to synthesize well-defined asymmetric 
macromolecules as molecular scaffolds to display chemical functionality.13-15  These scaffolds 
are oligomers assembled in a modular and efficient way from a modest library of monomers.  
The synthesis of macromolecules with well-defined shapes has been attempted using a host of 
oligomeric molecules and monomers; in most cases, the monomers are connected by a single 
covalent bond.  Our strategy is unique because each building block in the oligomer is coupled to 
neighboring building blocks through multiple covalent bonds.4  This increases the rigidity of the 
scaffold, allowing us to change the scaffold shape in predictable ways by changing the 
stereochemistry and sequence of the constituent monomers.  As this method uses simple building 
blocks to construct complex structures in a predictable way,16 it might ultimately provide a 
means to approach the functional capabilities of proteins. 
1.1 OLIGOMERIC APPROACHES TOWARD NANOSCALE STRUCTURES 
Nature assembles its wide assortment of nanoscale machinery using a small collection of 
simple building blocks.  Proteins are oligomers of the 20 naturally occurring amino acids; the α-
amino acids in peptides or proteins are connected to each neighboring residue by a single amide 
bonds.  A potential route to nanoscale devices and machines is the design of new proteins, or the 
redesign of existing proteins to perform new functions.17  The remarkable properties of proteins 
inspires us to design proteins.5  Also, protein synthesis relies on a relatively small library of 
interchangeable monomers, and there are existing chemical and biochemical ways to synthesize 
homogeneous proteins quickly and reliably to scale.18  The design of new proteins, unfortunately, 
is non-trivial because of the complexities associated with protein folding.19 
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For a protein to perform its required function, random-coil polypeptide oligomers must 
fold into compact, functional forms (Figure 1-2).  Protein folding is an incredibly complex 
process of self-assembly driven by non-covalent interactions such as Van der Waals forces, 
hydrogen bonding, and the hydrophobic effect.20  Although the primary sequence of amino acids 
in a protein contains the information required for a protein to fold into its functional, three-
dimensional form,21 the complexity of the folding process impedes prediction of the folded 
tertiary structure of a protein based upon the primary sequence.19,20,22,23 
 
Figure 1-2: Proteins must fold to assume a functional form 
 
There have been significant advances in experimental and computational methods used to 
redesign proteins to perform new functions,17,24,25 and some examples of novel protein design 
from first principles.26,27  Nonetheless, most proteins created by de novo design do not behave as 
“natural” proteins and enzymes.  Many of these structures are designed around general structural 
motifs, without consideration or prediction of the atomic-level positioning of individual atoms, 
which may be required for the construction of effective catalysts.28 
An alternative approach which tries to circumvent some of the complexity of folding α-
amino acid polypeptides is to design peptide-like molecules with simplified folding rules.29  Like 
peptides and proteins, foldamers are oligomers constructed from monomers; the monomers are 
connected through single bonds, and the oligomers fold into secondary structural motifs, driven 
by non-covalent interactions.30  Foldamers mimic some aspects of the folding and organization 
of peptides and proteins.1,30  While short peptides tend to be conformationally mobile, short 
foldamer oligomers adopt well-defined conformations in solution.  The literature on foldamers is 
vast, and an extraordinary number of foldamer-type oligomers have been reported.30  Several 
foldamer backbones are illustrated in Figure 1-3.  The study of β-peptides has been particularly 
intense.31,32  In solution, β-peptides form secondary structures, such as helices, that are 
considerably more stable than analogous α-peptide secondary structure.33 
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A.  vinylogous polypeptides: β-sheet and hairpin turn mimics (Schreiber, 1992);29 B.  β-peptides: helical secondary 
structure (Gellman, Seebach);31,33-39 C.  oligocarbamates (Schultz, 1993);40 D. trispyridylamide α-helix mimics 
(Hamilton, 2003);41,42 E.  peptide nucleic acids (Nielsen);43,44 F.  oligo(m-phenylene ethynylene) (Moore, 
2002)12,45,46 
Figure 1-3: A few representative examples of foldamer backbones 
 
The objective of current foldamer research is to identify oligomer backbones that fold 
into persistent secondary structures, such as helices and pleated sheets.  The ultimate goal, 
however, is to combine the secondary structural motifs into macromolecules with compact 
tertiary structures.1  Both foldamers and proteins form three-dimensional structures through self-
organization driven by weak, non-covalent interactions; in general, it is difficult to design 
shaped, asymmetric macromolecules using non-covalent interactions.12  Foldamers do not 
entirely avoid the “folding problem,” and there still is no way to predictably design foldamers 
with compact tertiary structures. 
To avoid folding altogether, numerous modular oligomers with limited rotational 
flexibility have been designed.2  Molecular “rods” might be useful as construction elements for 
the fabrication of large macromolecular assemblies.4  Michl’s molecular “Tinkertoys” are a 
representative example.47-49  The scaffold arms are rigid molecular rods composed of 
geometrically constrained building blocks, such as [1.1.1]propellane  and bipyrimidine.  The 
arms are typically connected to halogenated aromatic rings using palladium mediated cross-
coupling reactions.  The resulting macromolecules are nanometer scale, but symmetrical.  This 
approach is intended to provide synthetic access to “designer solids”: three-dimensional matrices 
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of molecular rods, functionalized at lattice points with functional groups that produce unique 
optical, magnetic or materials properties. 
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Figure 1-4: Michl’s “Tinkertoy” construction set 
 
Moore has also described molecular scaffolds using a similar design strategy.  Oligomers 
constructed from phenylacetylene based monomers are assembled by sequential palladium cross-
coupling coupling reactions.12  This methodology has been used to synthesize a variety of 
macrocycles, dendrimers, and other three-dimensional structures (Figure 1-5).12,46,50  The 
solubility of the resulting symmetrical scaffolds tends to be limited.  In some cases, it has been 
possible to overcome this issue by decorating the structures with linear alkane and t-butyl 
groups. 
C6H13O
C6H13O
OC6H13
OC6H13
Br
Br
SiMe3
 
Figure 1-5: Moore’s phenylacetylene based molecular architectures 
 
There are a number of biological applications for rigid-rod oligomers.  These applications 
require that the molecular rods be water-soluble, which precludes the use of many rigid 
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oligomers.41  There are relatively few designed molecular scaffolds for biological applications.  
Oligoproline is the best known example of a water-soluble molecular rod.  Proline oligomers 
form stable helices in water (the polyproline II helix, Figure 1-6).51  By changing the number of 
proline residues in the oligomer, the length of the helix can be changed in a predictable way;  
polyproline has been used as a molecular “ruler”.52  It is not an ideal molecular rod to incorporate 
into macromolecular architectures, however, because the rigidity of this peptide is a function of 
solvent and temperature.53  Double stranded DNA has also been used as a rigid spacer for certain 
biological applications.54 
 
Figure 1-6: Oligo-L-proline, the standard molecular spacer for biological applications 
 
Whitesides recently reported a water-soluble oligomer based on oligopiperidine (Figure 
1-7),41 intended for use as a spacer for multi-valent ligand display.55  Construction of the 
oligomer is achieved by iterative reductive aminations with 4,4-piperidinediol.  Highly 
substituted p-oligophenyls have also received attention as molecular rods for trans-membrane 
ion-transport model systems.56  For most water-soluble molecular rods, it is possible to change 
the length of the scaffold.  These structures cannot, however, position functional groups 
arbitrarily in two or three dimensions. 
N N N N N N N N Cbz
O
O  
Figure 1-7: Oligo-piperidine spacer for biological applications 
 7 
1.2 A NOVEL APPROACH TOWARD THE SYNTHESIS OF MOLECULAR 
SCAFFOLDS 
The approach we have described for the synthesis of macromolecular scaffolds is to 
create oligomers without rotatable bonds.15  The oligomers do not fold to achieve their functional 
form; predicting the shape of the oligomer does not require determining the outcome of a 
complex folding process.  The shapes of the oligomers are directly related to the stereochemistry 
and structure of their constituent monomers. 
The monomers in our approach are orthogonally protected bis-amino acids; the oligomers 
created using these monomers are called bis-peptides.  The bis-amino acids that have already 
been synthesized are illustrated in Figure 1-8.  Each monomer is a small heterocycle 
functionalized with two α-amino acids.  The protecting groups, P1 and P2 are orthogonal; either 
may be removed selectively.  The selection of P1 and P2 also depends upon the linker used to 
tether the oligomer to solid phase.  R is usually a small alkyl group; this ester must survive the 
conditions used for the removal of P1 and P2, as well as the conditions used to cleave the 
oligomer from the solid support (see below). 
We are more concerned about isolating stereochemically pure monomers than about the 
stereoselectivity in the reactions used to generate the chiral centers in a monomer.  bis-Peptide 
shape is a function of the stereochemistry and conformational preferences of its monomer 
constituents; each monomer stereoisomer will affect bis-peptide shape in a different way.  Using 
4 monomers (e.g., the 4 possible stereoisomers of the pro4 monomer), 1024 non-equivalent 
pentamer bis-peptides could be synthesized.  The bis-amino acid stereoisomers provide access to 
structural diversity, so synthetic routes that provide access to all stereoisomers of a bis-amino 
acid are ideal. 
 
Figure 1-8: bis-Amino acid monomers that have been synthesized in our laboratory.  Asterisks 
represent stereocenters that are set during synthesis.  The generic monomer (right) is used for the 
discussion of bis-peptide oligomer assembly. 
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We assemble bis-peptide oligomers from bis-amino acids in two phases: chain 
elongation, and rigidification (annealing).  During elongation, the sequence of monomers in an 
oligomer is set by connecting the desired bis-amino acid monomers sequentially on solid support 
through single amide bonds.  For this process, we have elected to use the reliable method of 
solid-phase peptide synthesis (SPPS).57-59   
After attaching the first bis-amino acid to solid phase, protecting group P1 is removed 
(Figure 1-9).  The next monomer is coupled to the first, and the process is repeated until all of 
the desired monomers have been incorporated into the oligomer.  The oligomer is then cleaved 
from the resin; with our current protecting group strategy, this usually removes the P2 protecting 
groups as well.  The product is the “open-form” oligomer, because only one amide bond 
connects each monomer to neighboring monomer residues. 
 
A. Attachment of the first monomer to the solid phase resin; B. Removal of N-protecting group, P1; C. Sequence of 
deprotection and coupling reactions that elongate the chain; D. Cleavage from the solid support (can occur with or 
without cleavage of P2) 
Figure 1-9: Chain elongation by solid-phase peptide synthesis 
 
The second phase of bis-peptide synthesis is rigidification of the open-form oligomer.  
After cleavage and removal of the P2 protecting groups, the free amine of each monomer attacks 
the alkyl ester of the preceding monomer, forming a diketopiperazine ring between all adjacent 
monomers.  This process usually occurs within 24 hours under mild conditions (20% 
piperidine/DMF at room temperature).  Forming the second amide bond between adjacent 
monomers eliminates all rotational flexibility in the oligomer backbone.  The resulting bis-
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peptides are typically water soluble, and are usually stable under neutral or acidic aqueous 
conditions for weeks. 
 
Figure 1-10: Rigidification of the open-form oligomer to the bis-peptide 
 
To generate the second amide bond between adjacent monomers, the process of 
rigidification exploits a well-known side reaction that occurs during solid-phase peptide 
synthesis (Figure 1-11).60  This reaction is frequently observed when performing Fmoc solid-
phase peptide synthesis with benzyl ester resin linkers (Figure 1-11).61-63  After removing the Nα-
Fmoc group from the second α-amino acid residue, the primary amine will attack the ester 
linkage, causing premature release of a cyclic dipeptide from the solid support.  
Diketopiperazines occur in natural products,64 and are produced when peptides and proteins 
decompose under certain conditions.65,66 
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Figure 1-11.  Spontaneous DKP formation after removal of the Nα-Fmoc group from the second α-amino acid 
residue during Fmoc-SPPS generates a cyclic dipeptide that is released from the resin. 
 
Chain elongation uses the same chemistry employed for the synthesis of α-amino acids 
and β-peptides.  This process is rapid, and oligomers containing several bis-amino acids can be 
prepared in less than one day.  As elongation is a modular process, a modest library of bis-amino 
acids enables the synthesis of a large variety of molecular scaffolds.  Our primary hypothesis is 
that the shape of bis-peptides can be controlled in predictable ways because their shape is a 
function of the stereochemistry and conformational preferences of the constituent monomers. 
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2.0  PRO4 MONOMER SYNTHESIS 
To pursue bis-peptide oligomer development, suitable bis-amino acid monomers are 
required.  The bis-amino acids monomers must be stereochemically pure, and synthetic routes 
toward the monomers should be relatively short, reproducible, and scalable.  In this chapter, we 
discuss the synthesis and development of the pro4 bis-amino acid monomers (Figure 2-1). 
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Figure 2-1: The pro4 bis-amino acid monomers 
2.1 SYNTHESIS OF THE CBZ-PRO4(2S,4S) MONOMER 
The first monomer intended for bis-peptide synthesis was orthogonally protected 
piperizine bis-amino acid 1 (Figure 2-2).67  The synthesis of 1 is short, convergent, and provides 
access to all four stereoisomers of the piperazine monomer.  1 has all of the components required 
by the definition of a bis-amino acid monomer. 
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Figure 2-2: Piperazine bis-amino acid monomer 1 
 
During solid-phase peptide synthesis, it became evident that the piperazine monomers 
were far from ideal.  It was possible to couple the monomer to the N-terminus of a peptide 
anchored to a solid-phase resin, and to remove the terminal adamantyloxycarbonyl (Adoc)68 
protecting group using TFA.  Nonetheless, coupling a second piperazine monomer to the first 
was extremely difficult; even when 1 was activated as an acid chloride, yields were unacceptably 
low (usually less than 50%).  The nucleophilicity of the leading secondary amine appeared to be 
compromised, possibly by inductive effects from the other piperazine nitrogen atom. 
The synthesis of new types of bis-amino acid monomers was driven by the difficulties 
encountered with the piperazine monomer.  Developing methods for bis-peptide oligomer 
assembly was contingent on being able to couple monomers on solid support, preferably with 
well-established peptide synthesis protocols.  These factors were considered when designing the 
next generation of bis-amino acid monomers. 
The pro4 bis-amino acid monomer was based on the template illustrated in Figure 2-3.  
After removing protecting group P1, the monomer would be coupled to a resin bound amine by 
activating the revealed carboxylic acid.  Protecting group P2 would then be removed, and a 
second pro4 monomer would be activated and coupled to the primary amine on the quaternary 
carbon of the resin bound monomer.  This reaction is analogous to coupling proline to α-
aminoisobutyric acid (Aib), which can be achieved using reasonable conditions on solid phase.69  
Group P3 would be removed immediately before diketopiperazine formation between adjacent 
monomers. 
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Figure 2-3: Template for the pro4 monomer class: asterisks indicate chiral centers. 
2.1.1 First approach: attempted synthesis of o-Ns-pro4(2S,4S) monomer 
The original vision for the structure and retrosynthesis of the pro4 monomer is illustrated 
in Figure 2-4.  Monomer 5 was to be derived from trans-4-hydroxy-L-proline, 2, which is 
relatively inexpensive70 and has been used extensively as a building block for the synthesis of 
functionalized pyrrolidine rings.71  We named 5 o-Ns-pro4(2S,4S); pro4 refers to the starting 
material, 4-hydroxyproline, o-Ns designates the protecting group for the pyrrolidine N-atom, and 
(2S,4S) indicates the stereochemistry at C2 and C4 (as shown in Figure 2-4).  The key 
transformation is installation of the second amino acid at C4.  We planned to achieve this by 
hydrolysis of the hydantoin derived from ketone 3 using the Bucherer-Bergs reaction.72,73 
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Figure 2-4: Retrosynthesis for proposed o-Ns-pro4(2S,4S) monomer 5 
 
The 9-fluorenylmethoxycarbonyl (Fmoc) group74 was selected for protecting the primary 
amine on the quaternary carbon; it can be removed by exposure to secondary amines.  Fmoc-
based solid-phase peptide synthesis58 can be performed with resin linkers that are more acid-
labile than those used for Boc peptide synthesis;75 resin cleavage conditions are less aggressive 
than in Boc peptide synthesis.58  The o-nitrobenzenesulfonyl (o-Ns) group76,77 is stable to the 
conditions used to cleave the t-butyl ester and for removing the Fmoc group.  There has been 
some interest in the o-Ns group for use in peptide synthesis because o-Ns-protected α-amino 
acid chlorides cannot form oxazolones.78  During solid-phase peptide synthesis, tertiary amine 
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bases can promote the rapid conversion of Fmoc-protected amino acid chlorides to oxazolones,79 
attenuating the activity of the acid chlorides, and providing a route to epimerization at the α-
carbon; oxazolone formation is illustrated in Figure 2-5. 
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Figure 2-5: Fmoc-Val-Cl conversion to corresponding oxazolone79 
 
Another advantage of the o-Ns protecting group was that it could be removed without 
cleaving the oligomer from the resin, enabling oligomer rigidification on solid support.  
Deprotection can be monitored visually, because removing the o-Ns group releases a bright 
yellow chromophore into solution; when 2-mercaptoethanol and DBU are used to remove the o-
Ns group, 2-(2-nitrophenylthio)ethanol is liberated, as shown in Figure 2-6. 
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Figure 2-6: Deprotection of o-Ns group by means of the Meisenheimer80 complex 
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Reagents and Reaction Conditions 
(a) i. TMS-Cl, DIPEA, CH2Cl2, reflux. ii. o-NsCl, 0 °C to rt.  (b) Jones reagent, acetone, 20 °C.  (c) Isobutylene, 
H2SO4 (cat.), CH2Cl2, rt.  (d) (NH4)2CO3, KCN, 1:1 DMF/H2O, 60 °C. 
 
Scheme 2-1: First steps in the synthesis of o-Ns-pro4(2S,4S) monomer 5 
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Steps that were achieved in the synthesis of the o-Ns-pro4(2S,4S) monomer are shown in 
Scheme 2-1.  The first step of the synthesis was to generate the sulfonamide 6.  We attempted to 
protect the secondary amine of trans-4-hydroxy-L-proline methyl ester using o-NsCl under 
Schotten-Baumann conditions81 based on the procedure described by Natchus.82  The yield of 6 
by this method was poor: TLC analysis of the reaction mixture suggested incomplete conversion 
of the starting material even after 16 hours at room temperature. 
We decided to employ a procedure described by Bolin for the synthesis of Nα-urethane 
amino acids,83 a method based upon earlier work by Theodoropoulos.84  trans-4-Hydroxy-L-
proline, 2, was suspended in dichloromethane with DIPEA and TMS-Cl, and was converted 
under reflux to the N,O,O’-tri-TMS intermediate (not isolated), as shown in Figure 2-7.  The 
TMS groups increase the solubility of the amino acid in organic solvent, making the reaction 
setup and workup more convenient.  Bolin noted that this procedure suppresses the formation of 
peptide oligomers; under Schotten-Baumann conditions, a reaction between amino acids and 
Fmoc-Cl can result in the formation of dipeptide and tripeptide side products that have similar 
polarity as the desired product.  Furthermore, the TMS group increases the nucleophilicity of the 
nitrogen toward sp2 carbon centers; this effect has been described elsewhere85 and has been 
exploited to increase yields when coupling sterically hindered amino acids during SPPS.86,87  
Using Bolin’s procedure, crystalline 6 was obtained with excellent yield. 
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Figure 2-7: One-pot, 2-step procedure for the synthesis of N-Ns hydroxyproline 
 
Compound 6 was oxidized in acetone to 7 in high yield using the Jones reagent.82,88  t-
Butyl esterification of 7 proved more difficult than the oxidation of 6.  Exposing 7 to the 
esterification reagent t-butyl 2,2,2-trichloroacetimidate in the presence of the Lewis acid catalyst 
BF3·Et2O89 yielded no isolable product.  It was reported that Cbz-proline was converted to the 
corresponding t-butyl ester in quantitative yield using di-t-butyl dicarbonate (Boc2O) and 
catalytic DMAP in t-butyl alcohol;90 using these conditions, we observed only starting material 7 
by TLC. 
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The traditional conditions for t-butyl esterification provided the desired product.91  
Isobutylene was bubbled into a solution of 7 in dichloromethane containing a catalytic amount of 
sulfuric acid.  Following aqueous workup, the desired product 3 was obtained with 68% yield.  
This is the most atom economical92 method of generating a t-butyl ester (an excess of 
isobutylene is used, but it could be recovered from the solution by distillation). 
To synthesize amino acid 4, we planned to transform ketone 3 to the hydantoin 8 using 
the Bucherer-Bergs reaction,72,73 as shown in Scheme 2-1.  Hydantoins are convenient 
intermediates in the synthesis of amino acids from ketones and aldehydes.93  Unfortunately, we 
were not able to isolate the desired product from the reaction mixture; by TLC, it appeared that 
starting material 3 decomposed under the Bucherer-Bergs reaction conditions.  It is possible that 
cyanide, a soft nucleophile, was able to attack and cleave the o-Ns protecting group. 
N
O
t-BuO
O
Ns
(NH4)2CO3, KCN,
1:1 DMF/H2O,
60 °C, sealed tube
N
O
t-BuO
Ns
N
H
NH
O O3 8
 
Figure 2-8: Failed Bucherer-Bergs reaction of the o-Ns protected ketone 
2.1.2 Second approach: Cbz-pro4(2S,4S) monomer 
The o-Ns protecting group was incompatible with the planned synthetic route for the 
pro4(2S,4S) monomer.  Rather than change the synthetic strategy, we decided to protect the 
pyrrolidine nitrogen as the benzyl carbamate (Cbz group).94  The Cbz protecting group can be 
removed by catalytic hydrogenolysis94 or using strong acid, such as HBr in acetic acid57 or triflic 
acid.95  Changing the protecting group proved to be a good choice.  The Cbz-pro4(2S,4S) 
monomer, 18, was synthesized in 9 steps with 23% overall yield on multi-gram scale, as shown 
in Scheme 2-2. 
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Reagents and Reaction Conditions 
(a) i. TMS–Cl, NEt(i-Pr)2, CH2Cl2, reflux; ii. Cbz-Cl, 0 °C to room temperature.  (b) Jones reagent, acetone, 20 °C.  
(c) Isobutylene, H2SO4 (cat.), CH2Cl2, room temperature.  (d) (NH4)2CO3, KCN, 1:1 DMF/H2O, 60 °C, sealed tube.  
(e) (Boc)2O, DMAP, THF, 0 °C to room temperature.  (f) KOH, 1:1 H2O/THF.  (g) i. TMS–Cl, NEt(i-Pr)2, CH2Cl2, 
reflux; ii. Fmoc–Cl, 0 °C to room temperature.  (h) TMS–CHN2, MeOH, Et2O.  (i)  CF3COOH, CH2Cl2. 
 
Scheme 2-2: Synthesis of the Cbz-pro4(2S,4S) monomer 18 
 
Compound 9 was prepared from trans-4-hydroxy-L-proline using Bolin’s procedure.83  
The secondary alcohol of 9 was oxidized to the ketone in excellent yield using the Jones reagent, 
affording 10.  Removal of chromium during the workup was facilitated by performing the 
reaction in a large volume of acetone.  Residual CrVI is converted to CrIV by the addition of 
methanol.  The CrIV salts are insoluble in acetone, and precipitate from the reaction mixture 
during the methanol quench; the majority of the chromium salts can then be removed by 
filtration.  Although CrO3 is quite toxic, it is inexpensive.  The Jones reagent has been used for 
the oxidation of hydroxyproline previously.71,82,96  A recent review97 contrasts the atom-economy 
and environmental impact of the Jones oxidation with other oxidation methods, including the 
Swern98 and Dess-Martin99 oxidation protocols.  Following the oxidation, 10 was converted to 
the t-butyl ester 11 with isobutylene and catalytic sulfuric acid.91 
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t-Butyl ester 11 was then subjected to Bucherer-Bergs reaction conditions (ammonium 
carbonate and potassium cyanide) at 60 °C for 4 hours, affording a 5:1 mixture of diasteromeric 
hydantoins, 12 and 13.  These hydantoins were originally separated using flash chromatography 
over silica using a step gradient.15  The separation procedure was tedious.  The crude mixture of 
hydantoins was loaded onto silica, and eluted with 99:1 CH2Cl2/MeOH; this resulted in a large 
number of dilute fractions containing 12.  Later fractions containing 12 were contaminated with 
hydantoin 13.  The methanol concentration was then increased by one percent, usually affording 
several mixed fractions of 12 and 13, and finally some fractions containing only 13.  This 
procedure required multiple purifications, and it was difficult to isolate large quantities of the 
less-polar diastereomer 13.  Continuous gradient elution methods have since enabled the 
separation of much larger batches of hydantoin.100  Using less than 2 equivalents of KCN in the 
Bucherer-Bergs reaction has improved the yield of the reaction slightly (see experimental details, 
below); excess cyanide ion promotes unproductive formation of the cyanohydrin.101 
The stereochemistry of the major and minor products, 12 and 13, was confirmed by 2D-
NMR experiments.  The stereochemical assignment of 13 is supported by NOESY correlations 
H1-H9a, H1-H6a, and H1-H8 (Figure 2-9).  The NOESY correlations for 12 do not provide 
positive evidence for its relative stereochemistry, but the absence of the H1-H8 correlation is 
consistent with the proposed structure. 
 
Figure 2-9: The NOESY correlations used to assign the stereochemistry of the major and minor hydantoins (12, 
left; 13, right).  NOESY correlations are represented by gold cylinders.  The structures were generated by a 
stochastic search using the MMFF94x forcefield within MOE.102 
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Hydantoin 12 is the major product of the Bucherer-Bergs reaction (Scheme 2-2).  We 
predicted the stereochemistry of the major and minor hydantoin products based upon Tanaka’s 
results with a similar substrate (A, Scheme 2-3).103  The selectivity (B over C, Scheme 2-3) is 
driven by an unfavorable steric interaction between the ester and the C=NH group of the imino-
oxazolidinone intermediate (Figure 2-10).  The diastereoselectivity of the reaction in Scheme 2-3 
increases in proportion to the steric bulk of the ester. 
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Scheme 2-3: Diastereoselectivity of the Bucherer-Bergs reaction reported by Tanaka103 
 
Our results15 and Tanaka’s results103 are consistent with the mechanism proposed by 
Edward and Jitrangsri (Figure 2-10),104 an elaboration of the mechanism first proposed by 
Bucherer and Steiner.73  Edward’s mechanism is based upon studies of hydantoin formation from 
4-tert-butylcyclohexanone; the α-hydantoin (E, Figure 2-10) is the predominant product.  The 
transformation from B to C and from G to H (Figure 2-10) is the rate limiting step;104 it is an 
endothermic transformation, suggesting a product-like transition state.105  There is an 
unfavorable steric interaction in H between the 3,5 axial hydrogen atoms and the C=NH group of 
the imino-oxazolidinone; this interaction is avoided in C.  Under the reaction conditions, there is 
rapid equilibrium between aminonitriles A and F, and the barrier of the rate limiting step from B 
to C is less than that from G to H.  Accordingly, the route from A to E is kinetically favored.106 
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Figure 2-10:  Edward and Jitrangsri’s proposed mechanism of the Bucherer-
Bergs reaction of 4-tert-butylcyclohexanone that accounts for the observed 
product selectivity. 
 
Harsh conditions are usually required to hydrolyze a hydantoin to the corresponding 
amino acid, such as long exposure to concentrated aqueous HCl or Ba(OH)2 in a sealed tube at 
temperatures greater than 100 °C.93  These methods were incompatible with the protecting 
groups we had selected; neither the tert-butyl ester or Cbz group of 12 would survive exposure to 
these conditions.  There are enzymatic methods for hydantoin hydrolysis,107,108 but poor substrate 
scope limits their application.  We chose to employ a relatively mild method for hydantoin 
hydrolysis reported by Rebek.109  The amide and imide nitrogen atoms of the hydantoin are both 
converted to tert-butyl carbamates; the bis-Boc hydantoin is more susceptible to nucleophilic 
attack, and can be hydrolyzed to the amino acid using 1 M aqueous lithium hydroxide.  The 
increased nucleophilic sensitivity of the hydantoin is likely due to increased steric strain, and 
because the Boc protected nitrogen atom is a better leaving group.109  A similar method was first 
described by Grieco for the regioselective hydrolysis and alcoholysis of secondary amides.110 
Using Boc2O and catalytic DMAP, hydantoin 12 was converted efficiently to bis-Boc 
hydantoin 14.  TLC analysis of the reaction revealed that the starting material was almost 
entirely consumed within 30 minutes.  DMAP was removed from the reaction by filtration 
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through a silica plug, and the bis-Boc hydantoin 14 was hydrolyzed without further purification.  
Conversion of the hydantoin 12 to bis-Boc hydantoin 14 was achieved with nearly quantitative 
yield. 
Hydrolysis of 14 using aqueous lithium hydroxide and THF as co-solvent109 gave poor 
yields of 15.  When the reaction was neutralized and concentrated, the amino acid was 
contaminated with a significant amount of salt (lithium chloride) and di-tert-butyl 
imidodicarbonate (Boc2NH).  Boc2NH is a product of bis-Boc hydantoin hydrolysis; it was 
identified by comparison with an authentic sample by TLC.  Additionally, the tert-butyl ester of 
some amino acid had been hydrolyzed to the carboxylic acid.  Isolating pure 15 from this 
intractable mixture proved difficult. 
In order to improve the yield and simplify recovery of the amino acid, we attempted a 
variation of the procedure reported by McLaughlin.111  Aqueous potassium hydroxide was added 
to a solution of the bis-Boc hydantoin 14 in THF; the aqueous and organic solutions were stirred 
vigorously, generating a milky-white suspension.  When allowed to stand, the suspension broke 
into two layers that could be analyzed separately by TLC.  The progress of the reaction was 
monitored by TLC of the aqueous and organic layers.  The starting material 14 was soluble only 
in the THF layer, and was consumed within 30 minutes.  The desired product 15 migrated to the 
aqueous layer.  Boc2NH was predominantly confined to the THF.  Adding diethyl ether to 
reaction mixture (after all of the starting material had been consumed) promoted migration of 
Boc2NH to into the organic layer, and 15 into the aqueous layer.  The aqueous solution was 
separated from the ethereal solution; and the organic solution was washed with small portions of 
water to recover additional amino acid.  The aqueous layer and water washes were combined, 
chilled, and then acidified to pH 6.5 with an aqueous HCl solution with mechanical stirring.  The 
resulting white precipitate was filtered from the solution and dried in a vacuum oven.  1H and 13C 
NMR analysis of the precipitate verified that it was the desired product 15.  The amorphous 
precipitate can be crystallized using hot EtOH/H2O solution.100 
The primary amine of 15 was protected with an Fmoc group using a similar procedure as 
that described for the Cbz protection of 2.83  The product, Fmoc protected amino acid 16, was 
converted to the methyl ester 17.  This was originally achieved using DCC, DMAP and methanol 
in CH2Cl2,15 affording only a modest yield of the methyl ester (71%).  Considerably better yields 
of the methyl ester have been achieved by dissolving 16 in a mixture of anhydrous methanol and 
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ether, and then slowly adding ethereal TMS-CHN2 to the solution.  This generates the methyl 
ester 17 in high yield (typically, > 90%), and TMS-CHN2 is safer than the explosive and toxic 
reagent diazomethane.112  Finally, the tert-butyl ester was cleaved from 17, affording the Cbz-
pro4(2S,4S) monomer 18 as a shelf-stable solid that has been used for solid-phase oligomer 
synthesis without further purification. 
2.2 BOC-PRO4(2S,4S) MONOMER AND PRO4 DIASTEREOMERS 
2.2.1 Boc to Cbz exchange 
The Cbz-pro4(2S,4S) monomer 18 was used successfully in the synthesis of bis-peptide 
oligomers.15,100  The Cbz group is stable to the conditions used for the removal of the Fmoc 
group during solid phase synthesis.  This protecting group is usually removed by catalytic 
hydrogenation with heterogeneous Pd/C and H2, or by using very strong acid.94  For the synthesis 
of the first bis-peptide (page 59), the Cbz groups were removed after the oligomer was cleaved 
from the solid phase resin using hydrogen gas and Pd/C.15  Because the polarity of the open-form 
oligomers increases dramatically when the Cbz groups are removed, it was difficult to find 
appropriate solvent conditions for the hydrogenation reaction, especially for longer oligomers.  
Although the Cbz groups could be removed using triflic acid in TFA without solubility 
problems, these aggressive conditions were not compatible with some functional groups (i.e., 
dansyl) that we wanted to attach to the oligomers.100  Accordingly, we exchanged the Cbz 
protecting group with a Boc group, which can be cleaved by treatment with TFA.  The Boc 
groups could be removed simultaneously with cleavage of the oligomer from the resin. 
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Scheme 2-4: Cbz to Boc exchange reaction 
Following a one-pot procedure described by Sakaitani,113 the Cbz group of 18 was 
converted to a Boc group with good yield (Scheme 2-4).  The tert-butyl ester of 17 was cleaved 
using TFA in dichloromethane.  After removing the reaction solvent, the residue (crude 18) was 
dissolved in THF.  Pd/C and Boc2O were added to this solution; and the reaction mixture was 
stirred under a hydrogen atmosphere for approximately 24 hours, providing Boc-pro4(2S,4S) 
monomer 19 in 83% yield from 17. 
2.2.2 Cbz and Boc-pro4(2R,4R) monomers 
The Cbz- and Boc-pro4(2R,4R) monomers (29 and 30, respectively) were prepared using 
the same methods described for the synthesis of the pro4(2S,4S) monomers (Scheme 2-5).100 
 23 
H
N
O
OH
HO
N
O
OH
HO
Cbz
N
O
OH
O
Cbz
N
O
Ot-Bu
O
Cbz
N
O
Ot-Bu
O
Cbz
31
N
O
Ot-Bu
Cbz
N
H
HN
OO
N
O
Ot-Bu
Cbz
N
H
HN
OO
N
O
Ot-Bu
Cbz
N
N
OO
Boc
Boc
N
O
Ot-Bu
Cbz
H2N
OHO
N
O
Ot-Bu
Cbz
HN
OHO
Fmoc
N
O
Ot-Bu
Cbz
HN
OMeO
Fmoc
N
O
OH
Cbz
HN
OMeO
Fmoc
20 21 22
2322 24
23
25 26 27
27
28 29
a
97%
+
b
89%
c
83%
d 5:1 23/24 (by NMR)
52% 23 from 22
  8% 24 from 22
e f
59%
(2 steps)
g
87%
h
91%
i
94%
N
O
OH
Boc
HN
OMeO
Fmoc
30
i, then j, 82%
 
Reagents and Reaction Conditions 
(a) i. TMS–Cl, NEt(i-Pr)2, CH2Cl2, reflux; ii. Cbz-Cl, 0 °C to room temperature.  (b) Jones reagent, acetone, 20 °C.  
(c) Isobutylene, H2SO4 (cat.), CH2Cl2, room temperature.  (d) (NH4)2CO3, KCN, 1:1 DMF/H2O, 60 °C, sealed tube.  
(e) (Boc)2O, DMAP, THF, 0 °C to room temperature.  (f) KOH, 1:1 H2O/THF.  (g) i. TMS–Cl, NEt(i-Pr)2, CH2Cl2, 
reflux; ii. Fmoc–Cl, 0 °C to room temperature.  (h) TMS–CHN2, MeOH, Et2O.  (i) CF3COOH, CH2Cl2.  (j) Boc2O, 
Pd/C, H2, THF. 
 
Scheme 2-5: Synthesis of the Cbz-pro4(2R,4R) (29) and  Boc-pro4(2R,4R) (30) monomers. 
 
Although cis-4-hydroxy-D-proline (31) is commercially available, it is fairly expensive 
($47.60 / gram from Acros 2006/2007; compare with $1.59 / gram for trans-4-hydroxy-L-proline 
(2)).  Fortunately, 31 can be prepared from 2 (the starting material for the synthesis of the Cbz-
pro4(2S,4S) monomer).  A method for epimerization of 2 with acetic acid and acetic anhydride 
was described in 1951;114 we used a variation of this procedure described by Lowe.115  
Epimerization of 2 proceeds through an azalactone (B, Figure 2-11).116  Under the epimerization 
reaction conditions, there is equilibrium between the cis and trans forms of the acetylated 
hydroxyproline (A and C, Figure 2-11).  The hydroxyl group of the cis form (C) can attack the 
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mixed anhydride, trapping the epimerized product as a bicyclic lactone (B).  Acidic hydrolysis 
with aqueous HCl converts the lactone to the hydrochloride salt of 31.  From 20 grams of trans-
4-hydroxy-L-proline, we typically obtain cis-4-hydroxy-D-proline in ~ 40% yield.  Though this 
recovery is not ideal, epimerization of the trans isomer is far less expensive than purchasing 
similar quantities of the cis isomer. 
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Figure 2-11: Proposed mechanism for the epimerization of trans-4-hydroxy-L-proline with acetic acid and acetic 
anhydride 
2.2.3 Measuring the enantiopurity of the pro4(2S,4S) and pro4(2R,4R) monomers 
1H NMR, 13C NMR and reverse phase HPLC chromatography suggested that monomers 
18, 19, 29, and 30 were single diastereomers, but these methods cannot be used (directly) to 
detect the presence of enantiomers.  Epimerization at the α-carbon (from hydroxyproline) during 
synthesis would have resulted in mixtures of enantiomers.  We determined the enantiopurity of 
the monomers by coupling them to both enantiomers of a chiral amine, as shown for 19 in 
Scheme 2-6.  The L-(–)-α-methylbenzylamine and D-(+)-α-methylbenzylamine derivatives of the 
monomers were prepared on analytical scale and analyzed by HPLC-MS. 
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Scheme 2-6: Coupling of monomer 19 to both enantiomers of methylbenzylamine for a test 
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Monomer derivatives 32 and 33 are baseline separable by HPLC (Figure 2-12).  The 
sample of 32 contained less than 3% of an UV-active compound with a retention time equivalent 
to that of 33; 33 contained less than 1% of an impurity with the retention time of 32 (the 
enantiopurity of the amine used to make 33 was greater than that used to make 32).  Similar 
results were obtained for the derivatives of monomers 18, 29, and 30.  This result confirms that 
there is insignificant epimerization at the α-carbon along the synthetic routes described in 
Scheme 2-2 and Scheme 2-5. 
 
HPLC: column, Microsorb 100 C18, 4.6 mm × 250 mm; mobile phase, CH3CN (0.05% TFA) / water (0.1% TFA), 
50% to 95% CH3CN over 30 minutes; flow rate, 1.00 mL / min; UV detection at 274 nm; tR for 32, 17.4 min: tR for 
33, 18.4 min. 
 
Figure 2-12: HPLC chromatograms (overlaid) of chiral amine derivatives of Boc-pro4(2S,4S) monomer.  The two 
derivatives are baseline separable. 
 26 
2.2.4 Boc-pro4(2S,4R) and Boc-pro4(2R,4S) monomers  
Monomers 37, named Boc-pro4(2S,4R), and 41, named Boc-pro4(2R,4S), are the final 
stereoisomers of the pro4 monomer class.  Their synthesis was achieved on gram scale using 
procedures similar to those described for the pro4(2S,4S) and pro4(2R,4R) monomers, as shown 
in Scheme 2-7.  The synthesis of 37 and 41 begins with hydantoins 13 and 24, respectively.  
These hydantoins are the minor products of the Bucherer-Bergs reaction; they are isolated during 
the synthesis of Boc-pro4(2S,4S) 19 and Boc-pro4(2R,4R) 30. 
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(a) (Boc)2O, DMAP, THF, 0 °C to room temperature.  (b) KOH, 1:1 H2O/THF.  (c) i. TMS–Cl, NEt(i-Pr)2, CH2Cl2, 
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Scheme 2-7: Synthesis of monomers Boc-pro4(2S,4S) (37) and Boc-pro4(2R,4R) (41) 
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Product yields were similar to those achieved during the synthesis of 19 and 30.  While 
amino acids 15 and 26 were soluble in methanol, their respective diastereomers, 34 and 38, were 
almost entirely insoluble in room temperature methanol or ethanol.  34 and 38 were crystallized 
by dissolving them in hot methanol and then allowing the solution to cool.117 
2.3 DISCUSSION 
The synthesis of all four stereoisomers of the pro4 monomer class has been achieved 
from a common starting material.15,100,117  These monomers have been used extensively for the 
synthesis of bis-peptide oligomers,13-15,100,117,118 some of which are described in the following 
chapters. 
The methods developed for pro4 monomer synthesis are scalable; the Boc-pro4(2S,4S) 
and Boc-pro4(2R,4R) monomers have been prepared in > 10 gram batches without a significant 
change in yield for each step.  In practice, silica chromatography of intermediates is only 
required following the Bucherer-Bergs reaction and the methyl esterification.15  Nonetheless, 
gradient elution flash chromatography has enabled rapid and easy purification of the Fmoc 
protected amino acid intermediates (16, 27, 35, and 39), as well as the final Boc-pro4 or Cbz-
pro4 monomers.100,117 
Typically, the pro4 monomers are prepared starting with 20 to 25 grams of 
hydroxyproline; beyond this, the workups become unwieldy.  Furthermore, separating greater 
than ~ 30 gram batches of the diasteromeric hydantoins (12 from 13, and 23 from 24) is time 
consuming.  Fmoc protection of the amino acids remains the most difficult and least reproducible 
reaction; it seems to be sensitive the purity of the starting material.  Crystallization of the amino 
acids prior to Fmoc protection has improved the consistency in yield from batch to batch, but the 
crystallization procedure is somewhat difficult.  The synthesis would be improved considerably 
by developing a more reproducible method for de-salting and purification of the amino acid (e.g., 
ion exchange chromatography). 
The pro4 monomer has been described as “complicated”.41  Monomer synthesis requires 
9 (Cbz-pro4) or 10 (Boc-pro4) linear steps, but several of these steps are straightforward, high-
yield protecting group manipulations.  Moreover, a number of asymmetric building blocks for 
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foldamers and other oligomers have been reported that require syntheses of comparable 
length.29,31,35,39 
Others in our laboratory have expanded upon the synthesis of the pro4 monomer.  
Starting from hydroxyproline, they have synthesized the structurally similar pipecolic acid based 
monomers, pip4 and pip5 (Figure 2-1); these also have been incorporated into bis-peptide 
oligomers.13,119  All of the transformations described for the synthesis of the pro4 monomer class 
have been translated successfully for the synthesis of the pip4 and pip5 monomers. 
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Figure 2-13:  The pipecolic acid based monomer class 
2.4 EXPERIMENTAL DETAILS 
2.4.1 General procedures 
THF was dried by distillation from sodium/benzophenone ketyl under nitrogen.  CH2Cl2 
was dried by distillation over CaH2 under nitrogen.  trans-4-hydroxy-L-proline was obtained 
from Acros Chemical Company.  Reactions were carried out under a nitrogen atmosphere using 
oven dried glassware, unless otherwise noted.  Column chromatography was performed using 
ICN Silitech 32 – 63 D (60 Å) grade silica gel and TLC analyses were performed on EM Science 
Silica Gel 60 F254 plates (250 μm thickness).  Flash chromatography was either performed by 
hand or using the ISCO CombiFlash Companion, with cartridges filled with Silitech 32 – 63 D 
(60 Å) grade silica gel.  NMR experiments were performed on Bruker Avance 300 MHz, 500 
MHz, or 600 MHz instruments.  Chemical shifts are reported in parts per million (ppm) on the δ 
scale, and were referenced to residual protonated solvent peaks (unless otherwise noted): spectra 
obtained in DMSO-d6 were referenced to (CHD2)(CD3)SO at  δH 2.50 and (CD3)2SO at δC 39.5; 
spectra obtained in acetic acid-d4 were referenced to (CHD2)COOD at δH 2.07 and (CD3)COOD 
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at δC 20.0.  If possible, rotational isomers were resolved by obtaining spectra at 75 °C in DMSO-
d6.  IR spectra were obtained using a Nicolet Avatar E.S.P. 360 FT-IR.  Optical rotations were 
measured at 25 °C ( ± 2 °C) in chloroform, unless otherwise noted, using a Perkin-Elmer 241 
Polarimeter with a 1 mL cell (10 cm path length). 
Mass spectrometry was performed either on a Micromass Autospec high resolution mass 
spectrometer (CEBE geometry) with an electron impact ion source (HRMS-EI), or on a Waters 
Micromass LC/Q-Tof Premier mass spectrometer using an electrospray ion source 
(HRESIQTOFMS).  HPLC analysis was performed on a Hewlett-Packard Series 1050 instrument 
with a diode array detector, using a Varian Chrompack Microsorb 100 C18 column (5 μm 
packing, 4.6 mm x 250 mm).  HPLC-MS analysis was performed on a Hewlett-Packard Series 
1050 instrument with diode array detector, Agilent 1100 series LC-MSD detector (ES ion 
source) using a Waters XTerra MS C18 column (3.5 μm packing, 4.6 mm x 100 mm) 
2.4.2 Synthetic procedures and analytical data 
(2S,4R)-4-hydroxy-1-(2-nitrobenzenesulfonyl)-pyrrolidine-2-carboxylic acid (6) 
trans-4-hydroxy-L-proline (15.2 g, 116 mmol) and a magnetic stir bar were transferred into a 
500 mL three-neck round bottom flask equipped with a Friedrichs condenser and nitrogen inlet 
adaptor.  DCM (250 mL) was added to the flask.  DIPEA (66.5 mL, 383 mmol) was added by 
syringe; TMS-Cl (66.5 mL, 522 mmol) was added carefully to the stirred mixture by syringe.  
The solution was heated to reflux for 1.5 hours, and the flask was then immersed in an ice bath.  
o-Ns-Cl (23.1 g, 104 mL) was added to the solution in one portion, and the reaction mixture was 
stirred while it slowly warmed to room temperature.  The solution was concentrated to an oil, 
which was dissolved in 2.5% aqueous NaHCO3 solution (~ 250 mL).  The aqueous solution was 
washed with 2 portions of Et2O.  The organic layers were combined and washed with water; all 
aqueous portions were then combined and acidified to pH 2 with 1M aq. HCl.  The desired 
product was extracted from the aqueous layers with EtOAc (3 × 100 mL).  The EtOAc solution 
was concentrated by rotary evaporation, and the resulting oil was recrystallized from hot water 
yielding 6 (29.7 g, 93.9 mmol, 90%) as off-white crystals.  1H NMR (300 MHz, DMSO-d6): δ 
12.90 (br s, 1H), 8.11 (m, 1H), 7.93 (m, 1H), 7.88 – 7.79 (m, 2H), 5.11 (br s, 1H, –OH), 4.44 (t, J 
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= 7.8 Hz, 1H), 4.30 (m, 1H), 3.51 (dd, J = 10.7, 3.9 Hz, 1H), 3.36 (dt, J = 10.7, 1.7 Hz, 1H), 2.19 
(m, 1H), 2.03 (ddd, J = 12.6, 7.9, 4.6 Hz,. 1H); 13C NMR (75.4 MHz, DMSO-d6): δ 173.0, 147.9, 
134.4 (CH), 132.2 (CH), 131.1, 130.3 (CH), 124.1 (CH), 68.5 (CH), 59.9 (CH), 56.4 (CH2), 39.1 
(CH2); EI-MS m/z (relative intensity): 317 (<1%, M + H+), 271 (82%, [M – COOH]+), 186 
(100%); HRMS-EI calcd for C11H13N2O7S (M + H+) 317.0438, found 317.0459. 
 
(S)-1-(2-Nitrobenzenesulfonyl)-4-oxopyrrolidine-2-carboxylic acid (7) 
Compound 6 (10 g, 32 mmol) was dissolved in acetone (86 mL) that had been distilled from 
KMnO4; this solution was transferred to a round bottom flask containing a magnetic stir bar. 
Freshly prepared Jones Reagent88 (8 M, 34 mL) was added slowly to the stirred solution of 6.  
After 4 hours, the reaction mixture was diluted with water (~ 300 mL) and the product was 
extracted from the aqueous solution with EtOAc (3 ×).  The organic layers were washed with 
water (2 ×) and brine (2 ×), dried over Na2SO4, and concentrated by rotary evaporation.  
Residual solvent was removed from the resulting clear oil under reduced pressure overnight 
yielding 7 (9.7 g, 31 mmol, 98%) as a white foam, used without further purification.  1H NMR 
(300 MHz, DMSO-d6): δ 8.11 (dd, J = 7.5, 1.8 Hz, 1H), 8.00 (dd, J = 7.7, 1.5 Hz, 1H), 7.88 (m, 
2H), 4.76 (dd, J = 10.0, 2.2 Hz, 1H), 3.94 (d, J = 16.9, 1H), 3.85 (d, J = 16.9 Hz, 1H), 3.17 (dd, J 
= 18.2, 9.9 Hz, 1H), 2.62 (dd, J = 18.2, 2.2 Hz, 1H); 13C NMR (75.4 MHz, DMSO-d6): δ 206.7, 
172.1, 147.5, 134.9, 132.7, 130.4, 130.4, 124.4, 58.0, 52.5, 41.5; EI-MS m/z (relative intensity): 
297 (<1%, [M – OH]+), 269 (<1%, [M – COOH]+), 186 (100%); HRMS-EI calcd for 
C10H9N2O5S (M – COOH) 269.0232, found 269.0235. 
 
(S)-1-(2-Nitrobenzenesulfonyl)-4-oxopyrrolidine-2-carboxylic acid tert-butyl ester (3) 
Compound 7 (8.0 g, 25 mmol) and a magnetic stir bar were transferred to a 200 mL round 
bottom flask.  DCM (51 mL) was added to the flask.  Concentrated sulfuric acid (254 μL) was 
added to the resulting solution by syringe.  While stirring the mixture, isobutylene gas was gently 
bubbled into the solution through a glass pipette until the volume of the reaction mixture had 
increased by 50%.  The reaction mixture was allowed to stir for 2 hours, at which time the 
reaction mixture was washed with an aqueous NaHCO3 solution (saturated) to neutralize residual 
sulfuric acid.  The organic layer was separated, washed with water, dried over MgSO4, filtered, 
and then concentrated by rotary evaporation.  Residual solvent was removed under reduced 
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pressure yielding 3 (6.4 g, 17 mmol, 68%) as a pale yellow foam.  An analytical sample was 
prepared by recrystallizing a portion of the product from hot water: 
1H NMR (300 MHz, DMSO-d6): δ 8.14 (dd, J = 7.1, 2.1 Hz, 1H), 8.00 (dd, J = 7.4, 1.9 Hz, 1H), 
7.90 (m, 2H), 4.77 (dd, J = 9.8, 1.9 Hz, 1H), 4.00 (d, J = 16.8 Hz, 1H), 3.90 (d, J = 16.9 Hz, 1H), 
3.23 (dd, J = 18.1, 9.9 Hz, 1H), 2.60 (dd, J = 18.2, 1.8 Hz, 1H), 1.31 (s, 9H); 13C NMR (75.4 
MHz, DMSO-d6): δ 206.4, 169.4, 147.5, 134.9 (CH), 132.7 (CH), 130.9, 130.4 (CH), 124.4 
(CH), 82.3, 58.6 (CH), 52.5 (CH2), 41.6 (CH2), 27.4 (CH3); EI-MS m/z (relative intensity): 314 
(1.8%, [M – C4H9 + H]+), 269 (29%, [M – CO2C(CH3)3]+), 186 (100%); HRMS-EI calcd for 
C11H10N2O7S (M – C4H9 + H) 314.0203, found 314.0211. 
 
(2S,4R)-4-Hydroxypyrrolidine-1,2-dicarboxylic acid 1-benzyl ester (9) 
An oven-dried 1000 mL three-neck flask containing a magnetic stir bar was charged with trans-
4-hydroxy-L-proline (2, 25 g, 190 mmol).  Dichloromethane (406 mL) was transferred into the 
flask.  The flask was fitted with a reflux condenser with nitrogen inlet adapter, a glass stopper 
and rubber septum.  DIPEA (96.8 mL, 557 mmol, 2.92 equivalents) was added to the stirred 
suspension via syringe through the rubber septum; this was followed by slow addition of TMS-
Cl (72.8 mL, 572 mmol, 3 equivalents), also by syringe.  The flask was thoroughly flushed with 
nitrogen, the rubber septum was replaced with a glass stopper, and the reaction mixture was 
heated to reflux for 1.5 hours.  The three-neck flask was submerged in an ice bath, and benzyl 
chloroformate (Cbz-Cl, 26 mL, 181 mmol, 2 equivalents) was added to the reaction mixture 
which was stirred overnight while warming to room temperature.  The solution was concentrated 
by rotary evaporation to a dark red oil which was distributed between 2.5% aqueous NaHCO3 
(1250 mL) and Et2O (750 mL), then transferred to a 2 L separatory funnel.  The ether layer was 
removed, and the aqueous solution was washed with additional portions of Et2O (2 × 200 mL).  
The combined ether layers were washed with water (2 × 100 mL).  All aqueous layers were then 
combined and acidified to pH 2 with 1 M aqueous HCl; the desired product was then extracted 
from the acidified solution with EtOAc (3 × 350 mL).  The EtOAc solution was dried over 
Na2SO4, filtered, and concentrated by rotary evaporation.  Residual solvent was removed 
overnight under reduced pressure yielding 9 (42.9 g, 161 mmol, 89%) as an off-white foam that 
was used without further purification.  1H NMR (300 MHz, 75 °C, DMSO-d6): δ 12.2 – 12.4 (br 
s, 1H), 7.31 – 7.35 (m, 5H), 5.08 (s, 2H), 4.30 – 4.35 (m, 2H), 3.51 (dd, J = 11.0, 4.7 Hz, 1H), 
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3.41 (ddd, J = 11.0, 2.8, 1.4 Hz, 1H), 2.19 (dddd, J = 12.0, 8.3, 4.1, 1.2 Hz, 1H), 2.02 (ddd, J = 
12.0, 6.7, 5.2 Hz, 1H); 13C NMR (75.4 MHz, 75 °C, DMSO-d6): δ 172.8, 153.7, 136.5, 127.7 
(2C), 127.0, 126.7 (2C), 67.8, 65.6, 57.4, 54.2, 38.0; IR (neat film): 3407, 2951, 1684, 1499, 
1430, 1359, 1211, 1173, 1127, 1081, 992, 965 cm-1; [α]D -70.2° (c 6.2, CH2Cl2); EI-MS m/z 
(relative intensity) 265 (1.7%), 221 (0.9%), 176 (21%), 130 (36%), 108 (16%), 91 (100%); 
HRMS-EI calcd for C13H15NO5 (M•+) 265.0950, found 265.0959. 
 
(2S)-4-Oxopyrrolidine-1,2-dicarboxylic acid 1-benzyl ester (10) 
An 8 M solution of Jones reagent was prepared as described elsewhere.88  Compound 9 (39.0 g, 
147 mmol) was dissolved in reagent grade acetone (3 L) and transferred into a 5 L round bottom 
flask.  A Teflon paddle was submersed into the solution and attached to a mechanical stirring 
apparatus.  The Jones reagent (158 mL, 1265 mmol) was added dropwise to the stirred acetone 
solution from a graduated cylinder through a Teflon canula over ~ 20 minutes.  As the reagent 
was added to the reaction mixture, the color of the reaction mixture changed from clear to bright 
red, and finally to dark brown.  Following the addition, the reaction mixture was stirred for an 
additional 2 hours.  Methanol (119 mL, 2942 mmol) was then added dropwise to the reaction 
mixture with vigorous stirring in order to consume the residual Jones reagent; the color of the 
solution changed from dark brown to light green, and a large amount of fine, green precipitate 
was evolved.  The entire mixture was filtered through paper to remove the precipitated 
chromium salts, and then concentrated by rotary evaporation to an oil (a clear oil with a 
suspension of green droplets).  This oil was dissolved in 1 L of EtOAc, transferred to a 2 L 
separatory funnel, and washed with water (5 × 100 mL); the combined aqueous layers were then 
backwashed with EtOAc (1 × 200 mL).  The EtOAc layers were combined, washed with 
saturated brine, dried over Na2SO4, and concentrated by rotary evaporation.  Residual solvent 
was removed overnight under reduced pressure yielding 10 (38.2 g, 145 mmol, 98%) as slightly 
yellow foam, used without further purification.  1H NMR (300 MHz, 75 °C, DMSO-d6): δ 13.2 – 
13.8 (br s, 1H), 7.56 – 7.51 (m, 5H), 5.35 (s, 2H), 4.95 (dd, J = 10.4, 2.8 Hz, 1H), 4.14 (d, J = 
18.2 Hz, 1H), 3.98 (d, J = 18.2 Hz, 1H), 3.29 (ddd, J = 18.7, 10.4, 0.9 Hz, 1H), 2.72 (dd, J = 
18.5, 2.8 Hz, 1H); 13C NMR (75.4 MHz, 75 °C, DMSO-d6): δ 207.5, 172.4, 153.9, 136.3, 128.0 
(2C), 127.5, 127.1 (2C), 66.4, 56.0, 52.1, 41.2; IR (neat film): 3035, 2627, 1765, 1709, 1587, 
1431, 1360, 1263, 1195, 1163, 1028, 957, 874, 769, 752, 698 cm-1; EI-MS m/z (relative 
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intensity) 263 (1.2%), 218 (1.4%), 174 (2.4%), 128 (31%), 108 (23%), 91 (100%); HRMS-EI 
calcd for C13H13NO5 (M•+) 263.0794, found 263.0783. 
 
(2S)-4-Oxopyrrolidine-1,2-dicarboxylic acid 1-benzyl ester 2-tert-butyl ester (11) 
Compound 10 (38.9 g, 148 mmol) was transferred to a heavy-walled 1000 mL round bottom 
flask containing a magnetic stir bar and dissolved in dichloromethane (295 mL).  The flask was 
submersed in an ice bath, concentrated sulfuric acid (1.5 mL) was added to the mixture, and the 
solution was stirred gently.  Isobutylene gas was bubbled into the reaction mixture until the 
volume of the solution had increased by about 50%.  The flask was sealed with a rubber septum 
secured by a plastic strap and placed behind a blast shield.  The reaction mixture was stirred 
overnight, slowly warming to room temperature.  The following day, the septum was pieced by a 
needle in order to release accumulated pressure.  When the bubbling of the solution subsided, the 
septum was removed and solid NaHCO3 was added in order to neutralize residual sulfuric acid.  
This suspension was filtered through paper and concentrated by rotary evaporation.  The 
resulting oil was dissolved in EtOAc (1 L) and transferred to a 2 L separatory funnel, wherein it 
was washed with water (2 × 200 mL); the combined aqueous washes were backwashed with 
EtOAc (1 × 100 mL).  The organic layers were combined, dried over Na2SO4, filtered, then 
concentrated by rotary evaporation.  Residual solvent was removed under reduced pressure 
affording 11 (39.8 g, 124 mmol, 82%) as a yellow oil that was used without further purification.  
An analytical sample was prepared by silica column chromatography (3:7 EtOAc/hexanes, Rf = 
0.27).  1H NMR (300 MHz, 75 °C, DMSO-d6): δ 7.42 – 7.38 (m, 5H), 5.22 (s, 2H), 4.72 (dd, J = 
10.3, 2.5 Hz, 1H), 3.99 (d, J = 18.1 Hz, 1H), 3.81 (d, J = 18.1 Hz, 1H), 3.17 (dd, J = 18.5, 10.3 
Hz, 1H), 2.52 (dd, J = 18.5, 2.2 Hz, 1H), 1.44 (s, 9H); 13C NMR (75.4 MHz, 75 °C, DMSO-d6): 
δ 207.9, 171.0, 154.6, 137.1, 128.8, 128.3, 128.0, 82.3, 67.2, 57.5, 52.9, 40.8, 28.0; IR (neat 
film): 3065, 3034, 2979, 2934, 1767, 1716, 1499, 1455, 1415, 1368, 1298, 1259, 1233, 1211, 
1152, 1115, 1027, 968, 913, 834, 769, 699 cm-1; EI-MS m/z (relative intensity) 319 (0.28%), 263 
(12%), 218 (11%), 174 (10%), 128 (7.0%), 91 (100%); HRMS-EI calcd for C17H21NO5 (M•+) 
319.1420, found 319.1412. 
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(5S,8S)-2,4-Dioxo-1,3,7-triaza-spiro[4.4]nonane-7,8-dicarboxylic acid 7-benzyl ester 8-tert-
butyl ester (12) 
(5S,8R)-2,4-Dioxo-1,3,7-triaza-spiro[4.4]nonane-7,8-dicarboxylic acid 7-benzyl ester 8-tert-
butyl ester (13) 
A solution of 11 (42.3 g, 132.5 mmol) in DMF (330 mL) was transferred to a pressure vessel 
containing a magnetic stir bar.  Potassium cyanide (12.9 g, 198 mmol, 1.5 equivalents) was 
carefully transferred into an Erlenmeyer flask in a fume hood.  Ammonium carbonate (63.7 g, 
663 mmol, 5 equivalents) was then measured into the same Erlenmeyer flask.  The salts were 
transferred into the pressure vessel with deionized water (330 mL), and then the vessel was 
sealed and immersed in a 60 °C oil bath behind a blast shield.  The reaction mixture was stirred 
vigorously for 6 hours.  The flask was removed from the oil bath, allowed to cool, and cautiously 
opened behind the blast shield.  The solution was transferred from the pressure vessel into a 2 L 
Erlenmeyer flask containing a large magnetic stir bar, and acidified with efficient stirring to pH 6 
with 1 M aqueous HCl (this must be done in an efficient fume hood because the excess KCN 
generates HCN gas); as a result of the acidification, amorphous crude 12 and 13 crash out of the 
aqueous solution.  A portion of EtOAc (~ 250 mL) was added to the stirred solution in the 
Erlenmeyer flask, causing the insoluble products to dissolve in the organic phase.  The entire 
biphasic mixture was transferred to a 2 L separatory funnel.  The EtOAc layer was set aside, and 
the aqueous solution was extracted with EtOAc (5 × 200 mL).  The combined organic layers 
were washed with brine, dried over Na2SO4, and concentrated by rotary evaporation to a yellow 
oil containing a crude mixture of 12 and 13 in a ratio of 5:1.  The crude products were dissolved 
in dichloromethane, concentrated by rotary evaporation onto Celite, and then purified by 
chromatography on silica (gradient elution from CH2Cl2 to 95:5 CH2Cl2/MeOH).  Each fraction 
was tested by TLC.  The developed TLC plates were briefly immersed in the bromophenol blue 
solution and then heated, causing the hydantoin spots to stain bright yellow against a dark blue 
background.  Similar fractions were combined, concentrated by rotary evaporation, and placed 
under reduced pressure affording 12 (33.1 g, 85.1 mmol, 64% recovered yield from 11) and 13 
(4.0 g, 10 mmol, 7.8% recovered yield from 11), both as off-white foams.  The overall recovered 
yield of hydantoin from 11 was 72%, and the ratio of 12 to 13 based upon purified, recovered 
material was 8:1.  
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Less polar 12: 
1H NMR (300 MHz, 25 °C, DMSO-d6): δ 10.82 (s, 1H), 7.89 (s, 1H), 7.34 – 7.29 (m, 5H), 5.09 – 
5.04 (m, 2H), 4.33 – 4.23 (m, 1H), 3.89 – 3.82 (m, 1H), 3.43 – 3.36 (m, 1H), 2.70 – 2.63 (m, 
1H), 2.06 – 1.97 (m, 1H), 1.39 and 1.30 (s, rotameric, 9H); 1H NMR (300 MHz, 75 °C, DMSO-
d6): δ 7.32 (m, 5H), 5.10 (s, 2H), 4.36 (dd, J = 8.2, 7.4 Hz, 1H), 3.84 (d, J = 11.2 Hz, 1H), 3.50 
(d, J = 11.9 Hz, 1H), 2.63 (dd, J = 13.3, 8.6 Hz, 1H), 2.11 (dd, J = 13.3, 7.2 Hz, 1H), 1.40 (s, 
9H); 13C NMR (75.4 MHz, DMSO-d6): mixture of rotamers δ 176.7, 170.8 and 170.4, 156.0, 
153.6 and 153.3, 136.6 and 136.3, 128.4 and 128.2, 127.8 and 127.7, 127.3, 81.4 and 81.2, 66.5 
and 66.3, 64.5 and 63.8, 58.7 and 58.2, 52.3 and 51.8, 37.9 and 37.0, 27.5 and 27.4; IR (neat 
film): 3247, 2067, 2979, 2751, 1782, 1720, 1587, 1537, 1499, 1417, 1355, 1293, 1232, 1155, 
1114, 1084, 1050, 1013, 971, 833, 768, 738, 698, 641 cm-1; [α]D -11.7° (c 8.0, CHCl3); EI-MS 
m/z (relative intensity) 333 (3.8%), 288 (2.8%), 276 (0.7%), 244 (0.6%), 108 (17%), 91 (100%), 
84 (29%), 65 (7.7%), 57 (26.5%); HRMS-EI calcd for C15H15N3O6 (M•+ - t-Bu + H) 333.0961, 
found 333.0963. 
 
More polar 13: 
1H NMR (300 MHz, 25 °C, DMSO-d6): δ 10.93 (s, 1H), 8.62 (s, 1H), 7.35 – 7.31 (m, 5H), 5.09 – 
4.99 (m, 2H), 4.36 – 4.32 (m, 1H), 3.78 – 3.69 (m, 1H), 3.55 – 3.40 (m, 1H), 2.57 – 2.37 (m, 
1H), 2.20 – 2.12 (m, 1H), 1.37 and 1.29 (s, rotameric, 9H); 1H NMR (300 MHz, 75 °C, DMSO-
d6): δ 7.34 (m, 5H), 5.08 (s, 2H), 4.42 (apparent t, J = 8.3 Hz, 1H), 3.72 (dd, J = 11.2, 1.6 Hz, 
1H), 3.61 (d, J = 11.2 Hz, 1H), 2.43 (ddd, J = 13.4, 8.1, 1.5 Hz, 1H), 2.30 (dd, J = 13.4, 8.5 Hz, 
1H), 1.39 (s, 9H); 13C NMR (75.4 MHz, DMSO-d6): mixture of rotamers δ 174.1 and 174.0, 
170.5 and 170.1, 156.2 and 156.1, 153.6 and 153.5, 136.7 and 136.4, 128.4 and 128.3 (CH), 
127.9 (CH), 127.55 and 127.48 (CH), 81.3 and 81.1, 66.7 and 66.0, 66.5 and 66.3 (CH2), 59.0 
and 58.4 (CH), 56.1 and 55.6 (CH2), 40.4 and 39.4 (CH2), 27.6 and 27.4 (CH3); IR (neat film): 
3253, 3067, 2979, 2750, 1779, 1735, 1499, 1420, 1357, 1312, 1232, 1191, 1158, 1139, 1060, 
1016, 975, 836, 736, 698 cm-1; [α]D -18.9° (c 2.7, CHCl3); EI-MS m/z (relative intensity) 346 
(0.3%), 333 (0.8%), 244 (8.0%), 154 (8.0%), 91 (100%), 65 (15.0%), 57 (35.0%); HRMS-EI 
calcd for C18H22N2O5 (M•+ – CONH) 346.1529, found 346.1519. 
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(5S,8S)-2,4-Dioxo-1,3,7-triazaspiro[4.4]nonane-1,3,7,8-tetracarboxylic acid 7-benzyl ester 
1,3,8-tri-tert-butyl ester (14) 
Hydantoin 12 (24.8 g, 63.7 mmol) was transferred into a 2 L round bottom flask containing a 
magnetic stir bar.  THF (1309 mL) was added to the flask followed by DMAP (299 mg, 2.44 
mmol).  The flask was sealed with a septum; a nitrogen inlet line was inserted into the septum 
and the flask was flushed with nitrogen, then immersed in an ice bath.  Boc2O (32.0 g, 147 
mmol) was added as a solid in one portion to the cold reaction mixture.  The solution was stirred 
under nitrogen while warming to room temperature.  The reaction was complete after 30 
minutes, as determined by TLC (1:2 EtOAc/hexanes, DMAP Rf = 0.0, 12 Rf = 0.08, 14 Rf = 
0.41, Boc2O Rf = 0.67).  The reaction mixture was concentrated by rotary evaporation and 
filtered through silica using 1:1 EtOAc/hexanes in order to remove DMAP.  The filtrate was 
concentrated to an oil and used immediately in the next reaction without further purification.  An 
analytical sample of 14 was prepared by silica column chromatography (1:2 EtOAc/hexanes).  
1H NMR (300 MHz, DMSO-d6) mixture of rotamers δ 7.34 (m, 5H), 5.10 (m, 2H), 4.35 (m, 1H), 
4.04 (apparent dd, J = 11.5, 4.1 Hz, 1H), 3.81 (apparent dd, J = 11.5, 8.7 Hz, 1H), 2.76 (m, 1H), 
2.64 (m, 1H), 1.54 – 1.25 (m, 27H); 13C NMR (75.4 MHz, DMSO-d6) mixture of rotamers δ 
169.9, 169.6, 169.5, 153.7, 153.4, 147.5, 146.6, 146.5, 144.8, 136.5, 136.4, 128.4, 128.3, 127.8, 
127.44, 127.36, 85.5, 85.3, 84.2, 81.2, 81.0, 66.4, 65.8, 65.1, 58.5, 58.0, 50.2, 49.6, 35.4, 34.4, 
27.6, 27.3, 26.8; IR (neat film): 2981, 2937, 1830, 1784, 1751, 1717, 1498, 1475, 1456, 1395, 
1419, 1370, 1356, 1255, 1213, 1145, 1071, 1029, 1003, 950, 843, 773, 698 cm-1; [α]D -7.0° (c 
1.0, CHCl3); EI-MS m/z (relative intensity) 433 (0.3%), 388 (0.8%), 368 (0.3%), 360 (0.2%), 333 
(7.8%), 288 (13.2%), 244 (23.5%), 198 (10.5%), 154 (10.8%), 107 (10.5%), 91 (100%), 69 
(11%), 65 (20%); HRMS-EI calcd for C15H15N3O6 (M – t-Bu – 2 COOC(CH3)3 + H) 333.0961, 
found 333.0962. 
 
(2S,4S)-4-Aminopyrrolidine-1,2,4-tricarboxylic acid 1-benzyl ester 2-tert-butyl ester (15) 
Crude 14 (37.5 g, 63.7 mmole, assuming quantitative conversion of 12 to 14) was transferred 
into a 1 L round bottom flask containing a magnetic stir bar and dissolved in THF (254 mL).  A 
2.0 M aqueous solution of potassium hydroxide (254 mL) was then added to the flask.  The 
reaction mixture was stirred vigorously for 30 minutes.  The solution and a portion of Et2O (250 
mL) were transferred into a 1 L separatory funnel and agitated; the aqueous and organic layers 
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were then allowed to separate completely.  The aqueous layer was removed and poured into large 
beaker which was immediately submerged into an ice bath.  The organic layer was washed with 
water (1 × 100 mL); the water wash was added to the aqueous solution in the beaker.  With 
mechanical stirring, the solution was acidified to pH 6.5 by slow addition of 2.0 M aqueous HCl, 
resulting in the precipitation of a fine, white solid.  We continued to stir the cold, aqueous slurry 
for another hour; during this time, the pH of the slurry tended to rise, and HCl solution was 
added to maintain the pH at 6.5.  The slurry was filtered through a fine-fritted sintered glass 
funnel, and the precipitate was washed with ice cold water.  Hot water (~ 70 mL) was added to 
the solid in a 500 mL Erlenmeyer flask containing a large magnetic stir bar; this was just enough 
water to barely cover the precipitate, and generated a wet slurry.  The stirred suspension was 
brought to near boiling on a hot plate, and hot ethanol was added in small portions until the solid 
had dissolved.  The hot solution was filtered through paper into a clean flask and allowed to cool 
to room temperature; the flask was covered and placed in the 4 °C refrigerator overnight.  The 
crystalline material that formed was filtered and then dried at 50 °C in a vacuum oven affording 
15 (14.4 g, 39.5 mmol, 62% from 12) as white crystals.  1H NMR (300 MHz, 25 °C, CD3OD): δ 
7.20 (m, 5H), 5.01 – 4.95 (m, 2H), 4.37 – 4.32 (m, 1H), 3.89 (d, J = 11.6 Hz, 1H), 3.63 (d, J = 
11.7 Hz, 1H), 2.84 – 2.73 (m, 1H), 2.06 – 2.00 (m, 1H), 1.35 and 1.18 (s, rotameric, 9H); 13C 
NMR (75.4 MHz, 25 °C, CD3OD): mixture of rotamers δ 174.8, 173.2, 156.0 and 155.8, 137.7 
and 137.4, 129.5 (CH), 129.2 (CH), 129.1 (CH), 84.2, 68.8 and 68.6 (CH2), 65.4 and 64.5, 61.1 
and 60.6 (CH), 56.0 and 55.6 (CH2), 39.8 and 38.8 (CH2), 28.1 and 28.0 (CH3); IR (neat film): 
3416, 2978, 1712, 1643, 1499, 1421, 1393, 1354, 1296, 1232, 1153, 976, 851, 829, 768, 733, 697 
cm-1; [α]D -23.5° (c 3.0, methanol); EI-MS m/z (relative intensity) 308 (8.0%), 263 (8.0%), 217 
(23.5%), 173 (7.9%), 155 (9.5%), 127 (9.0%), 100 (8.8%), 91 (100%), 65 (17.5%); HRMS-EI 
calcd for C14H16N2O6 (M – t-Bu + H) 308.1008, found 308.1004. 
 
(2S,4S)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-pyrrolidine-1,2,4-tricarboxylic acid 1-
benzyl ester 2-tert-butyl ester (16) 
Finely divided 15 (13.2 g, 36.3 mmol) was transferred to a three-neck round bottom flask 
containing a stir bar.  The flask was evacuated on a vacuum line and backfilled with nitrogen 
three times.  Dichloromethane (727 mL) was then added to the flask.  The flask was fitted with a 
reflux condenser equipped with a nitrogen inlet adapter, a rubber septum with a needle (allowing 
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nitrogen to flow freely through and out of the flask), and a glass stopper.  Distilled DIPEA (15.8 
mL, 90.8 mmol) was added by syringe through the septum to the stirred solution, followed by 
TMS-Cl (9.3 mL, 73.0 mmol).  After flushing the flask briefly with nitrogen, the septum was 
removed and replaced with a glass stopper, and the solution was refluxed for 1.5 hours.  The 
flask was then immersed in an ice bath, and Fmoc-Cl (8.9 g, 34.5 mmol) was added to the 
reaction mixture.  The solution was stirred for 5 hours while warming to room temperature, and 
then concentrated by rotary evaporation.  The resulting oil was dissolved in EtOAc (1 L), 
transferred to a 2 L separatory funnel, then washed with 1 M aqueous HCl (1 × 200 mL), and 
with brine (2 × 200 mL).  The organic layer was dried over MgSO4, filtered, and concentrated by 
rotary evaporation; residual solvent was removed under reduced pressure affording crude 16 as a 
white foam that was used in the next reaction without further purification.  An analytical sample 
was prepared by chromatography on silica (gradient elution from CHCl3 with 0.1% AcOH to 
90:10 CHCl3/MeOH with 0.1% AcOH).  1H NMR (300 MHz, 75 °C, DMSO-d6) δ 12.12 (br s, 
1H), 7.84 (d, J = 7.1 Hz, 2H), 7.74 (br s, Fmoc-NH, 1H), 7.69 (d, J = 7.2 Hz, 2H), 7.42 – 7.29 
(m, 9H), 5.10 (s, 2H), 4.39 – 4.20 (br m, 4H), 4.06 (d, J = 11.3 Hz, 1H), 3.68 (d, J = 11.3 Hz, 
1H), 2.87 (br m, 1H), 2.36 (dd, J = 13.1, 5.14 Hz, 1H), 1.31 (s, 9H); 13C NMR (75.4 MHz, 
DMSO-d6): mixture of rotamers δ 172.6, 169.9, 155.4, 153.3, 143.4, 140.5, 136.4, 127.9 (CH), 
127.4 (CH), 127.3 (CH), 127.0 (CH), 126.7 (CH), 124.8 (CH), 119.6 (CH), 80.6, 65.9 (CH2), 
65.5 (CH2), 62.4 and 61.8, 58.5 (CH), 54.7 and 54.6 (CH2), 46.5 (CH), 39.4 and 38.3 (CH2), 28.0 
(CH3); IR (neat film): 3319, 3066, 2978, 1721, 1531, 1450, 1423, 1357, 1259, 1157, 1118, 1087, 
1044, 957, 911, 841, 760, 739, 698, 648 cm-1; [α]D 3.6° (c 9.9, CHCl3); ESI-MS m/z (ion): 586.2 
(M+), 609.2 (M + Na+), 625.2 (M + K+). 
 
(2S,4S)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-pyrrolidine-1,2,4-tricarboxylic acid 1-
benzyl ester 2-tert-butyl ester 4-methyl ester (17) 
Unpurified 16 (20.5 g, 35.0 mmol, assuming quantitative conversion of 15 to 16) was transferred 
to a 500 mL round bottom flask containing a stir bar.  Anhydrous Et2O (208 mL) was added to 
the flask, followed by anhydrous methanol (142 mL).  The flask was fitted with a pressure-
equalizing dropping funnel that was charged with a 2 M solution of TMS-CHN2 in Et2O.  The 
dropping funnel was capped with a rubber septum containing two needles: one for a nitrogen 
line, and another for pressure release.  The TMS-CHN2 solution was added very slowly to the 
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stirred solution of 16 causing the reaction mixture to bubble gently.  When the reaction mixture 
had developed a persistent yellow color (after addition of approximately 30 mL of the TMS-
CHN2 solution), TLC analysis revealed complete consumption of the starting material (1:1 
EtOAc/hexanes, 16 Rf = 0.05, 17 Rf = 0.49).  Residual TMS-CHN2 was quenched by extremely 
slow addition of a 9:1 MeOH/AcOH solution.  The reaction mixture was concentrated by rotary 
evaporation and purified by chromatography on silica (gradient elution from hexanes to 1:1 
EtOAc/hexanes).  Fractions containing the desired product were pooled and concentrated, then 
residual solvent was removed under reduced pressure affording 17 (19.5 g, 32.5 mmol, 92% 
from 15) as a white foam.  1H NMR (300 MHz, 75 °C, DMSO-d6): δ 7.83 (d, J = 7.5 Hz, 2H), 
7.66 (d, J = 7.5 Hz, 2H), 7.59 (br s, Fmoc-NH, 1H), 7.42 – 7.31 (m, 9H), 5.09 (s, 2H), 4.43 – 
4.18 (m, 4H), 4.01 (d, J = 11.4 Hz, 1H), 3.61 (s, 3H), 3.59 (d, overlap with –CO2CH3, 1H), 2.80 
(dd, J = 13.6, 8.9 Hz, 1H), 2.27 (dd, J = 13.6, 5.9 Hz, 1H), 1.37 (s, 9H); 13C NMR (75.4 MHz, 
DMSO-d6): δ 171.7, 170.2 and 169.9, 155.7, 153.5 and 153.3, 143.6, 140.7, 136.6 and 136.4, 
128.3 (CH), 128.2 (CH), 127.6 (CH), 127.5 (CH), 127.3 (CH), 127.0 (CH), 125.2 (CH), 125.1 
(CH), 120.0 (CH), 81.0, 66.2 (CH2), 65.6 (CH2), 63.0 and 62.1, 58.3 and 58.0 (CH), 54.7 and 
54.3 (CH2), 52.7 (CH3), 46.5 (CH), 38.4 and 37.3 (CH2), 27.3 (CH3); IR (neat film): 2932, 2852, 
1743, 1716, 1653, 1557, 1540, 1450, 1418, 1356, 1297, 1249, 1157, 1108, 1084, 1049, 976, 750, 
741, 698 cm-1; [α]D 4.3° (c 4.4, CHCl3); EI-MS m/z (relative intensity) 600 (0.1%), 499 (0.5%), 
455 (1.05), 409 (0.1%), 393 (0.2%), 361 (0.2%), 322 (5.3%), 303 (3.0%), 277 (4.0%), 259 
(6.6%), 233 (8.2%), 216 (14.5%), 196 (6.0%), 178 (77.0%), 165 (24.0%), 126 (7.5%), 91 
(100%); ESI-MS m/z (ion): 623.2 (M + Na+), 639.2 (M + K+); HRMS-EI calcd for C34H36N2O8 
(M•+) 600.2472, found 600.2523. 
 
(2S,4S)-4-(9H-Fluoren-9-yloxycarbonylamino)-pyrrolidine-1,2,4-tricarboxylic acid 1-benzyl 
ester 4-methyl ester (18) 
A solution of 17 (2.25 g, 3.75 mmol) in dichloromethane (1.0 mL) was added to a 100 mL round 
bottom flask equipped with a stir bar. TFA (~25 mL) was added to the reaction flask, and the 
solution was stirred for 1 hour. The mixture was concentrated, and residual TFA was removed by 
dissolving the residue in toluene, then re-concentrating the solution using the rotary evaporator at 
50 °C 2 times.  The resulting yellow oil was dissolved in EtOAc (50 mL), transferred to a 
separatory funnel, and was washed with 2.5% aqueous NaHCO3 (25 mL), dilute aqueous HCl, 
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pH ~2 (25 mL), and brine (2 x 50 mL).  The EtOAc layer was dried over Na2SO4, the solution 
was concentrated, and residual solvent was removed under reduced pressure yielding 18 (1.8 g, 
3.4 mmol, 90%) as a foamy white solid, used without further purification.  1H NMR (300 MHz, 
75 °C, DMSO-d6): δ 7.83 (d, J = 7.3 Hz, 2H), 7.66 (d, J = 7.5 Hz, 2H), 7.62 (s, Fmoc-NH, 1H), 
7.39 – 7.29 (m, 9H), 5.11 (s, 2H), 4.39 – 4.35 (m, 3H), 4.21 (t, J = 6.5 Hz, 1H), 4.10 (d, J = 11.5 
Hz, 1H), 3.61 (s, 3H), 3.59 (d, overlap with -CO2CH3, 1H), 2.84 (dd, J = 13.6, 8.9 Hz, 1H), 2.29 
(dd, J = 13.6, 6.4 Hz, 1H); 13C NMR (75.4 MHz, DMSO-d6): mixture of rotamers δ 172.1, 171.8, 
155.4, 153.4, 143.5 and 143.4, 140.5, 139.2, 136.5, 128.0 (CH), 127.4 (CH), 127.3 (CH), 126.9 
(CH), 126.7 (CH), 124.3 (CH), 119.7 (CH), 66.0 (CH2), 65.6 (CH2), 62.6 and 61.9, 57.6 (CH), 
54.7 (CH2), 52.3 (CH3), 46.5 (CH), 38.3 and 37.3 (CH2); IR (neat film): 3314, 3037, 2952, 1710, 
1529, 1450, 1422, 1356, 1297, 1250, 1215, 1109, 1085, 1051, 973, 769, 741, 697 cm-1; [α]D -
31.6° (c 9.7, CHCl3); EI-MS m/z (relative intensity) 544 (0.4%), 439 (0.6%), 365 (0.5%), 259 
(1.3%), 231 (3.5%), 217 (2.1%), 178 (100%), 165 (22.3%), 152 (5.0%), 126 (14.5%), 114 
(6.7%), 91 (57.4%); HRMS-EI calcd for C30H28N2O8 (M•+) 544.1846, found 544.1833. 
 
(2S,4S)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-pyrrolidine-1,2,4-tricarboxylic acid 1-
tert-butyl ester 4-methyl ester (19) 
Compound 17 (6.30 g, 11.5 mmol) was transferred to a 500 mL round bottom flask containing a 
magnetic stir bar, then dissolved in 1:1 CH2Cl2/TFA (210 mL).  The reaction mixture was stirred 
at room temperature and monitored by TLC (5:1 CHCl3/MeOH, 17 Rf = 0.7, 18 Rf = 0.4).  When 
all of the starting material was consumed (approximately 4 h), the solution was concentrated by 
rotary evaporation.  Residual solvent was removed under reduced pressure overnight.  Pd/C (10 
wt. %, 1.1 g), THF (300 mL), and Boc2O (7.2 mL, 32 mmol) were added to the flask, and the 
solution was degassed under reduced pressure, then back-filled with H2 gas. The reaction 
mixture was stirred overnight under a H2 atmosphere (~ 1 atm). The reaction mixture was 
filtered, and the filtrate was concentrated by rotary evaporation to an oil, which was purified by 
chromatography on silica (gradient elution over 10 column volumes from CHCl3 to 10% 
MeOH/CHCl3). Fractions containing the desired product were concentrated, and residual solvent 
was removed under reduced pressure giving 19 (4.5 g, 8.8 mmol, 83% from 17) as a white foam.  
1H NMR (300 MHz, DMSO-d6): mixture of rotamers δ 8.32 (s, Fmoc–NH, 1H), 7.93 (d, J = 7.4 
Hz, 2H), 7.75 (d, J = 7.1 Hz, 2H), 7.48 – 7.35 (m, 4H), 4.29 – 3.94 (m, 5H), 3.58 (s, 3H), 3.41 – 
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3.32 (m, 1H), 2.76 – 2.59 (m, 1H), 2.18 – 2.08 (m, 1H), 1.39 and 1.34 (s, 9H, rotameric); 13C 
NMR (75.4 MHz, DMSO-d6): mixture of rotamers δ 174.9, 172.4, 155.6, 153.4 and 153.3, 143.6 
and 143.5, 140.6, 127.5 (CH), 127.0 (CH), 125.1 (CH), 120.0 (CH), 78.7 and 78.5, 65.6 (CH2), 
62.6 and 61.9, 59.1 and 58.9 (CH), 55.0 and 54.5 (CH2), 52.3 (CH3), 46.5 (CH), 39.3 and 38.4 
(CH2), 28.0 and 27.9 (CH3, 3C); IR (neat film): 3307, 3016, 2979, 1744, 1529, 1477, 1450, 1408, 
1369, 1254, 1156, 1088, 1050, 972, 913, 858, 759, 667 cm-1; [α]D -61.8° (c 1.42, CHCl3); ESI-
MS m/z (relative intensity): 533.2 (100%, M + Na+), 477.1 (35%), 433.1 (90%), 411.2 (20%); 
HRESIQTOFMS calcd for C27H30N2NaO8 (M + Na+) 533.1900, found 533.1887. 
 
(2R,4R)-4-Hydroxypyrrolidine-1,2-dicarboxylic acid 1-benzyl ester (20) 
Commercially available trans-4-hydroxy-L-proline (2) was converted in modest yield to cis-4-
hydroxy-D-proline (31) using a method described elsewhere.115  cis-4-Hydroxy-D-proline (31, 
9.50 g, 72.4 mmol) and a magnetic stir bar were added to a 250 mL three neck round bottom 
flask fitted with a reflux condenser, rubber septum and nitrogen inlet adapter.  The flask was 
flushed with nitrogen, and then the amino acid was suspended in CH2Cl2 (155 mL).  DIPEA 
(36.8 mL, 212 mmol) was added to the suspension followed by TMS-Cl (27.7 mL, 217 mmol), 
which was added slowly via syringe through the rubber septum. The reaction mixture was heated 
to reflux and stirred vigorously for 1.5 hours.  The resulting red-orange solution was cooled to 0 
°C using an ice bath.  Cbz-Cl (9.8 mL, 69 mmol) was added to the solution in one portion while 
nitrogen was flushed through the flask.  The solution was allowed to warm to room temperature 
overnight with stirring, and was then concentrated by rotary evaporation.  The resulting paste 
was dissolved in 2.5% aqueous NaHCO3 (700 mL) and diethyl ether (600 mL) and transferred to 
a 2000 mL separatory funnel.  The aqueous layer was separated and washed with ether (2 × 150 
mL).  The ether layers were combined and backwashed with water (2 × 60 mL).  All of the 
aqueous layers were combined and acidified to pH 2 with 1 M aqueous HCl.  The aqueous 
solution was transferred to another separatory funnel, and the product was extracted with ethyl 
acetate (3 × 250 mL).  The ethyl acetate layers were combined, dried over Na2SO4, and filtered.  
The solvent was removed by rotary evaporation and then under reduced pressure overnight 
yielding the desired product 20 (17.8 g, 67.5 mmol, 97.6%) as a straw-colored foam used without 
further purification.  1H NMR (300 MHz, 75 °C, DMSO-d6): δ 7.29 – 7.35 (m, 5H), 5.07 (s, 2H), 
4.24 – 4.30 (m, 2H), 3.63 (dd, J = 10.8, 5.7 Hz, 1H), 3.24 (dd, J = 10.8, 3.9 Hz, 1H), 2.38 (ddd, J 
 42 
= 13.7, 9.1, 5.7 Hz, 1H), 1.92 (m, 1H); 13C NMR (75.4 MHz, DMSO-d6): mixture of rotamers δ 
173.4 and 173.1, 154.1 and 153.9, 137.0, 128.4 and 128.3 (2C), 127.8 and 127.6, 127.5 and 
127.1 (2C), 68.6 and 67.7, 65.9, 57.7 and 57.3, 54.6 and 54.1, 37.7; IR (neat film): 3419, 2953, 
1685, 1498, 1428, 1358, 1210, 1123, 1084, 1003, 969 cm-1; [α]D 28.1° (c 9.71, CHCl3); EI-MS 
m/z (relative intensity) 265 (20%), 220 (83%), 176 (34%), 130 (35%), 108 (5.5%), 91 (100%); 
HRMS-EI calcd for C13H15NO5 (M•+) 265.0950, found 265.0954. 
 
(R)-4-Oxopyrrolidine-1,2-dicarboxylic acid 1-benzyl ester (21) 
An 8 molar solution of Jones reagent was prepared as described elsewhere.  Compound 20 (17.8 
g, 67.1 mmol) was dissolved in acetone (1350 mL) and transferred to a 2 L Erlenmeyer flask.  
The solution was mixed with an overhead mechanical stirrer while adding the Jones reagent 
(72.2 mL, 577 mmol) slowly (over approximately 10 minutes).  As the reaction mixture was 
stirred, the color of the solution changed from bright red to dark brown.  This solution was 
stirred for an additional 3 hours, and then the excess oxidant was consumed by slow addition of 
MeOH (~ 50 mL).  The solution was filtered through a Celite packed chromatography column in 
order to remove precipitated chromium salts, concentrated by rotary evaporation, and diluted 
with EtOAc (1000 mL).  The resulting solution was transferred to a 2 L separatory funnel, 
washed with brine (6 × 250 mL), dried over Na2SO4, filtered, and concentrated by rotary 
evaporation.  Residual solvent was evaporated under reduced pressure, yielding the product 21 
(15.7 g, 59.9 mmol, 89.3%) as a pale yellow oil, which was used without further purification.  1H 
NMR (300 MHz, 75 °C, DMSO-d6): δ 12.42 (br s, 1H), 7.13 – 7.05 (m, 5H), 4.90 (s, 2H), 4.47 
(dd, J = 10.5, 2.4 Hz, 1H), 3.69 (d, J = 18.3 Hz, 1H), 3.52 (d, J = 18.3 Hz, 1H), 2.89 (dd, J = 
18.6, 10.5 Hz, 1H), 2.28 (dd, J = 18.6, 2.4 Hz, 1H); 13C NMR (75.4 MHz, 75 °C, DMSO-d6): δ 
207.6, 172.3, 153.7, 136.1, 127.9 (CH, 2C), 127.3 (CH), 126.9 (CH, 2C), 66.1 (CH2), 55.7 (CH), 
52.0 (CH2), 40.3 (CH2); IR (neat film): 3035, 1766, 1713, 1587, 1499, 1433, 1360, 1264, 1163, 
1028, 959, 874, 699 cm-1; EI-MS m/z (relative intensity) 263 (6.5%), 218 (9.5%), 174 (12%), 
128 (58%), 108 (31%), 91 (100%); HRMS-EI calcd for C13H13NO5 (M•+) 263.0794, found 
263.0803. 
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(R)-4-Oxopyrrolidine-1,2-dicarboxylic acid 1-benzyl ester 2-tert-butyl ester (22) 
A 500 mL round bottom flask containing a stir bar was charged with a solution of 21 (17.0 g, 
64.6 mmol) in CH2Cl2 (130 mL).  The solution was cooled to 0 °C using an ice bath, and 
concentrated sulfuric acid (645 μl) was added with stirring.  Isobutylene was bubbled into the 
solution until the volume of the mixture had increased by ~ 50%.  The flask was sealed with a 
rubber septum secured with a plastic strap, and the reaction mixture was stirred overnight while 
warming to room temperature.  The septum was then carefully punctured, allowing the 
isobutylene to evaporate.  The remaining solution was concentrated by rotary evaporation, and 
the resulting residue was distributed between EtOAc (500 mL) and 2.5% aqueous NaHCO3 (125 
mL).  The EtOAc was washed with additional NaHCO3 solution (2 × 125 mL), and the aqueous 
layers were combined and backwashed with EtOAc (250 mL).  The combined organic layers 
were washed with brine, dried over Na2SO4, filtered, and concentrated by rotary evaporation.  
Residual solvent was evaporated under reduced pressure overnight, yielding the desired product 
22 (17.2 g, 53.9 mmol, 83.4%) as a yellow oil that was used without further purification. An 
analytical sample was prepared by silica column chromatography (1:2 EtOAc/hexanes, Rf = 
0.33).  1H NMR (300 MHz, 75 °C, DMSO-d6): δ 7.33 – 7.36 (m, 5H), 5.14 (s, 2H), 4.63 (d, J = 
10.3 Hz, 1H), 3.93 (d, J = 18.1 Hz, 1H), 3.73 (d, J = 18.1 Hz, 1H), 3.13 (dd, J = 18.5, 10.3 Hz, 
1H), 2.46 (d, J = 18.5 Hz, 1H), 1.35 (s, 9H); 13C NMR (75.4 MHz, DMSO-d6): mixture of 
rotamers δ 208.6, 208.0, 170.8, 170.6, 154.3, 153.7, 136.5, 136.3, 128.4, 128.3, 127.9, 127.5, 
81.7, 81.6, 66.5, 56.8, 56.6, 52.6, 52.3, 40.8, 27.4, 27.3; IR (neat film): 3066, 3034, 2979, 2934, 
1767, 1713, 1499, 1414, 1368, 1297, 1258, 1211, 1152, 1114, 1027, 967, 912, 836, 768, 699 cm-
1; EI-MS m/z (relative intensity) 263 (11%), 218 (27%), 174 (39%), 128 (53%), 91 (100%); 
HRMS-EI calcd for C13H13NO5 (M – C4H9• + H+) 263.0794, found 263.0789. 
 
(5R,8R)-2,4-Dioxo-1,3,7-triaza-spiro[4.4]nonane-7,8-dicarboxylic acid 7-benzyl ester 8-tert-
butyl ester (23) 
(5R,8S)-2,4-Dioxo-1,3,7-triaza-spiro[4.4]nonane-7,8-dicarboxylic acid 7-benzyl ester 8-tert-
butyl ester (24) 
A 350 mL pressure vessel was charged with ammonium carbonate (10.3 g, 107.2 mmol), 
potassium cyanide (2.10 g, 32.2 mmol) deionized water (54 mL) and a magnetic stir bar.  
Compound 22 (6.9 g, 22 mmol) was dissolved in DMF (54 mL) and added to the pressure vessel.  
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After sealing the vessel, the flask was warmed to 60 °C in an oil bath and the solution stirred for 
4 hours.  The pressure vessel was then cooled to room temperature, opened cautiously, and the 
solution and stir bar were transferred to a 250 mL Erlenmeyer flask.  The solution was adjusted 
to pH 6.5 by slow addition of 1M aqueous HCl, and diluted with EtOAc (200 mL) and water (~ 
600 mL).  The aqueous layer was removed and extracted with additional EtOAc (2 × 200 mL).  
The organic layers were combined, washed with brine (2 × 100 mL), dried over MgSO4, and 
concentrated by rotary evaporation yielding a crude mixture of the products 23 and 24 in a ratio 
of 5:1 (determined by 1H NMR by integration of the hydantoin amide proton).  The crude 
mixture of products was purified by flash chromatography on silica (gradient elution from 
CH2Cl2 to 95:5 CH2Cl2/MeOH).  Fractions containing the less polar diastereomer (determined by 
TLC, 95:5 CH2Cl2/MeOH, Rf = 0.21) were concentrated by rotary evaporation and then under 
reduced pressure overnight yielding 23 (4.3 g, 11 mmol, 52% recovered yield).  The fractions 
containing the more polar diastereomer (determined by TLC, 95:5 CH2Cl2/MeOH, Rf = 0.10) 
were similarly treated yielding 24 (1.0 g, 2.6 mmol, 12% recovered yield).  The stereochemical 
assignment of 23 and 24 was based upon the 2D-NMR analysis of their respective enantiomers.15 
 
Less polar 23: 
1H NMR (300 MHz, 75 °C, DMSO-d6): δ 10.64 (s, 1H), 7.64 (s, 1H), 7.34 (m, 5H), 5.10 (s, 2H),  
4.35 (apparent t, J = 7.8 Hz, 1H), 3.86 (d, J = 11.1 Hz, 1H), 3.49 (d, J = 11.1 Hz, 1H), 2.65 (dd, J 
= 13.1, 8.3 Hz, 1H), 2.09 (dd, J = 13.1, 7.7 Hz, 1H), 1.38 (s, 9H); 13C NMR (75.4 MHz, 75 °C, 
DMSO-d6): δ 176.1, 170.3, 155.5, 153.2, 136.2, 127.9 (2C), 127.4, 127.0 (2C), 81.0, 66.1, 64.1, 
58.4, 52.3, 37.6, 27.2 (3C); IR (neat film): 3242, 3068, 2979, 1783, 1724, 1499, 1417, 1356, 
1293, 1233, 1156, 1113, 1014, 833, 767, 698 cm-1; [α]D +11.9° (c 3.9, CHCl3); EI-MS m/z 
(relative intensity) 333 (13%), 288 (11%), 244 (16%), 198 (7.0%), 154 (9.5%), 91 (100%); 
HRMS-EI calcd for C15H15N3O6 (M – C4H9• + H+) 333.0955, found 333.0967. 
 
More polar 24: 
1H NMR (300 MHz, 75 °C, DMSO-d6): δ 10.68 (s, 1H), 8.40 (s, 1H), 7.36 (m, 5H), 5.10 (s, 2H), 
4.40 (apparent t, J = 8.4 Hz, 1H), 3.75 (dd, J = 11.2, 1.7 Hz, 1H), 3.58 (d, J = 11.2 Hz, 1H), 2.44 
(ddd, J = 13.2, 8.0, 1.7 Hz, 1H), 2.25 (dd, J = 13.2, 8.9, 1H), 1.37 (s, 9H); 13C NMR (75.4 MHz, 
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DMSO-d6): mixture of rotamers δ 173.9 and 173.8, 170.4 and 170.0, 156.0 and 155.9, 153.4 and 
153.3, 136.5 and 136.3, 128.3 and 128.2 (CH), 127.8 (CH), 127.4 and 127.3 (CH), 81.2 and 81.0, 
66.6 and 65.8, 66.4 and 66.2 (CH2), 58.9 and 58.3 (CH), 55.9 and 55.5 (CH2), 40.3 and 39.3 
(CH2), 27.5 and 27.3 (CH3, 3C); IR (neat film) 3246, 2980, 1781, 1733, 1498, 1418, 1367, 1312, 
1217, 1192, 1159, 1138, 1060, 1014, 977, 836, 755, 698 cm-1; [α]D +23.9° (c 2.5, CHCl3); EI-
MS m/z (relative intensity) 333 (0.5%), 288 (3.0%), 244 (5.2%), 198 (1.5%), 154 (5.2%), 121 
(6.2), 91 (100%); HRMS-EI calcd for C15H15N3O6 (M – C4H9• + H+) 333.0955, found 333.0963. 
 
(2R,4R)-4-Aminopyrrolidine-1,2,4-tricarboxylic acid 1-benzyl ester 2-tert-butyl ester (26) 
Compound 23 (16.8 g, 43.1 mmol) was dissolved in THF (647 mL) and transferred to a 1 L 
round bottom flask containing a magnetic stir bar.  The solution was cooled to 0 °C, and DMAP 
(263 mg, 2.16 mmol) was added to the flask followed by di-tert-butyl dicarbonate (28.2 g, 129 
mmol).  The reaction mixture was stirred under nitrogen while warming to room temperature.  
After three hours, the starting material 23 had been completely consumed (by TLC).  The 
solution was concentrated by rotary evaporation, and then filtered through a plug of silica with 
1:2 EtOAc/hexanes to remove DMAP from crude product 25.  The filtrate was concentrated and 
the resulting yellow oily residue was dissolved in THF (172 mL) and transferred to a 500 mL 
round bottom flask containing a magnetic stir bar.  To this solution was added a 2.0 M aqueous 
solution of potassium hydroxide (172 mL).  The reaction mixture was stirred vigorously for 30 
minutes.  The solution was then transferred to a 1 L separatory funnel with an additional volume 
of ether (172 mL) and agitated.  After the aqueous and organic layers had completely separated, 
the aqueous layer was transferred to a 250 mL beaker and cooled to 0 °C using an ice bath.  With 
mechanical stirring, this solution was acidified to pH 6.5 by slow addition of 2.0 M aqueous HCl, 
causing the precipitation of a fine, white solid.  The solution was filtered and the precipitate was 
washed with cold water (~ 100 mL).  The precipitate was crystallized from ~ 150 mL of a hot 2:1 
water/ethanol solution, yielding white needle-like crystals.  These were dried in a vacuum oven 
at 60 °C yielding 26 (mp 187 °C dec) (9.32 g, 25.6 mmol, 59.4% recovered yield from 23).  1H 
NMR (300 MHz, CD3COOD): mixture of rotamers δ 7.41 – 7.38 (m, 5H), 5.25 – 5.20 (m, 2H), 
4.56 – 4.52 (m, 1H), 4.14 (br s, 2H), 3.25 – 3.10 (m, 1H), 2.47 – 2.42 (m, 1H), 1.55 and 1.36 (s, 
9H, rotameric); 13C NMR (75.4 MHz, CD3COOD): mixture of rotamers δ 176.0, 172.7, 156.0 
and 155.8, 137.0, 129.5, 129.2, 129.1, 85.0, 69.2, 67.2 and 66.2 (CH2), 60.5 and 60.0 (CH), 55.8 
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and 55.4 (CH2), 39.1 and 38.1 (CH2), 28.0 (CH3, 3C); IR (crushed powder): 3500, 2977, 1707, 
1659, 1656, 1500, 1464, 1421, 1392, 1354, 1311, 1261, 1238, 1170, 1150, 1150, 1131, 1100, 
730; [α]D +25.8° (c 1.0, methanol); ESI-MS m/z (relative intensity, ion) 387 (19%, M + Na+), 
331 (100%, M – C4H9+ + H+ + Na+), 309 (11%, M – C4H9+ + H+), 265 (34%); HRESIQTOFMS 
calcd for C14H16N2O6 (M – C4H9+ + H+ + Na+) 331.0906, found 331.0894. 
 
(2R,4R)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-pyrrolidine-1,2,4-tricarboxylic acid 1-
benzyl ester 2-tert-butyl ester (27) 
Finely divided 26 (3.90 g, 10.7 mmol) was transferred to an oven dried 500 mL three neck flask 
with a magnetic stir bar.  This flask was placed in a vacuum oven for 4 hours under reduced 
pressure (50 °C, ~ 0.5 mm Hg) to remove any residual moisture.  After backfilling with nitrogen, 
the flask was fitted with a reflux condenser, nitrogen inlet adapter, glass stopper, and rubber 
septum.  After suspending the solid in CH2Cl2 (215 mL), DIPEA (4.50 mL, 25.8 mmol) was 
added to the suspension via syringe through the rubber septum.  This was followed by similar 
addition of TMS-Cl (2.73 mL, 21.5 mmol).  The flask was flushed with nitrogen, and the 
solution was refluxed for 1.5 hours.  The solution was cooled to 0 °C in an ice bath and 9-
fluorenylmethyl chloroformate (Fmoc-Cl, 2.5 g, 9.7 mmol) was added in one portion.  The 
reaction mixture was allowed to stir overnight while warming to room temperature.  The reaction 
mixture was concentrated by rotary evaporation to an oil which was dissolved in EtOAc (500 
mL) and transferred to a 1 L separatory funnel.  This solution was washed with 1M aqueous HCl 
(2 × 250 mL), then brine (250 mL).  The organic layer was dried over Na2SO4, filtered, and 
concentrated by rotary evaporation.  Residual solvent was removed under reduced pressure to 
give the desired product 27 (5.0 g, 8.5 mmol, 87%) as a white foamy solid which was used 
without further purification.  An analytical sample was prepared by chromatography on silica 
(gradient elution from CHCl3 to 95:5 CHCl3/MeOH).  1H NMR (300 MHz, 75 °C, DMSO-d6): δ 
12.46 (br s, 1H), 7.85 (d, J = 7.5 Hz, 2H), 7.74 (br s, Fmoc-NH, 1H), 7.69 (d, J = 7.4 Hz, 2H), 
7.42-7.29 (m, 9H), 5.09 (s, 2H), 4.50 – 4.20 (m, 4H), 4.02 (d, J = 11.2 Hz, 1H), 3.64 (d, J = 11.2 
Hz, 1H),  2.84 (m, 1H), 2.32 (dd, J = 13.4, 5.5 Hz, 1H), 1.37 (s, 9H); 13C NMR (75.4 MHz, 
DMSO-d6): mixture of rotamers δ 172.9, 170.2 and 169.9, 155.6, 153.5 and 153.3, 143.5, 140.7, 
136.6 and 136.4, 128.2 (CH), 128.1 (CH), 127.8 (CH), 127.6 (CH), 127.5 (CH), 127.2 (CH), 
127.1 (CH), 126.9 (CH), 125.1 (CH), 119.9 (CH), 80.8 and 80.7, 66.1 (CH2), 65.6 (CH2), 62.7 
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and 61.9, 58.6 and 58.3 (CH), 54.9 and 54.5 (CH2), 46.5 (CH), 41.5 (CH2), 37.5 and 37.5 (CH2), 
27.4 and 27.3 (CH3, 3C); IR (neat film): 3319, 2978, 1713, 1530, 1450, 1423, 1357, 1257, 1188, 
1157, 1119, 1087, 1045, 957, 911, 877, 841, 760, 739, 698 cm-1; [α]D -3.3° (c 2.4, CHCl3); ESI-
MS m/z (relative intensity): 767.2 (7.5%), 699.2 (12%), 631.2 (33%), 609.2 (100%), 553.2 
(70%), 487.2 (17%); HRESIQTOFMS calcd for C33H34N2NaO8 (M + Na+) 609.2213, found 
609.2225. 
 
(2R,4R)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-pyrrolidine-1,2,4-tricarboxylic acid 1-
benzyl ester 2-tert-butyl ester 4-methyl ester (28) 
A solution of 27 (14.2 g, 24.3 mmol) in anhydrous diethyl ether (150 mL) was transferred into a 
500 mL three neck flask containing a magnetic stir bar and equipped with a pressure equalizing 
dropping funnel.  Anhydrous methanol (98 mL, 2.4 mol) was added to the solution by syringe.  
A 2 M ethereal solution of TMS-CHN2 (~ 20 mL, 40 mmol) was loaded into the dropping funnel 
under a N2 atmosphere.  The TMS-CHN2 solution was added to the reaction mixture dropwise 
until the solution developed a persistent yellow color, at which time the starting material had 
been completely consumed (determined by TLC, 1:2 EtOAc/hexanes, Rf = 0.2).  The flask was 
immersed in an ice bath and a 9:1 MeOH/AcOH solution (48 mL) was slowly added to quench 
residual TMS-CHN2.  The reaction mixture was concentrated by rotary evaporation to a yellow 
oil which was purified by chromatography on silica (gradient elution from hexanes to 1:1 
EtOAc/hexanes).  Fractions containing the desired product were concentrated by rotary 
evaporation.  Residual solvent was removed under reduced pressure overnight giving the product 
28 as a white foam (13.4 g, 22.2 mmol, 91%).  1H NMR (300 MHz, 75 °C, DMSO-d6): δ 7.86 (d, 
J = 7.4 Hz, 3H, overlap with Fmoc-NH), 7.66 (d, J = 7.5 Hz, 2H), 7.41 – 7.32 (m, 9H), 5.09 (s, 
2H), 4.40 – 4.20 (m, 4H), 3.97 (d, J = 11.3 Hz, 1H), 3.60 (m, 4H), 2.80 (br m, 1H), 2.27 (br m, 
1H), 1.36 (s, 9H); 13C NMR (75.4 MHz, DMSO-d6): mixture of rotamers δ 171.8 and 171.7, 
170.2 and 169.8, 155.7, 153.5 and 153.3, 143.5, 140.6, 136.6 and 136.4, 128.3 (CH), 128.1 (CH), 
127.8 (CH), 127.7 (CH), 127.5 (CH), 127.4 (CH), 127.2 (CH), 126.9 (CH), 125.1 (CH), 125.0 
(CH), 120.0 (CH), 80.9 and 80.8, 66.2 (CH2), 65.6 (CH2), 63.0 and 62.1, 58.4 and 58.0 (CH), 
54.7 and 54.3 (CH2), 52.6 (CH3), 46.5 (CH), 38.4 and 37.4 (CH2), 27.4 and 27.3 (CH3, 3C); IR 
(neat film): 3320, 2977, 1743, 1711, 1526, 1450, 1417, 1356, 1296, 1246, 1157, 1114, 1084, 
979, 918, 843, 760, 740, 698 cm-1; [α]D -3.6° (c 2.0, CHCl3); ESI-MS m/z (relative intensity): 
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681.5 (4.5%), 623.4 (100%), 567.4 (45%), 501.4 (13%); HRESITOFMS calcd for 
C34H36N2NaO8 (M + Na+) 623.2369, found 623.2360. 
 
(2R,4R)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-pyrrolidine-1,2,4-tricarboxylic acid 1-
benzyl ester 4-methyl ester (29) 
Compound 28 (4.1 g, 6.8 mmol) was transferred to a 200 mL round bottom flask with a magnetic 
stir bar and dissolved in a solution of 1:1 TFA/CH2Cl2 (70 mL).  The reaction mixture was 
stirred for 4 h and then concentrated by rotary evaporation; the resulting oily residue was 
dissolved in toluene and concentrated again.  Solvent was removed under vacuum overnight, 
yielding 29 (3.4 g, 6.4 mmol, 94%) as a foam, used without further purification.  An analytical 
sample was purified by chromatography on silica (gradient elution over 14 column volumes from 
CHCl3 (0.1% AcOH) to 95:5 CHCl3/MeOH (0.1% AcOH)).  1H NMR (300 MHz, 75 °C, 
DMSO-d6): δ 7.96 (br s, Fmoc-NH, 1H), 7.86 (d, J = 9.3 Hz, 2H), 7.68 (d, J = 7.5 Hz, 2H), 7.43 
– 7.31 (m, 9H), 5.11 (s, 2H), 4.36 (m, 3H), 4.22 (apparent t, J = 6.3 Hz, 1H), 4.08 (d, J = 9.0 Hz, 
1H), 3.61 (s, 3H), 3.58 (overlap with –CO2CH3, 1H), 2.84 (m, 1H), 2.28 (dd, J = 12.8, 5.6 Hz, 
1H); 13C NMR (75.4 MHz, DMSO-d6): mixture of rotamers δ 172.5, 172.2, 171.9, 155.6, 153.6 
and 153.3, 143.5 and 143.4, 140.6, 136.5, 128.2 (CH), 128.1 (CH), 127.7 (CH), 127.4 (CH), 
127.3 (CH), 126.9 (CH), 125.0 (CH), 119.9 (CH), 66.1 (CH2), 65.6 (CH2), 62.7 and 61.9, 57.7 
and 57.4 (CH), 54.8 and 54.4 (CH2), 52.5 (CH), 46.5 (CH3), 37.6 and 37.5 (CH2); IR (neat film): 
3308, 3065, 2953, 1715, 1529, 1450, 1423, 1357, 1251, 1110, 1085, 1051, 973, 826, 760, 740, 
699 cm-1; [α]D +31.3° (c 1.4, CHCl3); HPLC: C18 column, mobile phase, CH3CN (0.05% 
TFA)/water (0.1% TFA), 5% to 95% CH3CN over 30 min, 1.00 mL/min, UV detection at 274 
nm; tR for 29, 23.80 min; ESI-MS m/z (relative intensity): 567.2 (100%), 501.2 (11%); 
HRESIQTOFMS calcd for C30H28N2NaO8 (M + Na+) 567.1743, found 567.1743. 
 
(2R,4R)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-pyrrolidine-1,2,4-tricarboxylic acid 1-
tert-butyl ester 4-methyl ester (30) 
Compound 28 (13.4 g, 22.2 mmol) was transferred to a 500 mL round bottom flask containing a 
magnetic stir bar, then dissolved in 1:1 CH2Cl2/TFA (222 mL).  The reaction mixture was stirred 
at room temperature and monitored by TLC (1:2 EtOAc/hexanes, 28 Rf = 0.24, 29 Rf = 0.07).  
When all of the starting material was consumed, the solution was concentrated by rotary 
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evaporation.  A portion of toluene was added to the flask, and the solution was concentrated 
again.  Residual solvent was removed under reduced pressure overnight.  Pd/C (10 wt. %, 1.1 g), 
THF (635 mL), and Boc2O (12.1 g, 55.6 mmol) were added to the flask, and the solution was 
degassed under reduced pressure, then back-filled with H2 gas. The reaction mixture was stirred 
overnight under a H2 atmosphere (~ 1 atm). The reaction mixture was filtered, and the filtrate 
was concentrated by rotary evaporation to an oil, which was purified by chromatography on 
silica (gradient elution from CHCl3 to 10% MeOH/CHCl3). Fractions containing the desired 
product were concentrated, and residual solvent was removed under reduced pressure giving 30 
(9.3 g, 18.2 mmol, 82% from 30) as a white foam.  1H NMR (300 MHz, DMSO-d6): mixture of 
rotamers δ 8.29 (s, Fmoc-NH, 1H), 7.88 (d, J = 7.4 Hz, 2H), 7.71 (d, J = 7.1 Hz, 2H), 7.44 – 7.31 
(m, 4H), 4.31 – 4.20 (m, 4H, rotameric), 3.98 (apparent dd, J = 24.3, 11.2 Hz, 1H), 3.60 (s, 3H), 
3.48 (apparent t, J = 10.4 Hz, 1H), 2.89 – 2.76 (m, 1H), 2.29 – 2.20 (m, 1H), 1.41 and 1.36 (s, 
9H, rotameric); 13C NMR (75.4 MHz, DMSO-d6): mixture of rotamers δ 173.5, 172.2, 155.7, 
153.3, 152.9, 143.6 and 143.5, 140.7, 127.6 (CH), 127.0 (CH), 125.2 (CH), 120.0 (CH), 79.0, 
65.6 (CH2), 62.7 and 61.9, 58.1 and 57.7 (CH), 54.8 and 54.4 (CH2), 52.5 (CH3), 46.6 (CH), 38.8 
and 37.9 (CH2), 28.0 and 27.8 (CH3, 3C); IR (neat film): 3307, 3016, 2979, 1744, 1530, 1477, 
1450, 1409, 1368, 1297, 1253, 1217, 1160, 1088, 1050, 972, 913, 858, 759, 667 cm-1; [α]D 
+61.8° (c 1.9, CHCl3); HPLC: C18 column, mobile phase, CH3CN (0.05% TFA)/water (0.1% 
TFA), 5% to 95% CH3CN over 30 min, 1.00 mL/min, UV detection at 274 nm, tR for 30, 23.20 
min; ESI-MS m/z (relative intensity): 533.2 (100%, M + Na+), 477.1 (30%), 433.1 (90%); 
HRESIQTOFMS calcd for C27H30N2NaO8 (M + Na+) 533.1900, found 533.1904. 
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Figure 2-14: Phenethylamine derivatives of the Boc-pro4(2S,4S) and Boc-pro4(2R,4R) 
 
(3S,5S)-3-(9H-Fluoren-9-ylmethoxycarbonylamino)-5-((S)-1-phenylethylcarbamoyl)-
pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-methyl ester (32) 
(3S,5S)-3-(9H-Fluoren-9-ylmethoxycarbonylamino)-5-((R)-1-phenylethylcarbamoyl)-
pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-methyl ester (33) 
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(3R,5R)-3-(9H-Fluoren-9-ylmethoxycarbonylamino)-5-((S)-1-phenylethylcarbamoyl)-
pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-methyl ester (42) 
(3R,5R)-3-(9H-Fluoren-9-ylmethoxycarbonylamino)-5-((R)-1-phenylethylcarbamoyl)-
pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-methyl ester (43) 
General procedure for the preparation of the methylbenzylamine derivatives of monomers 30 and 
19: 
Two 4 mL conical vials with magnetic spin vanes were dried in an oven. To each vial was added 
the monomer (~ 5 mg), HATU (3.7 mg, 9.8 μmol), DIPEA (3.2 μL, 19.6 μmol) and CH2Cl2 (~ 
100 μL). L(-)-α-methylbenzylamine (2 μL, 9.8 μmol) was added to the solution in the first vial, 
and D(+)-α-methylbenzylamine (2 μL, 9.8 μmol) was added to the second. The addition of the 
amine to the solution caused an immediate color change from pale to bright yellow.  The vials 
were sealed with a rubber septum, and the solutions were stirred for an additional 30 minutes at 
room temperature.  pH 4 aqueous HCl (2 mL) was added to each vial, and the mixture was 
extracted with CHCl3 (2 mL). The CHCl3 extracts were washed with brine, dried over Na2SO4, 
filtered, and then concentrated by centrifugal evaporation.  The residues were dissolved in 
CH3CN (~ 2 mL), filtered through 0.2 μm nylon filters into vials, and analyzed by HPLC using 
appropriate gradient elution methods. 
Compound 32, Compound 33 
HPLC: column, Microsorb 100 C18, 4.6 mm × 250 mm; mobile phase, CH3CN (0.05% TFA) / 
water (0.1% TFA), 50% to 95% CH3CN over 30 minutes; flow rate, 1.00 mL / min; UV 
detection at 274 nm; tR for 32, 17.4 min: tR for 33, 18.4 min. 
Compound 42, Compound 43 
HPLC: column, Microsorb 100 C18, 4.6 mm × 250 mm; mobile phase, CH3CN (0.05% TFA) / 
water (0.1% TFA), 5% to 95% CH3CN over 30 minutes; flow rate, 1.00 mL / min; UV detection 
at 274 nm; tR for 42, 27.4 min: tR for 43, 27.9 min. 
 
(2S,4R)-4-Amino-pyrrolidine-1,2,4-tricarboxylic acid 1-benzyl ester 2-tert-butyl ester (34) 
13 (3.7 g, 9.6 mmol) was dissolved in THF (144 mL) and transferred to a round bottom flask 
containing a magnetic stir bar.  DMAP (59 mg, 0.48 mmol) was added to the solution, and the 
flask was sealed with a rubber septum and flushed with nitrogen.  The flask was then submerged 
in an ice bath.  Boc2O (6.3 grams, 29 mmol) was added to the solution in one portion.  This 
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mixture was stirred under nitrogen and the reaction progress was monitored by TLC (1:2 
EtOAc/hexanes, 13 Rf = 0.1, product Rf = 0.5).  When the starting material was entirely 
consumed (about 4 hours) the solution was concentrated by rotary evaporation, and the residue 
was dissolved in 1:2 EtOAc/hexanes.  This solution was filtered through a short silica plug to 
remove DMAP.  All fractions containing the desired product (determined by TLC) were pooled 
and concentrated by rotary evaporation; residual solvent was removed under reduced pressure 
overnight.  The resulting white foam was dissolved in THF (38 mL).  2 M aqueous KOH (38 
mL) was added to this solution.  This biphasic mixture was stirred vigorously for 40 minutes.  
Et2O (~ 60 mL) was added to the reaction mixture, and the entire solution was transferred to a 
250 mL separatory funnel.  The solution was agitated then allowed to separate entirely.  The 
aqueous layer was removed and the organic layer washed with water (1 × 15 mL); the aqueous 
layers were combined in a beaker.  This beaker was submerged in an ice bath.  The solution was 
adjusted to pH ≈ 6.5 by slow addition of 2 M aqueous HCl under mechanical stirring.  The 
resulting precipitate was filtered from the solution, dried under reduced pressure overnight at 50 
°C then crystallized from hot methanol affording the desired product 34 (2.0 g, 5.4 mmol, 56% 
yield over two steps) as white needle-like crystals (mp 255 °C dec).  1H NMR (300 MHz, 
CD3COOD): mixture of rotamers δ 7.40 (m, 5H), 5.20 (m, 2H), 4.57 (apparent ddd, J = 8.5, 8.4, 
5.4 Hz, 1H), 4.21 (apparent dd, J = 12.3, 6.5 Hz, 1H), 4.05 (apparent t, J = 12.8 Hz, 1H), 2.87 
(m, 1H), 2.75 (m, 1H), 1.47 and 1.39 (s, 9H, rotameric); 13C NMR (75.4 MHz, CD3COOD): 
mixture of rotamers δ 172.8, 171.8 and 171.6, 156.3 and 156.0, 137.4 and 137.1, 129.5 (CH), 
129.3 (CH), 129.1 (CH), 128.8 (CH), 83.7, 69.0 and 68.8 (CH2), 67.4 and 66.6, 59.9 and 59.5 
(CH), 55.7 and 55.4 (CH2), 39.9 and 39.0 (CH2), 28.2 (3C, CH3); IR (crushed powder): 2981, 
1743, 1705, 1641, 1498, 1453, 1426, 1369, 1283, 1231, 1158, 1116, 1030, 984, 955, 919, 853, 
819, 759 cm-1; [α]D -36.2° (c 0.66, AcOH); ESI-MS m/z (relative intensity): 365.2 (100%, M + 
H+), 387.2 (45%, M + Na+), 403.1 (3%, M + K+); HRESIQTOFMS calcd for C18H25N2O6 (M + 
H+) 365.1713, found 365.1704. 
 
(2S,4R)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-pyrrolidine-1,2,4-tricarboxylic acid 1-
benzyl ester 2-tert-butyl ester (35) 
Finely divided 34 (2.9 g, 7.9 mmol) and a magnetic stir bar were added to a 250 mL 3-neck 
round bottom flask equipped with a nitrogen inlet adapter and a reflux condenser.  CH2Cl2 (160 
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mL) was added to the flask, and the suspension was stirred vigorously.  DIPEA (3.5 mL, 20 
mmol) was added to the suspension by syringe, followed by TMS-Cl (2.0 mL, 16 mmol).  The 
flask was flushed with nitrogen, and then the solution was refluxed for 1 hour.  The reaction 
mixture was cooled to 0 °C in an ice bath, and Fmoc-Cl (2.0 g, 7.6 mmol) was added to the flask 
in one portion.  The mixture was allowed to warm to room temperature overnight with stirring.  
The solution was concentrated by rotary evaporation, and the residue dissolved in EtOAc (500 
mL).  This solution was transferred to a separatory funnel and washed with 1 M aqueous HCl (2 
× 100 mL) then brine (1 × 100 mL), dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  The resulting white foam was purified by chromatography on silica (gradient 
elution over 14 column volumes from CHCl3 (0.1% AcOH) to 95:5 CHCl3/MeOH (0.1% 
AcOH)).  Desired fractions were pooled and concentrated, and residual solvent was removed 
under reduced pressure overnight yielding 35 (4.1 g, 7.0 mmol, 93%) as a white foam.  1H NMR 
(300 MHz, 350 K, DMSO-d6): δ 12.60 (br s, 1H), 7.86 (d, J = 7.5 Hz, 2H), 7.81 (s, 1H, Fmoc-
NH), 7.68 (d, J = 7.4 Hz, 2H) 7.41 (t, J = 7.2 Hz, 2H), 7.32 (m, 7H), 5.08 (m, 2H), 4.32 (m, 3H), 
4.22 (t, J = 6.8 Hz, 1H), 4.07 (apparent dd, J = 11.3, 1.3 Hz, 1H), 3.73 (d, J = 11.3 Hz, 1H), 2.69 
(dd, J = 12.7, 8.2 Hz, 1H), 2.26 (dd, J = 13.0, 8.9 Hz, 1H), 1.92 (s, 9H); 13C NMR (75.4 MHz, 
DMSO-d6): mixture of rotamers δ 171.5 and 171.4, 170.4 and 170.0, 155.3, 153.8 and 153.7, 
143.6 and 143.5, 140.6, 136.5 and 136.2, 128.1 (CH), 127.9 (CH), 127.6 (CH), 127.4 (CH), 
127.2 (CH), 127.1 (CH), 126.9 (CH), 125.0 (CH), 119.9 (CH), 80.9 and 80.8, 66.2 and 66.0 
(CH2), 65.4 (CH2), 63.4 and 62.6, 58.5 and 58.0 (CH), 54.3 and 53.8 (CH2), 46.5 (CH), 38.7 and 
37.8 (CH2), 27.4 and 27.3 (CH3); IR (thin film): 3317, 2979, 2613, 1709, 1586, 1529, 1450, 
1358, 1259, 1193, 1150, 1084, 1046, 987, 846, 758, 698, 667 cm-1; [α]D -35.4° (c 0.99, CHCl3); 
ESI-MS m/z (relative intensity): 553.2 (45%), 587.2 (30%), 604.3 (40%), 609.2 (100%); 
HRESIQTOFMS calcd for C33H34N2O8Na (M + Na+) 609.2207, found 609.2227. 
 
(2S,4R)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-pyrrolidine-1,2,4-tricarboxylic acid 1-
benzyl ester 2-tert-butyl ester 4-methyl ester (36) 
35 (5.2 g, 8.9 mmol) and a magnetic stir bar were transferred to a 200 mL round bottom flask.  
Anhydrous Et2O (53 mL) was added to the flask, which was then sealed with a rubber septum.  A 
needle connected to a nitrogen line was inserted into the septum, as well as a needle open to the 
air.  Anhydrous methanol (36.2 mL, 900 mmol) was added to the flask by syringe.  The solution 
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was stirred, and TMS-CHN2 (2 M in ether) was added dropwise from a syringe until there was a 
persistent yellow color in the solution (~ 10 to 15 mL of the TMS-CHN2 solution).  The reaction 
endpoint was confirmed by analytical TLC (5:1 CHCl3/MeOH, 35 Rf = 0.2, 36 Rf = 0.8).  Excess 
TMS-CHN2 was quenched by careful, slow addition of a 10% AcOH/MeOH solution to the 
reaction mixture (CAUTION: quenching the excess TMS-CHN2 generates a significant amount 
of nitrogen gas).  The solution was concentrated by rotary evaporation and the desired product 
was isolated through chromatography on silica (gradient elution over 14 column volumes from 
hexanes to 1:1 EtOAc/hexanes) giving 36 (4.6 g, 7.6 mmol, 85%) as a white foam.  1H NMR 
(300 MHz, 350 K, DMSO-d6): δ 7.94 (s, 1H, Fmoc-NH), 7.86 (d, J = 7.5 Hz, 2H), 7.67 (d, J = 
7.4 Hz, 2H), 7.41 (t, J = 7.2 Hz, 2H), 7.33 (m, 7H), 5.08 (m, 2H), 4.38 (m, 2H), 4.29 (m, 1H), 
4.22 (t, J = 6.6 Hz, 1H), 4.00 (d, J = 11.3 Hz, 1H), 3.72 (d, J = 11.4 Hz, 1H), 3.62 (s, 3H), 2.65 
(dd, J = 12.0, 8.2 Hz, 1H), 2.24 (dd, J = 12.4, 9.2 Hz, 1H), 1.38 (s, 9H); 13C NMR (75.4 MHz, 
DMSO-d6): mixture of rotamers δ 170.4 and 170.3, 169.9, 155.3, 153.7 and 153.3, 143.6 and 
143.4, 140.6, 136.4 and 136.2, 128.1 (CH), 127.7 (CH), 127.5 (CH), 127.3 (CH), 126.9 (CH), 
124.9 (CH), 119.9 (CH), 81.1 and 80.9, 66.3 and 66.1 (CH2), 65.3 (CH2), 63.3 and 62.6, 58.3 and 
57.8 (CH), 54.2 and 53.7 (CH2), 52.5 (CH3), 46.5 (CH), 38.5 and 37.6 (CH2), 27.4 and 27.3 
(CH3); IR (thin film): 3319, 2979, 1702, 1529, 1421, 1358, 1244, 1192, 1150, 1081, 979, 847, 
741, 698, 667 cm-1; [α]D -34.6° (c 0.94, CHCl3); ESI-MS m/z (relative intensity): 501.2 (95%), 
623.2 (100%); HRESIQTOFMS calcd for C34H36N2O8Na (M + Na+) 623.2364, found 623.2357. 
 
(2S,4R)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-pyrrolidine-1,2,4-tricarboxylic acid 1-
benzyl ester 4-methyl ester (37) 
36 (5.3 g, 8.7 mmol) was dissolved in CH2Cl2 (43 mL) and transferred to a 200 mL round bottom 
flask containing a magnetic stir bar.  TFA (43 mL) was added to this solution.  The reaction 
mixture was stirred for 5 hours, and then concentrated by rotary evaporation; residual solvent 
was removed overnight under reduced pressure.  10 wt. % Pd/C (876 mg) was added to the 
resulting yellow-brown foam, which was then dissolved in THF (250 mL).  Melted Boc2O (6.0 
mL, 26 mmol) was added to the solution, and the reaction mixture was degassed by purging the 
flask under reduced pressure and backfilling with H2 gas several times.  The reaction mixture 
was then stirred vigorously under H2 (balloon) overnight.  The reaction was monitored by HPLC 
(C18 column; mobile phase, CH3CN (0.05% TFA)/water (0.1% TFA), 5% to 95% CH3CN over 
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30 min; flow rate, 1.00 mL/min; UV detection at 220 nm; Cbz-pro4(2S,4R) tR = 23.8 min, 37 tR 
= 23.0).  The catalyst was removed by filtration, and the solution was concentrated by rotary 
evaporation.  The product was purified by chromatography on silica (gradient elution over 14 
column volumes from CHCl3 to 10% MeOH/CHCl3).  The desired fractions were pooled and 
concentrated by rotary evaporation; residual solvent was removed under reduced pressure 
yielding 1 (4.3 g, 8.4 mmol, 95%) as a white foam.  1H NMR (300 MHz, DMSO-d6): mixture of 
rotamers δ 12.83 (br s, 1H), 8.18 (apparent d, J = 5.6, 1H, Fmoc-NH), 7.89 (d, J = 7.4 Hz, 2H), 
7.69 (t, J = 5.4 Hz, 2H), 7.42 (t, J = 7.3 Hz, 2H), 7.33 (t, J = 7.3 Hz, 2H), 4.38 (m, 2H), 4.20 (m, 
2H), 3.88 (apparent dd, J = 10.8, 6.5 Hz, 1H), 3.65 (apparent s, 1H, overlap with –COOCH3), 
3.61 (s, 3H), 2.59 (m, 1H), 2.19 (m, 1H), 1.35 (s, 9H); 13C NMR (75.4 MHz, DMSO-d6): mixture 
of rotamers δ 173.3 and 172.8, 170.7, 155.5, 153.5 and 152.8, 143.6 and 143.5, 140.7, 127.6 
(CH), 127.0 (CH), 125.1 (CH), 120.1 (CH), 79.4 and 79.3, 65.5 and 65.3 (CH2), 63.5 and 62.7, 
57.6 and 57.4 (CH), 54.0 and 53.6 (CH2), 52.6 (CH3), 46.6 (CH), 38.4 and 37.8 (CH2), 27.9 and 
27.8 (CH3); IR (thin film): 3323, 3015, 2979, 1725, 1529, 1477, 1450, 1415, 1369, 1321, 1247, 
1153, 1107, 1084, 931, 862, 758, 667 cm-1; [α]D -39.5° (c 1.41, CHCl3); ESI-MS m/z (relative 
intensity): 411.1 (100%), 533.2 (28%), 1043.4 (28%, 2M + Na+); HRESIQTOFMS calcd for 
C27H30N2O8Na (M + Na+) 533.1894, found 533.1917. 
 
 
HPLC: C18 column; mobile phase, CH3CN (0.05% TFA) / water (0.1% TFA), 5% to 95% CH3CN over 30 min; flow 
rate, 1.00 mL/min; UV detection at 220 nm; tR for 37, 23.0 min 
 
Figure 2-15: HPLC chromatogram of purified 37 
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(2R,4S)-4-Amino-pyrrolidine-1,2,4-tricarboxylic acid 1-benzyl ester 2-tert-butyl ester (38) 
24 (2.6 g, 6.7 mmol) was dissolved in THF (100 mL) and transferred to a round bottom flask 
containing a magnetic stir bar.  DMAP (41 mg, 0.33 mmol) was added to the solution, and the 
flask was sealed with a rubber septum and flushed with nitrogen.  The flask was then submerged 
in an ice bath.  Boc2O (4.4 g, 20 mmol) was added to the solution, and the mixture was stirred 
under nitrogen and monitored by TLC (1:2 EtOAc/hexanes, 24 Rf =  0.2, product Rf = 0.6) until 
the starting material was entirely consumed (about 4 hours).  The reaction mixture was 
concentrated by rotary evaporation, and the residue was dissolved in 1:2 EtOAc/hexanes; this 
solution was filtered through a silica plug to remove DMAP.  Fractions containing the desired 
product were pooled and concentrated by rotary evaporation; residual solvent was removed 
under reduced pressure overnight.  The resulting white foam was dissolved in THF (85 mL).  2 
M aq. KOH (85 mL) was added to this solution.  This biphasic mixture was stirred vigorously for 
35 minutes.  Et2O (~ 85 mL) was added to the mixture, and the entire solution was transferred to 
a 500 mL separatory funnel.  The solution was agitated and then allowed to separate entirely.  
The aqueous layer was removed and transferred to a beaker.  This beaker was submerged in an 
ice bath.  The solution was adjusted to pH ≈ 6.5 by slow addition of 2 M aqueous HCl under 
mechanical stirring.  The resulting precipitate was filtered from the solution, dried under reduced 
pressure overnight at 50 °C, and crystallized from hot methanol producing the desired product 38 
(1.7 g, 4.7 mmol, 73% yield over two steps) as white needle-like crystals (mp 253 °C dec).  1H 
NMR (300 MHz, CD3COOD): mixture of rotamers δ 7.37 (m, 5H), 5.20 (m, 2H), 4.61 (apparent 
t, J = 8.3 Hz, 1H), 4.25 (apparent dd, J = 12.4, 4.2 Hz, 1H), 4.04 (apparent t, J = 11.9 Hz, 1H), 
2.91 (m, 1H), 2.75 (m, 1H), 1.46 and 1.38 (s, 9H, rotameric); 13C NMR (75.4 MHz, CD3COOD): 
mixture of rotamers δ 172.4, 171.8 and 171.6, 156.2 and 156.0, 137.4 and 137.1, 129.5 (CH), 
129.2 (CH), 129.1 (CH), 128.8 (CH), 83.7, 69.0 and 68.8 (CH2), 67.0 and 66.2, 59.8 and 59.4 
(CH), 55.6 and 55.3 (CH2), 39.8 and 38.9 (CH2), 28.2 (CH3, 3C);  IR (crushed powder): 2980, 
1742, 1606, 1454, 1427, 1368, 1283, 1229, 1156, 1116, 984, 853, 756 cm-1; [α]D +37.2° (c 0.50, 
AcOH); ESI-MS m/z (relative intensity): 365.2 (100%, M + H+), 387.2 (45%, M + Na+), 403.1 
(3%, M + K+); HRESIQTOFMS calcd for C18H25N2O6 (M + H+) 365.1713, found 365.1717. 
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(2R,4S)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-pyrrolidine-1,2,4-tricarboxylic acid 1-
benzyl ester 2-tert-butyl ester (39) 
Finely divided 38 (1.5 g, 4.1 mmol) and a magnetic stir bar were added to a 250 mL 3-neck 
round bottom flask equipped with a nitrogen inlet adapter and a reflux condenser.  CH2Cl2 (160 
mL) was added to the flask, and the suspension was stirred vigorously.  DIPEA (1.7 mL, 10 
mmol) was added to the suspension by syringe, followed by TMS-Cl (1.1 mL, 8.3 mmol).  The 
flask was flushed with nitrogen, and then the solution was refluxed for ~ 2 hours.  The reaction 
mixture was cooled to 0 °C in an ice bath, and Fmoc-Cl (1.0 g, 3.9 mmol) was added to the flask 
in one portion.  The mixture was allowed to warm to room temperature overnight with stirring.  
The solution was concentrated by rotary evaporation and immediately purified by 
chromatography on silica (gradient elution over 14 column volumes from CHCl3 (0.1% AcOH) 
to 95:5 CHCl3/MeOH (0.1% AcOH)).  Desired fractions were pooled and concentrated, and 
residual solvent was removed under reduced pressure providing 39 (1.8 g, 3.1 mmol, 78%) as a 
white foam.  1H NMR (300 MHz, 350 K, DMSO-d6): δ 12.41 (br s, 1H), 7.86 (d, J = 7.5 Hz, 
2H), 7.81 (s, 1H, Fmoc-NH),  7.68 (d, J = 7.4 Hz, 2H), 7.41 (t, J = 7.2 Hz, 2H), 7.32 (m, 7H), 
5.08 (m, 2H), 4.33 (m, 3H), 4.22 (t, J = 6.8 Hz, 1H), 4.07 (apparent dd, J = 11.3, 1.4 Hz, 1H), 
3.74 (d, J = 11.3 Hz, 1H), 2.70 (dd, J = 12.7, 8.0 Hz, 1H), 2.26 (dd, J = 13.1, 8.9 Hz, 1H), 1.38 
(s, 9H); 13C NMR (75.4 MHz, DMSO-d6): mixture of rotamers δ 171.5 and 171.4, 170.4 and 
170.0, 155.3, 153.8 and 153.4, 143.6 and 143.5, 140.6, 136.5 and 136.2, 128.1 (CH), 127.6 (CH), 
127.5 (CH), 127.3 (CH), 127.1 (CH), 126.9 (CH), 125.0 (CH), 119.9 (CH), 81.0 and 80.8, 66.2 
and 66.0 (CH2), 65.4 (CH2), 63.4 and 62.6, 58.5 and 58.0 (CH), 54.3 and 53.8 (CH2), 46.5 (CH), 
38.7 and 37.8 (CH2), 27.4 and 27.3 (CH3); IR (thin film): 3322, 3018, 2979, 1713, 1531, 1450, 
1359, 1260, 1193, 1150, 1084, 1046, 987, 758, 698, 667, 621 cm-1; [α]D +39.1° (c 0.70, CHCl3); 
ESI-MS m/z (relative intensity): 569.1 (10%), 587.2 (30%), 604.3 (33%), 609.2 (100%); 
HRESIQTOFMS calcd for C33H34N2O8Na (M + Na+) 609.2207, found 609.2266. 
 
(2R,4S)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-pyrrolidine-1,2,4-tricarboxylic acid 1-
benzyl ester 2-tert-butyl ester 4-methyl ester (40) 
39 (1.8 g, 3.0 mmol) and a magnetic stir bar were transferred to a 100 mL round bottom flask.  
Anhydrous Et2O (15 mL) was added to the flask, which was then sealed with a rubber septum.  A 
needle connected to a nitrogen line was inserted into the septum, as well as a needle open to the 
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air.  Anhydrous methanol (15 mL) was added to the flask by syringe.  The solution was stirred, 
and TMS-CHN2 (2M in ether) was added dropwise from a syringe until there was a persistent 
yellow color in the solution.  The color change indicated the completion of the reaction, and was 
confirmed by analytical TLC (5:1 CHCl3/MeOH, 39 Rf = 0.2, 40 Rf = 0.8).  Excess TMS-CHN2 
was quenched by careful, slow addition of a 10% AcOH/MeOH solution to the reaction mixture.  
The solution was concentrated by rotary evaporation and the desired product purified by 
chromatography on silica (gradient elution over 14 column volumes from hexanes to 1:1 
EtOAc/hexanes) giving 40 (1.6 g, 2.7 mmol, 90%) as a white foam.  1H NMR (300 MHz, 350K, 
DMSO-d6): δ 7.93 (s, 1H, Fmoc-NH), 7.86 (d, J = 7.4 Hz, 2H), 7.66 (d, J = 7.4 Hz, 2H), 7.41 (t, 
J = 7.2 Hz, 2H), 7.32 (m, 7H), 5.08 (m, 2H), 4.38 (m, 2H), 4.29 (m, 1H), 4.22 (t, J = 6.6 Hz, 1H), 
3.99 (d, J = 11.3 Hz, 1H), 3.71 (d, J = 11.4 Hz, 1H), 3.61 (s, 3H), 2.64 (dd, J = 12.0, 8.2 Hz, 1H), 
2.23 (dd, J = 12.6, 9.1 Hz, 1H), 1.38 (s, 9H); 13C NMR (75.4 MHz, DMSO-d6): mixture of 
rotamers δ 170.4 and 170.3, 169.9, 155.3, 153.7 and 153.3, 143.6 and 143.4, 140.6, 136.4 and 
136.2, 128.1 (CH), 127.7 (CH), 127.4 (CH), 127.3 (CH), 126.8 (CH), 124.9 (CH), 119.9 (CH), 
81.1 and 80.9, 66.3 and 66.1 (CH2), 65.3 (CH2), 63.3 and 62.6, 58.3 and 57.8 (CH), 54.2 and 
53.7 (CH2), 52.5 (CH3), 46.5 (CH), 38.6 and 37.6 (CH2), 27.4 and 27.3 (CH3); IR (thin film): 
3319, 3011, 2979, 2953, 1713, 1528, 1450, 1422, 1359, 1243, 1192, 1150, 1081, 978, 847, 758, 
698, 667 cm-1; [α]D +40.3° (c 1.00, CHCl3); ESI-MS m/z (relative intensity): 567.2 (27%), 583.1 
(6%), 601.3 (8%), 618.3 (10%), 623.2 (100%); HRESIQTOFMS calcd for C34H36N2O8Na (M + 
Na+) 623.2364, found 623.2354. 
 
(2R,4S)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-pyrrolidine-1,2,4-tricarboxylic acid 1-
benzyl ester 4-methyl ester (41) 
40 (1.6 g, 2.7 mmol) was dissolved in CH2Cl2 (14 mL) and transferred to a 50 mL round bottom 
flask containing a magnetic stir bar.  Trifluoroacetic acid (14 mL) was added to the solution, the 
flask was sealed with a rubber septum, and the reaction mixture was stirred for approximately 4 
hours.  The reaction mixture was concentrated by rotary evaporation and residual solvent was 
removed under reduced pressure overnight.  The resulting yellow foam was dissolved in THF 
(77 mL) and transferred to a 200 mL round bottom flask containing a magnetic stir bar and 10 
wt. % Pd/C (270 mg).  Melted Boc2O (1.9 mL, 8.1 mmol) was added to the reaction mixture by 
syringe.  The solution was degassed by purging the flask under reduced pressure and backfilling 
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with H2 gas several times.  The solution was stirred overnight under an H2 atmosphere (balloon).  
The catalyst was removed by filtration, and the solution was concentrated by rotary evaporation.  
The product was isolated by chromatography on silica (gradient elution over 14 column volumes 
from CHCl3 to 10% MeOH/CHCl3).  Desired fractions were pooled and concentrated by rotary 
evaporation; residual solvent was removed under reduced pressure overnight affording 41 (1.1 g, 
2.2 mmol, 81%) as a white foam.  1H NMR (300 MHz, DMSO-d6): mixture of rotamers δ 12.69 
(br s, 1H), 8.19 (apparent d, J = 5.9 Hz, 1H, Fmoc-NH), 7.89 (d, J = 7.4 Hz, 2H), 7.69 (t, J = 5.1 
Hz, 2H), 7.42 (t, J = 7.3 Hz, 2H), 7.33 (t, J = 7.3 Hz, 2H), 4.35 (m, 2H), 4.20 (m, 2H), 3.89 
(apparent dd, J = 10.6, 6.2 Hz, 1H), 3.66 (apparent s, 1H, overlap with –COOCH3), 3.61 (s, 3H), 
2.59 (m, 1H), 2.21 (m, 1H), 1.36 (s, 9H); 13C NMR (75.4 MHz, DMSO-d6): mixture of rotamers 
δ 173.3 and 172.8, 170.7, 155.5, 153.5 and 152.8, 143.6, 140.7, 127.6 (CH), 127.0 (CH), 125.1 
(CH), 120.1 (CH), 79.4 and 79.3, 65.5 and 65.4 (CH2), 63.5 and 62.8, 57.6 and 57.4 (CH), 54.0 
and 53.7 (CH2), 52.6 (CH3), 46.6 (CH), 38.4 and 37.8 (CH2), 27.9 and 27.8 (CH3); IR (thin film): 
3318, 3016, 2978, 1725, 1529, 1477, 1450, 1415, 1369, 1321, 1247, 1152, 1106, 1084, 931, 862, 
758, 667 cm-1; [α]D +39.9° (c  1.06, CHCl3); ESI-MS m/z (relative intensity): 411.1 (100%), 
533.2 (65%), 1043.4 (85%, 2M + Na+); HRESIQTOFMS calcd for C27H30N2O8Na (M + Na+) 
533.1894, found 533.1912. 
 
 
HPLC: C18 column; mobile phase, CH3CN (0.05% TFA) / water (0.1% TFA), 5% to 95% CH3CN over 30 min; flow 
rate, 1.00 mL/min; UV detection at 220 nm; tR for 41, 23.0 min.   
 
Figure 2-16: HPLC chromatogram of Cbz to Boc exchange reaction (40 to 41) before the reaction was complete 
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3.0  OLIOGOMER SYNTHESIS AND NMR STUDIES 
Ultimately, functional bis-peptide oligomers will be designed in silico and then rapidly 
synthesized in the laboratory.  After measuring the properties of the oligomers, second-
generation oligomers could be tailored in silico to optimize their structure and function. To 
realize this strategy, reliable and scalable methods must be developed for the synthesis of bis-
peptide oligomers. 
Three Cbz-pro4(2S,4S) monomers were coupled using Fmoc solid phase peptide 
synthesis.  After removing the Cbz groups, simultaneous formation of the DKP rings between 
each of the monomer residues was achieved by basic catalysis.  The connectivity and 
stereochemistry of the resulting trimer bis-peptide oligomer was confirmed by NMR; the 
conformation of the trimer in aqueous solution was determined based upon the 2D-NMR data 
and molecular mechanics calculations.  A pentamer bis-peptide was synthesized in a similar 
manner to demonstrate the generality of the approach, and a model dimer oligomer was prepared 
to measure the rate of DKP formation under various basic conditions. 
The possibility of achieving productive iterative cycles of bis-peptide design, synthesis, 
testing and redesign is based upon the hypothesis that the shape of bis-peptide oligomers can be 
modified in predictable ways by changing the sequence and stereochemistry of the constituent 
monomers.  To start examining the relationship between bis-peptide shape and the 
stereochemistry and sequence of its constituent monomers, five tetramer oligomers were 
prepared.  Each tetramer was assembled using various combinations of the four stereoisomers of 
the pro4 monomer.  The conformation of each tetramer in aqueous solution was determined by 
analysis of their respective 2D-NMR spectra and by molecular mechanics calculations. 
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3.1 SYNTHESIS OF A TRIMER BIS-PEPTIDE 
Having developed a reproducible procedure for synthesizing the pro4 bis-amino acid 
monomers, we wanted to demonstrate the feasibility of bis-peptide synthesis.  The structure of 
the first bis-peptide oligomer, 44, is shown in Figure 3-1.  The connectivity and stereochemistry 
of 44 were confirmed by interpretation of its 2D-NMR spectra.  L-tyrosine was attached to the C-
terminus of the oligomer as a UV-active chromophore to simplify HPLC analysis of 
intermediates.  Tyrosine also increased the lipophilicity of the molecule; unlabeled bis-peptides 
are extremely polar, and are difficult to purify using C18 reverse phase HPLC. 
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Figure 3-1: Structure of the first bis-peptide, 44 
3.1.1 Synthesis of trimer bis-peptide 44, part 1: chain elongation and resin cleavage.  
The first part of bis-peptide synthesis is chain elongation.  During this phase, the 
monomers are connected to one another sequentially on solid phase through amide bonds.  The 
product of chain elongation is the “open-form” of the bis-peptide oligomer (the open-form of 
pro4 monomer oligomers are γ-peptides).120 
We selected Rink Amide AM resin (Scheme 3-1) as the solid support for the synthesis of 
44.  Rink Amide AM resin is aminomethylpolystyrene (1% divinylbenzene cross linker) resin, 
functionalized with the Rink amide linker.121  This resin is typically used for peptide synthesis 
using Fmoc-SPPS protocols.58  Peptides are cleaved from the linker using 95% TFA with 
appropriate cation scavengers122 affording C-terminal peptide amides. 
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Scheme 3-1: The structure of the Rink Amide AM linker 
is shown (top).  Removal of the terminal Fmoc protecting 
group from Rink Amide AM resin is achieved using 20% 
piperidine/DMF. 
 
The Fmoc protecting group was removed from the resin linker using 20% piperidine in 
DMF (Scheme 3-1).  The reported resin loading was confirmed by measuring the concentration 
of the dibenzofulvene-piperidine adduct (Figure 3-2) in the 20% piperidine/DMF solution.123  
This chromophore has a characteristic UV-absorption spectrum with a maxima at 301 nm (ε = 
7800 M-1 cm-1) and is used to quantify coupling yields during Fmoc-SPPS. 
N
H
O
O
HN
H
HN
O
O
HN
H+
N
H
 
Figure 3-2: Removing the Fmoc carbamate with piperidine generates a dibenzofulvene-piperidine adduct 
with a characteristic UV-absorbance spectrum that may be used to quantify coupling yields. 
 
After the Fmoc group was removed from the resin linker, the Cbz-pro4(2S,4S) monomer 
18 was coupled to the resin (Scheme 3-2).  We achieved quantitative coupling of 18 to the 
primary amine of the linker using coupling reagent HATU with DIPEA base in 20% 
CH2Cl2/DMF.  Quantitative coupling was confirmed by performing the ninhydrin resin test124 
and by measuring the release of the piperidine-dibenzofulvene adduct during subsequent Fmoc 
removal. 
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Reagents and Reaction Conditions: 
(a) 20% piperidine/DMF, 40 min. (b) 18, HATU, DIPEA, 20% CH2Cl2/DMF. 
 
Scheme 3-2: The first Cbz-pro4(2S,4S) monomer was coupled quantitatively to the solid support 
using HATU. 
 
The uronium salt HATU is a superior peptide coupling reagent125,126 that is used 
extensively for activating sterically hindered amino acids.127  Peptide fragments activated with 
HATU are less prone to racemization than fragments activated with analogous reagents, such as 
HBTU;128 adding less-polar solvents (i.e., dichloromethane) to the DMF during coupling has 
been shown to further suppress racemization.  The mechanism of amide bond formation with 
HATU is illustrated in Figure 3-3;129 the increased reactivity of HOAt esters relative to 
analogous HOBt esters is hypothesized to be due to the neighboring group effect illustrated in 
Figure 3-3.130  When used for the coupling of severely hindered amino acids, uronium reagents 
can generate guanidino side-products by reacting with the resin bound amine.127  We have 
avoided this side reaction by mixing the monomer, base, and HATU before adding these reagents 
to the resin, and have not observed guanidinium formation during Cbz-pro4(2S,4S) monomer 
coupling.  TFFH,69,131,132 a uronium coupling reagent that generates acid fluorides, was also a 
suitable coupling reagent for the pro4 monomer. 
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Figure 3-3: The mechanism of amide bond formation with HATU. 
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After removing the Fmoc group from the resin-bound monomer (affording 46, Scheme 
3-2) two additional monomers were coupled sequentially to the resin, followed by N-α-Fmoc-O-
tert-butyl-L-tyrosine (Scheme 3-3).  Removal of the Fmoc group also caused DKP formation 
between the tyrosine and the preceding Cbz-pro4(2S,4S) monomer residue, as expected (48, 
Scheme 3-3).60,62,133  DKP formation was confirmed by analysis of the resin cleavage products 
by HPLC-MS (see below). 
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Reagents and Reaction Conditions: 
(a) 18, HATU, DIPEA, 20% CH2Cl2/DMF.  (b) 20% piperidine/DMF.  (c)  N-α-Fmoc-O-tert-
butyl-L-tyrosine, HATU, DIPEA, 20% CH2Cl2/DMF. 
 
Scheme 3-3: Chain elongation of the oligomer on solid phase was achieved by sequential 
coupling and deprotection reactions. 
 
Product 49 was obtained upon cleavage of resin 48 with 95% TFA containing 
triisopropylsilane134 and water as cation scavengers.  The expected mass of 49 was confirmed by 
HPLC-MS; the HLPC chromatogram of the crude resin cleavage product is illustrated in Figure 
3-4.  DKP formation between the tyrosine and preceding monomer residues was quantitative.  
Crude 49 was taken into subsequent reactions without further purification. 
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Scheme 3-4: 49 was obtained by cleaving resin 48 with 95% TFA containing cation 
scavengers. 
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HPLC-MS: column, Waters XTerra MS C18, 4.6 × 100 mm; mobile phase, H2O (0.1% TFA) / CH3CN, 5% to 95% 
CH3CN over 30 min; flow rate, 0.40 mL/min; UV detection at 274 nm; tR for 49, 21.0 min; ESI-MS m/z (ion) 1061.2 
(M + H+). 
 
Figure 3-4: HPLC chromatogram of crude 49 following resin cleavage 
3.1.2 Synthesis of trimer bis-peptide 44, part 2: Cbz group removal and DKP formation. 
Crude 49 was subjected to catalytic hydrogenation to remove the Cbz groups, affording 
the open-form oligomer 50 (Scheme 3-5).  Methanol was not a good solvent for this reaction.  
When hydrogenation was performed in methanol, the starting material 49 was consumed, but 
very little of the desired product 50 could be recovered.  The Cbz or Boc protected open-form 
bis-peptides (e.g., 49) are non-polar, whereas the unprotected open-form bis-peptides (e.g., 50) 
are polar.  When the Cbz groups were removed, the product 52 either precipitated from the 
methanol solution and was filtered away with the catalyst, or was absorbed by the charcoal.  
Both 49 and 50 are soluble in mixtures of acetonitrile and water.  Catalytic hydrogenation in this 
solvent mixture did remove all of the Cbz groups, but the free amines were quantitatively 
ethylated, presumably by reduced acetonitrile playing the role of an aldehyde.135  7:2:1 
methanol/water/acetic acid proved to be an excellent solvent for this reaction (Scheme 3-5).  
Both the starting material and the product were soluble in this solvent mixture, and the reaction 
was complete in less than one hour.  These solvent conditions suppress the formation of 
alkylated side-products; alkylation of the amines can occur when methanol alone is used as the 
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solvent.136,137  An HPLC chromatogram of the reaction mixture following hydrogenolysis is 
illustrated in Figure 3-5. 
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Scheme 3-5: Removal of Cbz groups from 49 by catalytic hydrogenation was achieved in less than one 
hour with 10 wt. % Pd/C in 7:2:1 MeOH/H2O/AcOH under H2, affording the Cbz-deprotected open-form 
oligomer 50. 
 
 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 100 mm; mobile phase, H2O (0.1% TFA) / CH3CN, 5% to 95% 
CH3CN over 30 min; flow rate, 0.40 mL/min; UV detection at 274 nm; tR for 50, 8.03 min; ESI-MS m/z (ion) 659.2 
(M + H+). 
 
Figure 3-5: HPLC chromatogram of crude 50, the product of catalytic hydrogenolysis of 49 
 
Closure of the remaining DKPs was not spontaneous in the 7:2:1 MeOH/H2O/AcOH 
solution used for catalytic hydrogenation.  At low concentrations, acetic acid can behave as a 
bifunctional catalyst for DKP formation;60 in concentrated AcOH solutions, the pyrrolidine 
nitrogen atoms are protonated and non-nucleophilic.  After concentrating the filtered 
hydrogenation solution, we found that it was possible to accelerate DKP formation by dissolving 
50 in 20% piperidine/DMF (Scheme 3-6); these conditions accelerate unwanted DKP formation 
during Fmoc SPPS of α-peptides connected to the resin linker by a C-terminal ester (see Figure 
1-11, page 9).133 
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Scheme 3-6: The rigidified oligomer 44 was generated by dissolving 50 in 20% piperidine/DMF 
 
The conversion of open-form oligomer 50 to bis-peptide 44 was difficult to monitor by 
HPLC.  Although the starting material 50 was consumed, there appeared to be no corresponding 
evolution of the desired product 44.  Careful inspection of the reaction solution revealed a fine 
precipitate, as well as needle-like crystals.  The amorphous precipitate was filtered from the 
solution and found to be pure 44 by HPLC-MS; X-ray crystallography indicated that the needle-
like crystals were piperidine·HCl (the formation of piperidine salts during bis-peptide 
rigidification has since been avoided by using high-purity DMF and piperidine).  The 
precipitation of 44 from the 20% piperidine/DMF solution accounts for why this product was not 
detected using HPLC analysis, and also provided a convenient way to purify the product. 
A second batch of 50 was dissolved in 20% piperidine/DMF in a sealed HPLC vial and 
incubated for 48 hours at 2 °C (to facilitate product precipitation).  The precipitate 44 was 
filtered, and found to be soluble in D2O to more than 5 mg/mL. 44 was stable under neutral and 
acidic aqueous solutions at room temperature for weeks.  The recovered yield of 44, based upon 
the initial resin loading, was 17%.  An HPLC chromatogram of bis-peptide 44 in D2O solution is 
shown in Figure 3-6; this illustrating the exceptional purity of this bis-peptide oligomer, isolated 
without preparative HPLC purification. 
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HPLC-MS: column, Waters XTerra MS C18, 4.6 × 100 mm; mobile phase, H2O (0.1% TFA) / CH3CN, 5% to 20% 
CH3CN over 30 min; flow rate, 0.40 mL/min; UV detection at 274 nm; tR for 44, 8.84 min; ESI-MS m/z (ion) 595.2 
(M + H+). 
 
Figure 3-6: HPLC chromatogram of 44, the first trimer bis-peptide oligomer 
3.1.3 Structural analysis of trimer oligomer 44 
To simplify discussion of the NMR results, we have adopted the naming system for pro4 
bis-peptide oligomers illustrated in Figure 3-7 (right); the numbering of atoms and heterocycles 
in 44 is shown as well (left).  The diastereotopic Cβ and Cδ hydrogen atoms on the same face as 
Hα of that pyrrolidine ring are called Hβa and Hδa, respectively.  The pyrrolidine ring hydrogen 
atoms on the opposite face as Hα are called Hβb and Hδb. 
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Figure 3-7: The naming system for trimer bis-peptide 44.  C–H–N atom number is labeled on the top 
structure in blue.  Stereochemistry at each chiral center is labeled on the bottom structure in red.  The 
names of the diastereotopic protons on the pyrrolidine rings are shown on the three-dimensional model. 
 
To construct a model of oligomer 44, we carried out an in vacuo conformational search 
using the Amber94 force field138 within the molecular mechanics package MOE.102  This search 
revealed a cluster of six lowest energy conformations (the blue markers on the plot in Figure 
3-8).  The mean energy of this cluster of six conformations is separated from the next highest 
energy cluster of conformations (yellow markers on the plot in Figure 3-8) by a gap of 
approximately 2.0 kcal/mole.  This suggests that collectively, the molecule spends roughly 96% 
of its time in one of the six lowest energy conformations at room temperature.  A superposition 
of these predicted lowest energy conformations (inset structures, Figure 3-8) reveals that rings B, 
C, D, E, F and the folded tyrosine conformation are nearly identical.  The differences between 
these six calculated conformations involve combinations of rotamers around the C2-C3 bond, 
rotamers around the tyrosine –OH bond, and two envelope conformations of N-terminal 
pyrrolidine ring A. 
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Figure 3-8: Plot of the Amber94 calculated energies for conformations of 44 generated by the in vacuo 
stochastic search (left).  The six lowest energy conformations (blue markers) are superimposed (right).  Carbon 
atom coloring in the pyrrolidine ring A flipped conformations has been changed to green for contrast.  The 
names of the pyrrolidine and diketopiperazine rings are labeled. 
 
In the modeled conformers, the diketopiperazine rings are shallow boats, and the α-
protons are oriented in the axial position.  This is consistent with NMR and X-ray 
crystallographic studies on the conformations of cyclic dipeptides.63,139-141  For cyclic dipeptides 
containing proline, the preferred DKP conformation is boat-like, with axial α-protons (this 
conformation is referred to as “bowsprit boat”).  The bowsprit boat DKP conformation maintains 
the planarity of the amide bonds, and avoids steric interference between the amino acid side 
chains. 
The Amber94 molecular mechanics calculations also suggest that in the lowest energy 
oligomer conformations, the pyrrolidine rings assume an envelope conformation where atom Cβ 
is positioned out of the plane defined by Cα, Cγ, Cδ, and the pyrrolidine N-atom.  In this 
conformation (the “Cβ displaced conformation”), Hβb and Hδb are closer to one another than 
Hβa to Hδa.  This results in a unique pattern of transannular ROESY interactions characteristic 
of this pyrrolidine conformation.  The Cβ displaced conformation appears to avoid a 1,3-
interaction (a syn-pentane like interaction) between the quasiequatorial substituent on Cα and the 
substituents on Cγ. 
Trimer bis-peptide 44 was readily soluble in water, so for the NMR studies we dissolved 
approximately 5 mg of the bis-peptide in 0.7 mL of D2O.  The 1H NMR spectra indicated that the 
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sample was contaminated with piperidine trifluoroacetate; we used this as an internal standard 
for the NMR experiments.  At room temperature, the HOD peak in the NMR spectrum 
completely overlapped the peak corresponding to α-proton H18.  Accordingly, the NMR spectra 
were obtained with the sample at 10 °C; this shifted the HOD peak downfield by 0.16 ppm, 
allowing clear visualization of the signals from H18. 
Although the NMR spectra obtained in D2O (COSY, ROESY, HMQC, HMBC, 1H and 
13C) were consistent with the proposed structure of 44, deuterium exchange had silenced the 
signals from the amide protons.  To compliment the analysis in D2O, the sample was 
concentrated and dissolved in 90% H2O/D2O; 5 μL of TFA were added to the solution (final pH 
~ 0).  A similar set of NMR experiments were performed, but with pulse programs implementing 
presaturation of the solvent signal for the ROESY, COSY, and 1H spectra.  The amide protons 
produced interpretable signals under these conditions.  Cooling the sample slows amide proton 
exchange with the solvent; performing the experiments with solvent suppression at low 
temperature increased amide proton signal intensity relative to the intensities observed at room 
temperature.  Under acidic conditions, there were slight changes in the chemical shifts of some 
of the aliphatic protons (especially for α-protons H3, H10, and H26). 
The cross-peaks in the ROESY spectra of the sample in D2O and in H2O/D2O (pH ~ 0) 
were integrated, and designated as strong, medium, or weak.  The Amber94 minimized 
conformation that we judged most consistent with the ROESY data is depicted in Figure 3-9. 
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Figure 3-9: Both structures are illustrations of the modeled conformer of 44 found to be most consistent with the 
observed ROESY correlations.  ROESY correlations from the spectrum obtained in D2O are superimposed upon the 
left structure; ROESY correlations from the spectrum obtained in 90% H2O/D2O are superimposed upon the right 
structure.  The thin red, green and blue cylinders represent strong, medium, and weak ROESY correlations.   
 
The medium-intensity ROESY correlations between Hβb and Hδb for pyrrolidine rings A 
and C (H4b-H6b, H11b-H13b) contrast the weaker correlations between Hβa and Hδa (H4a-H6a, 
H11a-H13a, D2O spectrum) supporting the Cβ displaced envelope conformation for these 
pyrrolidine rings.  The strong trans-DKP H10-H4a correlation (which is visible in both ROESY 
spectra, but overlapped in the H2O/D2O spectrum) is also consistent with the ring A 
conformation illustrated.  Furthermore, it supports the predicted boat conformation of DKP ring 
B.  We had also anticipated a ROESY correlation across DKP ring D from α-proton H18 to β-
proton H13a.  Unfortunately, this region of the ROESY spectrum is overlapped by the interaction 
between H18-H19a. 
 72 
The ROESY correlations between the Hβ and Hδ protons of pyrrolidine ring E are 
overlapped.  Nonetheless, the weak H21a-H18, H24-H19b and H24-H21b correlations are not 
inconsistent with the modeled structure.  DKP ring F is calculated to be boat-like, positioning the 
aromatic ring of the tyrosine residue aside the δ-protons of pyrrolidine ring E.  This is supported 
by correlations between the aromatic ring protons and pyrrolidine ring E δ-protons (H31-H21a, 
H32-H21a) as well as by correlation H27-H31.  The chemical shift of δ-protons H21a and H21b 
is about 1 ppm upfield from the analogous δ-protons on pyrrolidine rings A and C; this might be 
an effect caused by their proximity to the face of the aromatic ring. 
Cyclic dipeptides containing tyrosine or phenylalanine have been studied by NMR and 
X-ray crystallography.  The DKP rings in these structures are boats, and the aromatic substituent 
is oriented in the axial position,139,141 in a manner similar to that proposed for 44.  Similar 
aromatic shielding NMR effects, like those observed for H21a and H21b, are described for the 
cyclic dipeptides.  If DKP ring F were to flip to the other boat conformation, H26 would be 
positioned closer to H19a; in the D2O ROESY spectrum, there is a very weak correlation 
between these protons.  This suggests that ring F may have some conformational mobility, and 
spend some time in the opposite boat conformation.  When modeled using the Amber94 force 
field without the Van der Waals energy term, the tyrosine aromatic ring tends not to fold back 
upon the scaffold, suggesting that these interactions may be responsible for the folded tyrosine 
conformation in solution.  In water, this may also be due to the hydrophobic effect. 
3.2 OLIGOMER PENTAMER SYNTHESIS 
To demonstrate the generality of the approach used for the synthesis of trimer bis-peptide 
44, we prepared pentamer bis-peptide 53, as illustrated in Scheme 3-7.  Rink Amide AM resin 
was charged with N-Fmoc protected tyrosine.  Five Cbz-pro4(2S,4S) monomers (18) were 
coupled sequentially to the tyrosine; 51 was then cleaved from the resin with TFA.  The Cbz 
groups were stripped from the pyrrolidine nitrogen atoms by catalytic hydrogenolysis in 7:2:1 
MeOH/H2O/AcOH, yielding 52.  Finally, the open-form oligomer 52 was rigidified in 20% 
piperidine/DMF for 24 hours.  The desired product, pentamer bis-peptide 53, was isolated by 
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precipitation from ether.  The overall yield of pentamer 53 was approximately 33%, based on the 
initial resin loading. 
 
Scheme 3-7: The synthesis of pentamer bis-peptide 53.  The Cbz-protected open-form oligomer 51 is 
converted to open-form oligomer 52 by catalytic hydrogenolysis; the oligomer is rigidified with base, 
yielding bis-peptide 53. 
 
HPLC analysis of precipitated 53 shows that the product was remarkably homogeneous 
(Figure 3-10), despite the fact that intermediates 51 and 52 were not purified by chromatography.  
HPLC-MS analysis confirms that the major product has the same m/z ratio as the desired 
product, 53.  The crude pentamer material was soluble in 10% D2O/H2O to at least 5 mg/mL.  
We did not attempt to analyze the structure of 53 in solution using 2D NMR experiments 
because of extensive overlap in its 1H NMR spectrum. 
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HPLC: column, Microsorb 100 C18, 4.6 × 250 mm; mobile phase, CH3CN (0.05% TFA) / water (0.1% TFA), 5% to 
95% CH3CN over 30 min; flow rate, 1.00 mL/min; UV detection at 220 nm; tR for 53, 8.50 min; ESI-MS m/z (ion) 
903.3 (M + H+). 
 
Figure 3-10: HPLC chromatogram of crude pentamer bis-peptide oligomer 53 
 
The small peak indicated in the HPLC chromatogram of crude 53 (Figure 3-10) has the 
same ESI mass spectrum as the major product; it is probably an epimer of 53.  Epimerization 
proceeds through the carbanion (enolate) resulting from deprotonation at the chiral α-carbon 
atoms of the DKP.65  N-methylated peptides and DKPs are prone to epimerization under basic 
conditions;63,65,142,143 Gund and Veber accounted for the ease of N-methyl peptide and DKP 
epimerization computationally.143  They calculated the energy required to deprotonate the α-
proton from the cis and trans conformers of N-acetylglycinamide (Figure 3-11, box A) and N-
methyl-N-acetylglycinamide (Figure 3-11, box B).  The results of this computational study 
indicate that removing the α-proton is facilitated by N-alkylation and by enforcing the cis-
peptide bond conformation. 
The conjugate bases of the cis conformers (the “transoid” amino carbanions, Figure 3-11, 
box E) are more stable than the conjugate bases of the trans conformers (the “cisoid” amino 
carbanions, Figure 3-11, box D).  One contributing factor is the dipole moment of the transoid 
amino carbanion, which is favorably opposed to the dipole moment of the amide C=O bond. 
N-alkylation has both a direct and indirect effect upon deprotonation.  The difference in 
energy between the cis and trans conformers of secondary amides (ΔE = 1.55 kcal for trans-cis 
isomerization shown in Figure 3-11, box A) is greater than the difference in energy between the 
cis and trans conformers of tertiary amides (0.20 kcal for the analogous isomerization shown in 
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Figure 3-7, box B).  N-methyl amides and proline residues increase the population of cis-amide 
bonds in peptides.144,145  N-alkylation thus indirectly promotes peptide epimerization by 
increasing the proportion of the cis conformation, which is easier to deprotonate.  N-alkylation 
also has a direct effect upon deprotonation by stabilizing the amino carbanion through 
hyperconjugation.146  Proline containing DKPs (Figure 3-11, box C), structurally similar to the 
DKP rings in the bis-peptides, are especially prone to epimerization because the amide bond is 
locked in the cis conformation, and because the amide nitrogen adjacent to the α-proton is 
alkylated. 
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Figure 3-11: Energies (in kcal) required to remove protons adjacent to amides (blue protons in figure), as calculated 
by Gund and Veber.143  The ΔE for the cis-trans isomerizations shown (from left to right) is given in kcal.  Box A: 
cis and trans conformers of N-acetylglycinamide.  Box B: cis and trans conformers of N-methyl-N-
acetylglycinamide.  Box C: cyclo-L-alanine-L-proline.  Box D: a cisoid amino carbanion.  Box E: a transoid amino 
carbanion. 
3.3 MEASURING THE RATE OF DKP CLOSURE: EXPLORING DKP CLOSING 
CONDITIONS 
Rigidification of trimer 44 and pentamer 53 by DKP formation was complete within 24 
hours.117  The small amount of epimerization that occurred during rigidification of pentamer bis-
peptide 53 was probably due to the basic annealing conditions (20% piperidine/DMF) and the 
susceptibility of DKPs to epimerization.  It was unclear at the time whether DKP formation 
would compete with epimerization during rigidification of very long bis-peptides.  Because bis-
peptide shape is related to its stereochemistry, analyzing the relationship between bis-peptide 
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structure and function requires that the oligomers retain the relative stereochemistry of their 
monomer constituents.  We typically assume that the major product of rigidification with the 
desired m/z ratio has the expected stereochemistry; this has been proven the case for every bis-
peptide that we have studied by NMR.13-15,100,117  Unfortunately, NMR analysis of the oligomers 
is non-trivial, and cannot be used to test the stereochemical fidelity of every bis-peptide 
synthesized. 
To start addressing the issue of the relative rates of epimerization and DKP formation, the 
rate of DKP formation was determined in a model bis-peptide.  Compound 54 (Scheme 3-8) was 
synthesized by coupling tyrosine, two Cbz-pro4(2S,4S) monomers, then 4-nitrobenzoic acid 
sequentially to Rink Amide resin using HATU.  To avoid reduction of the nitro group, the 
product was cleaved from the resin using triflic acid, which simultaneously removed the Cbz 
protecting groups from the monomer residues.95  54 is baseline separable from the product of 
DKP closure, 55 (Scheme 3-8, inset HPLC chromatogram). The desired product was 55; under 
certain conditions, the methyl ester of 55 would hydrolyze, causing gradual formation of 56. 
 
HPLC (inset): column, Microsorb 100 C18, 4.6 × 250 mm; mobile phase, CH3CN (0.05% TFA) / 
water (0.1% TFA), 28% to 35% CH3CN over 5 min; flow rate, 1.00 mL/min. 
 
Scheme 3-8: Compounds used or observed in the initial DKP closure study.  The inset HPLC 
chromatogram (top) is representative of analysis of a sample from the DKP closure reaction early 
in the reaction; the second chromatogram is a later injection in the same trial. 
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The model dimer was dissolved in various solvents; the reaction was monitored by HPLC 
until complete.  For each HPLC chromatogram, the UV-absorbance peaks corresponding to 54, 
55, and 56 (Scheme 3-8, inset) were integrated, and the data was normalized.  The progress of 
the DKP closing reaction for model compound 54 under each set of conditions is plotted with 
respect to reaction time in Figure 3-12. 
 
Figure 3-12: Plot of reaction progress during the conversion of 54 to 55 under various conditions 
 
The rate of change in the concentration of the starting material 54 with respect to time 
was consistent with first order reaction kinetics, described by differential equation 3.1 (where 
[A] = [54]): 
 
The rate of the reaction, k, was determined for each set of conditions by plotting ln[54] with 
respect to elapsed reaction time and deriving the slope. These results from the DKP closure study 
are summarized in Table 3-1. 
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Table 3-1: Summary of the reaction rate data for the DKP closure model study 
 
 
 
The average half-life of DKP closure using 20% piperidine/DMF at room temperature 
(the standard conditions for rigidifying pro4 oligomers thus far)15,100,117,118 is 232 minutes (~ 4 
hours), but there was considerable variation between the 20% piperidine/DMF trials A, B and C.  
This may have been caused by variable water content in the samples prior to adding the 
piperidine and DMF.  When water was added directly to the piperidine/DMF solution (trial H), 
the rate of DKP closure was much greater than the rate of trials A, B and C; hydrolysis of the 
methyl ester also occurred under these conditions.  Although TEA did not accelerate DKP 
formation, piperidine and n-butylamine were both effective.  DBU increased the rate of DKP 
formation significantly, but also the rate of methyl ester hydrolysis by adventitious water.  
Adding acetonitrile to the solvent mixture increased the rate of DKP formation (E and I); the t½ 
for trial I was less than the average for piperidine alone by nearly a factor of six.  Acetonitrile, 
and other aprotic dipolar protophobic solvents,61,147 were reported to accelerate the rate of DKP 
closure.61 
Based on the half-life of DKP closure between two pro4 monomers, we can extrapolate 
the time that it might take to rigidify longer bis-peptides.  For an oligomer containing (n + 1) 
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monomers, n DKPs must close during rigidification.  Assuming that closing each DKP ring is an 
independent event (that closing any DKP ring in an oligomer does not affect the rate of closure 
for other DKP rings in the molecule) the probability that n DKPs have closed at time t is given 
by a derivation of the Poisson distribution (equation 3-2) 
 
where k is the rate of DKP closure.  Using the average rate for DKP closure between two pro4 
monomers in 20% piperidine/DMF (~ 4 hours), rigidification of a pentamer would be 95% 
complete in around 25 hours; rigidification of a 25-mer would be 95% complete at 34 hours.  
The bis-peptides prepared for NMR studies were rigidified for greater than 24 hours; the major 
product of rigidification was the desired stereoisomer in each case.  This suggests that the rate of 
epimerization is considerably slower than the rate of DKP formation between adjacent pro4 
monomers in 20% piperidine/DMF.  While the addition of acetonitrile increased the rate of DKP 
formation for the model system, this is not generally applicable to solution phase rigidification 
because of problems with solubility.  DKP formation with DBU was rapid, but seems ill-advised 
because this might also increase the rate of epimerization. 
DKP formation between adjacent pro4(2S,4S) monomer residues has a half-life of ~ 4 
hours in 20% piperidine/DMF.  Unfortunately, these conditions are not effective for all of the 
bis-amino acid monomers that have been synthesized in our laboratory.13,14,119  In 20% 
piperidine/DMF, DKP formation between adjacent pip5(2S,4S) monomer residues cannot be 
detected (Figure 3-13).  For the pip5 monomer class, Sharad Gupta has addressed this issue by 
several approaches: using coupling reagents to generate the second amide bond in the DKP,13 
closing the DKPs on solid support at high temperature with acetic acid as a catalyst,60,61,119 and 
by changing the methyl ester to a better leaving group.119 
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Figure 3-13: DKP formation between adjacent pro4(2S,4S) monomer residues with 20% piperidine/DMF (A, top) 
occurs at a reasonable rate.  The analogous reaction between adjacent pip5(2S,4S) monomers (B, bottom) is 
immeasurably slow. 
3.4 MONOMER STEREOCHEMISTRY AND BIS-PEPTIDE SHAPE: 1. PRO4(2R,4R) 
MONOMER 
The trimer oligomer 44 is a linear, rod-like structure.  The Amber94 minimized model of 
pentamer oligomer 43 is also a linear rod.  Modeling suggests that every pro4(2S,4S) monomer 
increases the length of a bis-peptide by about 5 Å.  Increasing the number of pro4(2S,4S) 
monomers increases the length of a bis-peptide; this effect has been measured qualitatively by 
FRET,100 and quantitatively by ESR experiments.118  bis-Peptides containing only the 
pro4(2S,4S) monomer may prove ideal for biological applications that require rigid, rod-like, 
water-soluble molecules.42,51,54,148  To extend the scope of potential applications, access to a 
wider variety of oligomer shapes is required.  We wanted to demonstrate that this was possible 
by simply incorporating different monomer stereoisomers. 
Two bis-peptide tetramer oligomers containing combinations of the Cbz-pro4(2S,4S) 
monomer 18, and its enantiomer, Cbz-pro4(2R,4R) monomer 29 were synthesized.100  Structural 
analysis by NMR confirmed that it is possible to change the shape of a bis-peptide by changing 
the stereochemistry of its constituent monomers. 
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3.4.1 Oligomer synthesis 
Our goal is to accurately predict the structures of large oligomers.  Models of large bis-
peptides will be based on the conformational preferences of each monomer in the context of its 
immediate neighbors.  If we call the pro4(2S,4S) “A” and the pro4(2R,4R) monomer “B”, then 
all possible sequences of three monomers are: AAA, AAB, BAA, BAB (and their respective 
enantiomers BBB, BBA, ABB, and ABA).  The conformation of the central monomer of an 
AAA sequence was determined using trimer 44. 
To determine the conformation of the central monomer in the context of sequences AAB, 
BAA, and BAB, we synthesized bis-peptides 57 (sequence AABB) and 58 (sequence ABAB).  
The structure and naming of each of these tetramers is illustrated in Figure 3-14. 
 
Figure 3-14: Tetramer bis-peptide oligomers incorporating different sequences 
of the pro4(2S,4S) and pro4(2R,4R) monomers: 57 (top), 58 (bottom).  C–H–N 
atom number is labeled on structure 57 in blue.  The stereochemistry at each 
chiral center is labeled in red.  Heterocycle naming is indicated on 57 in cyan. 
 
The synthesis of oligomers 57 and 58 is summarized in Scheme 3-9.  Fmoc-(S)-2-
naphthylalanine was coupled to Rink Amide AM resin using HATU.  For 57, Cbz-pro4 
monomers 18, 18, 29, and 29 were coupled in sequence to the resin-bound naphthylalanine.  For 
58, the sequence for monomer coupling was 18, 29, 18, and 29.  The coupling reactions were 
performed for 30 minutes each with HATU as described for the synthesis of trimer 44 and 
pentamer 53.  Resin cleavage was affected by treatment with TFA.  As there was no acid-
sensitive functionality on either oligomer, we chose to remove the Cbz protecting groups using 
8% triflic acid in TFA, affording open-form oligomers 59 and 60.  This procedure was fast, 
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relatively clean, and avoided the use of heterogeneous Pd/C catalyst, which tended to complicate 
recovery of the highly polar open-form oligomers. 
The open-form oligomers 59 and 60 were dissolved in 20% piperidine/DMF.  DKP 
closure was complete within 2 days at room temperature, affording the desired bis-peptides 57 
(from 59) and 58 (from 60). 
 
Scheme 3-9: Synthesis of oligomers 57 and 58 
3.4.2 Modeling and NMR analysis of tetramers 57 and 58 
Tetramers 57 and 58 were both soluble in water, so the NMR experiments were 
performed in 9:1 H2O/D2O at a pH between 4 and 5.  Amide proton exchange was suppressed by 
cooling the sample to 2 °C.  The expected stereochemistry and connectivity of each tetramer was 
verified by analysis of their ROESY, HMBC, and COSY spectra; the composition of each was 
confirmed by high resolution mass spectroscopy. 
As with the trimer bis-peptide, 44, we generated working models of 57 and 58 by an in 
vacuo conformational search with the Amber94 force field138 within MOE.102  In the minimum 
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energy conformations, the diketopiperazine rings are, once again, shallow boats, with the Cα 
protons in the axial orientation.  As with the proposed structure of the trimer oligomer, the 
pyrrolidine rings assume the Cβ displaced envelope conformation, avoiding the potential 1,3-
interaction between the substituents on Cα and Cγ.  The ROESY correlations between non-J-
coupled protons were sorted by integrated intensity, classified as strong, medium and weak, and 
superimposed upon the modeled structures. 
For 57, the ROESY correlations were most consistent with the minimum energy 
Amber94 structure illustrated in Figure 3-15.  The H8b-H6b, H15b-H13b, and H21b-H23b 
medium intensity correlations support the Cβ displaced conformations for pyrrolidine rings A, C 
and E.  With the exception of the weak H23a-H21a correlation across pyrrolidine ring E, 
correlations across the opposite face of each pyrrolidine ring (Hβa-Hδa) are absent or 
overlapped. 
The boat-like conformations of the DKP rings are supported by a number of strong trans-
DKP correlations: H12-H6a, H20-H15a, and H28-H21a.  The strong H20-H15a, medium H20-
H15b, and weak H20-H15b correlations fit extremely well with the illustrated conformations of 
DKP ring D and pyrrolidine ring C.  There is a similar patterns of ROESY correlations across 
DKP rings B and F consistent with the Cβ displaced conformation of pyrrolidine rings A and E.  
There are relatively few ROESY correlations for pyrrolidine ring G, which may be 
conformationally mobile. 
 
Figure 3-15: Illustration of the Amber94 minimized conformer of 57 most consistent with the observed ROESY 
correlations.  The thin red, green and blue cylinders represent strong, medium, and weak ROESY correlations, 
respectively. 
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The minimized structure most consistent with the ROESY correlations for 58 is 
illustrated in Figure 3-16.  The medium intensity correlations H6b-H8b and H13b-H15b suggest 
the Cβ displaced conformation for pyrrolidine rings A and C.  The boat conformation of DKP B  
and Cβ displaced conformation of pyrrolidine A are consistent with correlations H12-H8a 
(strong), H12-H8b (medium), and H12-H10 (weak).  There was a considerable amount of 
overlap in the ROESY spectrum of 58.  For instance, the trans-DKP ring D correlations from Hα 
proton H20 to H15b and H15a (Hδ protons on pyrrolidine ring C) were overlapped.  Although it 
was not possible to integrate these peaks directly, by taking one-dimensional slices through the 
ROESY spectrum, the relative strengths of these correlations could be inferred. 
 
Figure 3-16: Illustration of the Amber94 minimized conformer of 58 most consistent with the observed 
ROESY correlations.  The thin red, green, blue and cyan cylinders represent strong, medium, weak, and 
undefined ROESY correlations, respectively.  The broken (dashed) cylinders correspond to ROESY 
correlations whose intensities were evaluated visually by examining 1D slices of the ROESY spectrum. 
 
Both 57 and 58 have an alternating sequence of pro4(2S,4S) and pro4(2R,4R) monomer 
residues.  The Amber94 minimized conformers for these structures are gently curved; the 
curvature of 58 is slightly greater than that for 57.  The shape imparted by this sequence motif 
was used to design a curved pentamer bis-peptide.  The design hypothesis was tested by 
comparing the end-to-end distance of the curved structure with that of a linear structure by 
fluorescence resonance energy transfer (Chapter 4, page 111). 
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3.5 MONOMER STEREOCHEMISTRY AND BIS-PEPTIDE SHAPE: 2. 
INCORPORATING ALL MONOMER STEREOISOMERS 
The library of four Boc-pro4 monomers allows an arbitrary stereochemical configuration 
at any chiral center within a bis-peptide, and the means to direct hydrogen bonding groups in 
three-dimensional space along the length of the molecule.  We synthesized three additional 
tetramers; each sequence was a permutation of all four members of the pro4 monomer class.  As 
for the previous structural studies, the ROESY data were used to select oligomer conformations 
generated by an in vacuo stochastic search with the Amber94 force field within MOE. 
3.5.1 Oligomer synthesis 
The structure and naming for each of the three bis-peptides is shown in Figure 3-17.  
Each tetramer contains a different permutation of all four stereoisomers of the pro4 monomer.  
As with trimer 44, tyrosine was incorporated into each as a UV tag and to ease purification. 
 
Figure 3-17: Tetramer bis-peptide oligomers incorporating permutations of all four stereoisomers 
of the pro4 monomer: 61 (top), 62 (middle), 63 (bottom).  C–H–N atom number is labeled on 61 
in blue.  Stereochemistry at each chiral center is labeled on each structure in red.  Heterocycle 
naming is labeled on 62 in cyan.  Relative pyrrolidine atom naming is illustrated in green on 63. 
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For oligomer 61, monomers 19, 37, 41, and 30 were coupled sequentially to solid 
support, followed by Fmoc-L-tyrosine (Scheme 3-10).  The synthesis was carried out on 100 mg 
of Rink Amide AM resin (0.64 mmol/g loading) using similar methods as those described for the 
synthesis of the previous tetramers (above).  The product was cleaved from the resin by 
treatment with 8% triflic acid in TFA for 1.5 hours in an ice bath.  The crude, open-form 
oligomer 64 was precipitated from diethyl ether to remove triflic acid.  The precipitate was 
dissolved in a solution of 20% piperidine/NMP to rigidify the oligomer; after ~ 48 hours, the 
desired bis-peptide 61 was precipitated from ether, and purified by preparative HPLC.  
Oligomers 62 and 63 were prepared in similar fashion, as described in Scheme 3-10. 
 
Scheme 3-10: Synthesis of oligomers 61, 62, and 63 
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3.5.2 Modeling and NMR analysis of tetramers 61, 62, and 63 
The structure shown for 61 in Figure 3-18 is identical to the Amber94 minimum energy 
conformation except for pyrrolidine ring E.  The integrated intensities of the Hβb-Hδb 
correlations across pyrrolidine rings A, C and G (H4b-H6b, H11b-H13b, H19b-H21b, H28b-
H29b) are four to five times greater than those for the corresponding Hβa-Hδa correlations, 
supporting the Cβ displaced conformation.  The expected ROESY correlations across DKP ring 
D of 61 are occluded due to overlap, but the H10-H4a correlation suggests the predicted boat 
conformation of DKP ring B, and provides additional evidence for the Cβ displaced 
conformation of pyrrolidine A.  Correlations between H27a and H27b with H39 and H40 evince 
the predicted boat conformation of DKP ring H, and suggest that the aromatic ring of the 
tyrosine residue is folded back against the backbone of the oligomer. 
The conformation of pyrrolidine ring E of 61 (Cδ displaced rather than Cβ displaced, 
with Hβa closer to Hδa than Hβb is to Hδb) is unexpected.  The integrated intensity of the H19a-
H21a correlation is two times greater than the intensity of correlation H19b-H21b correlation, 
and the H26-H21b correlation across DKP ring F is four times the integrated intensity of the 
H26-H21a correlation. 
 
Figure 3-18: Illustration of the modeled conformer of 61 most consistent with the observed 
ROESY correlations.  The thin red, green, and blue cylinders represent strong, medium, and weak 
ROESY correlations, respectively. 
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For compound 62, the ROESY correlations were consistent with the minimum energy 
Amber94 structure shown in Figure 3-19.  The four Hβb-Hδb correlations (H4b-H6b, H11b-
H13b, H19b-H21b, H27b-H29b,) are three to five times greater in integrated intensity than the 
corresponding Hβa-Hδa correlations, suggesting the Cβ displaced conformation for every 
pyrrolidine ring.  As with 61, correlations across DKP ring D are overlapped.  Nevertheless, the 
strong H10-H6a correlation supports the illustrated conformation of DKP ring B, while the 
strength of this correlation relative to H10-H6b (visibly weaker, but overlapped, preventing 
integration) supports the depicted conformation of pyrrolidine ring A.  Furthermore, correlation 
H26-H19a, across DKP ring F, is ten times the intensity of the correlation H26-H19b, which 
lends support to the conformation of DKP ring F and the envelope conformation of E shown in 
Figure 3-19. 
 
Figure 3-19: Illustration of the modeled conformer of 62 most consistent with the observed ROESY correlations.  
The thin red, green, blue and cyan cylinders represent strong, medium, weak, and undefined ROESY correlations, 
respectively. 
 
The structure of 63 shown in Figure 3-20 is consistent with its Amber94 predicted 
minimum energy structure, except for pyrrolidine ring C.  The Hβb-Hδb correlations across rings 
A, E, and G (H4b-H6b, H19b-H21b, H27b-H29b) are visibly stronger than the corresponding 
Hβa-Hδa interactions (though the integrated intensities are greater only by factors of 1.2 to 2.1) 
supporting the predicted Cβ displaced conformations.  For pyrrolidine ring C, correlation H11a-
H13a is slightly more intense (1.1 times) than H11b-H13b, suggesting the unexpected Cδ 
displaced conformation.  The integrated intensities of the Hβa-Hδa correlations in 63 were 
similar to those between Hβb-Hδb, contrasting with the results for 61 and 62, and providing only 
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weak support for the conformation of 63 shown.  There are very clear ROESY correlations 
across all of the DKP rings of 63 (H10-H6a, H18-H13b, and H26-H21a which are five, nine and 
two times the intensity of H10-6Hb, H18-H13b, and H26-H21b, respectively) supporting the 
illustrated conformation of DKP rings B, D, and F, and for pyrrolidine rings A, C, and E. 
 
Figure 3-20: Illustration of the modeled conformer of 63 most consistent with the observed ROESY correlations.  
The thin red, green, and blue cylinders represent strong, medium, and weak ROESY correlations, respectively. 
 
In 62, the pro4(2R,4S) residue is clearly in the Cβ displaced conformation; it precedes a 
pro4(2S,4R) residue in this oligomer.  In both 61 and 63, where pro4(2R,4S) precedes a 
pro4(2R,4R) residue, there is strong evidence that its pyrrolidine ring prefers the Cδ displaced 
conformation.  This suggests that the preferred envelope conformation of a particular residue 
may be context dependant. 
DFT calculations suggest small energy differences between the Cβ displaced and Cδ 
displaced pyrrolidine conformations (<1 kcal/mol), with no strong preference for one ring 
conformation over the other.117  Yet the NMR experiments suggest that the bis-peptides do have 
conformational preferences; the difference between experiment and theory may be due to solvent 
stabilization of one conformation over the other.  
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3.6 CONCLUSIONS 
We have demonstrated the synthesis of a number of bis-peptide oligomers.  The synthesis 
of bis-peptides occurs in two phases: assembly of the flexible oligomer by Fmoc-SPPS, and 
rigidification of the oligomer by forming a second amide bond between adjacent monomer 
residues.  Among the numerous examples of molecular rods and scaffolds2 these bis-peptides 
exhibit the rare property of water solubility, making them suitable for biological 
applications.41,51,54,56,148  bis-Peptides containing the pro4 monomer have rod-like three 
dimensional structures.  All four stereoisomers of the pro4 monomer have been incorporated into 
bis-peptides; NMR evidence suggests that curvature may be controlled by changing the 
stereochemistry of the constituent monomers. 
The half-life of DKP formation between pro4 monomer residues in 20% piperidine/DMF 
is around 4 hours; this is faster than the rate of DKP epimerization under the same conditions.  
Rigidification of bis-peptides in solution has been achieved numerous times.  The method is 
reliable, and reaction progress can be monitored by HPLC-MS.  On occasion, the product or 
intermediates of DKP closure have precipitated from the 20% piperidine/DMF solution; this 
proved beneficial in one case (for trimer 44). 
The method described for comparing the ROESY data to Amber94 minimized 
conformations is rather crude.149  At best, comparing the relative intensities of the ROESY 
correlations may support or refute the modeled conformation; it does not necessarily rule out 
similar conformations.  For example, calculations with the Amber94 force-field suggest that 
pyrrolidine ring C of 63 prefers the Cδ-displaced conformation (Figure 3-21, A).  This conformer 
should have a particular pattern of trans-pyrrolidine ROESY correlations.  Minimization of the 
same structure with a different force field (Amber89,150 for instance) generates the Cγ displaced 
conformation (Figure 3-21, B).  The pattern of ROESY correlations that result from the Cγ 
displaced conformation would be nearly indistinguishable from those arising from the Cδ  
displaced conformation.  In fact, the energy difference between conformers A and B (Figure 
3-21) is likely very small; the ROESY correlations may actually reflect the dynamic equilibrium 
between the two.  Better modeling of the bis-peptides will require a more quantitative analysis of 
pyrrolidine conformation and dynamics. 
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Figure 3-21: Comparison of the Cδ and Cγ displaced pyrrolidine conformations of an internal 
pro4(2R,4S) monomer residue in the context of a bis-peptide.  Structure A (left) was minimized with 
the Amber94 force field, structure B (right) with Amber89.  The dotted lines represent the expected 
ROESY correlation intensities for each conformation: red is strong, blue is weak.  
3.7 EXPERIMENTAL DETAILS 
3.7.1 General methods and procedures 
High resolution mass spectrometry was performed on a Waters Micromass LC/Q-Tof 
Premier mass spectrometer using an electrospray ion source (HRESIQTOFMS).  HPLC analysis 
was performed on a Hewlett-Packard Series 1050 instrument with a diode array detector, using a 
Varian Chrompack Microsorb 100 C18 column (5 μm packing, 4.6 mm × 250 mm) or Waters 
XTerra C18 column (3.5 μm packing, 4.6 mm × 150 mm).  Preparative HPLC was performed on 
a Varian ProStar 500 HPLC system with a Varian Chrompack Microsorb 100 C18 column (8 μm 
packing, 21.5 mm x 50 mm).  HPLC-MS analysis was performed on a Hewlett-Packard Series 
1050 instrument with diode array detector, Agilent 1100 series LC-MSD detector (ES ion 
source) using a Waters XTerra MS C18 column (3.5 μm packing, 4.6 mm × 100 mm).  UV-
visible absorbance spectra were obtained using a Cary Bio-50 UV-visible spectrophotometer.  
1H, 13C, and 2D NMR experiments were performed on a Bruker 500 MHz or 600 MHz 
instrument. 
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General Procedure A: reagents and equipment for solid-phase peptide synthesis (SPPS) 
There is extensive literature explaining the techniques and best-practices for Fmoc solid-
phase peptide synthesis.18,59,123  SPPS was performed manually in fritted polypropylene reaction 
vessels using a homemade peptide synthesis apparatus (Supplemental Figure 96, page 292).  
Small reaction vessels (Note 1) were used for solid-phase synthesis on batches of resin between 
5 and 15 mg.  The tip of a glass pipette was heated in a flame and used to spot weld the frits to 
the bottom of the reaction vessels; this prevented the frits from dislodging during SPPS.  
Medium reaction vessels (Note 2) were used for batches of resin between 10 mg and 50 mg.  
Large reaction vessels (Note 3) were typically used for batches of resin exceeding 50 mg. 
CH2Cl2 used in coupling reactions was distilled from CaH2.  Anhydrous DMF for 
coupling reactions and diketopiperazine formation was purchased from Aldrich; it was used as 
received.  DIPEA was distilled from ninhydrin, and then under a nitrogen atmosphere from 
potassium hydroxide.  After distillation, it was stored in amber bottles over activated 4 Å 
molecular sieves.  HATU was obtained from Aldrich, Acros, or GenScript, and was used as 
received (Note 4).  All solid-phase reactions were performed at ambient room temperature unless 
otherwise noted. 
 
Notes on General Procedure A: 
1. 1.5 mL polypropylene solid-phase extraction reservoirs were purchased from Alltech (part 
number 210001, frit part number 211401). 
2. 10 mL polypropylene fritted PolyPrep columns were purchased from Bio-Rad (part number 
731-1550), and did not require spot welding. 
3. 20 mL polypropylene fritted EconoPac columns were purchased from Bio-Rad (part number 
732-1010).  The frits of the 20 mL reaction vessels were spot welded into place. 
4. At the time of publication, HATU from GenScript was considerably less expensive than that 
purchased from Acros or Aldrich, and performed similarly in coupling reactions. 
 
General Procedure B: resin mixing/agitation (argon bubbling) 
To mix a suspension of solid-phase resin, argon gas was bubbled into the SPPS reaction 
vessel.  Argon (Note 1) was passed through a drying tube containing granular calcium sulfate 
with indicator (Drierite, 10 to 20 mesh) into the argon pressure reservoir (Supplemental Figure 
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96).  Argon flow to each SPPS reaction vessel from the pressure reservoir was limited using a 
needle valve (Note 2).  The gas was bubbled through the frit of the solid-phase reaction vessel 
through the solution in which the solid-phase resin was suspended.  The gas flow rate through 
the reaction vessel was carefully adjusted to gently churn and mix the resin suspension (Note 3). 
 
Notes on General Procedure B: 
1. Argon was purchased from Valley National Gases: catalog listing AR336, “industrial” grade. 
2. The 1/4-28 threaded needle valves were purchased from Upchurch: catalog listing P-721. 
3. If gas flow rate was too great, the solvents would evaporate (i.e., CH2Cl2 and DIPEA) or the 
suspension would become frothy. 
 
General Procedure C: resin mixing/agitation (argon bubbling with stirring) 
For reactions involving larger batches of resin (typically, greater than 50 mg of resin), 
argon bubbling did not provide adequate mixing of the resin suspension; the resin would clump 
and stick to the sides of the reaction vessel.  To augment mixing by argon bubbling, a magnetic 
stir bar (7 mm × 2 mm) was placed into the solid-phase reaction vessel.  The stir bar was 
actuated by a custom-built stir plate mounted near the outside of the solid-phase reaction vessel 
(Supplemental Figure 96).  Larger stir bars (e.g., 10 mm × 3 mm) would grind the solid-phase 
resin, generating fine particles that clogged the frit of the reaction vessel. 
 
General Procedure D: preparation of the solvent for coupling Nα-protected amino acids or pro4 
monomers using HATU 
A 25 mL round bottom flask was removed from the oven (125 °C) (Note 1) and capped 
with a rubber septum.  A needle connected to a positive pressure nitrogen line was inserted into 
the septum.  A second needle open to air was then inserted into the septum.  The flask was 
allowed to cool to room temperature while flushing with nitrogen.  Anhydrous DMF (16 mL) 
and CH2Cl2 (4 mL) (Note 2) were transferred into the flask through the septum by syringe.  The 
solution was mixed by swirling the flask.  The needle open to air was removed from the rubber 
septum (Note 3). 
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Notes on General Procedure D: 
1. The round bottom flask was kept in the oven for at least 4 h. 
2. CH2Cl2 was distilled as described in General Procedure A. 
3. Each batch of 20% CH2Cl2/DMF was used to prepare coupling reaction mixtures for 2 days.  
After 2 days, remaining solution was discarded, and a fresh batch of 20% CH2Cl2/DMF 
solution was prepared. 
 
General Procedure E: resin washing 
Residual solvent or reaction mixture was filtered from the resin by vacuum-assisted 
filtration.  The appropriate reagent-grade solvent was transferred into the solid-phase reaction 
vessel using a squirt bottle.  The volume of solvent was typically greater than 5 times the volume 
of solvent used for the coupling reactions (see General Procedure F).  Care was taken to wash the 
inside walls of the reaction vessel using the squirt bottle.  The resin was mixed in the solvent 
(using either General Procedure B, argon bubbling, or General Procedure C, argon bubbling 
augmented with magnetic stirring, depending on the amount of resin) from 1 to 3 min.  The wash 
solvent was then removed from the resin using vacuum assisted filtration. 
 
General Procedure F: coupling Nα-protected amino acids or pro4 monomers using HATU 
The amino acid or pro4 monomer (2 equiv) (Note 1) was added to a 2 mL 
microcentrifuge tube (Notes 2, 3, 4), followed by HATU (2 equiv) (Notes 1, 5).  Freshly 
prepared 20% CH2Cl2/DMF solution (see General Procedure D) was added to the 
microcentrifuge tube by syringe (0.2 M) (Note 6).  Diisopropylethylamine (DIPEA, 4 equiv) 
(Notes 1, 7) was added to the mixture using an adjustable volume pipette (Notes 8, 9). 
The microcentrifuge tube was capped, and the solution was mixed using a bench-top 
vortex mixer for ~ 3 s.  The tube was centrifuged in a bench-top microcentrifuge (~ 5 to 10 s) 
(Note 10).  The coupling solution was transferred from the microcentrifuge tube to the resin in 
the fritted solid-phase reaction vessel (see General SPPS methods, above) using an adjustable 
volume pipette (Note 8).  The resin-solution suspension was mixed either by General Procedure 
B (argon bubbling) or General Procedure C (argon bubbling with magnetic stirring) for 30 min.  
The coupling solution was removed from the solid-phase reaction vessel by vacuum-assisted 
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filtration.  The resin was washed with DMF, i-PrOH and DMF sequentially as described in 
General Procedure E. 
After the resin wash, this procedure for the coupling reaction was usually repeated one 
time using exactly the same reagents and methods (Notes 11, 12). 
 
Notes on General Procedure F: 
1. Equivalents relative to resin loading 
2. Microcentrifuge tubes were made of polypropylene. 
3. The pro4 monomers are shelf stable, and could be transferred into the microcentrifuge tubes 
days in advance of coupling.  This decreased the time required to prepare for each coupling 
reaction during the course of SPPS. 
4. No special care was taken to dry the polypropylene tubes. 
5. HATU is relatively stable.127  As a precaution, HATU was stored in a dessicator at room 
temperature and added to the microcentrifuge tube containing the amino acid or pro4 
monomer within 1 h prior to the coupling reaction. 
6. 0.2 M in amino acid or pro4 monomer. 
7. Distilled DIPEA was used for the coupling reactions 
8. Eppendorf “Research” adjustable volume micropipettor with Molecular BioProducts Aerosol 
Resistant Tips; no special care was taken to dry the pipette tips. 
9. Upon the addition of DIPEA, the color of the solution would usually change from pale yellow 
to darker yellow. 
10. After using the vortex mixer, the solution adheres to the sides and top of the microcentrifuge 
tube.  Centrifugation forces all of the coupling solution to the bottom of the microcentrifuge 
tube so that it can be recovered easily.  
11. Repeating a coupling reaction is known as “double coupling”; this is performed to ensure 
quantitative coupling.  Resin beads adhere to the walls of the solid-phase reaction vessel and 
are potentially underexposed to the coupling solution during the first coupling cycle. 
12. The resin wash between the first and second cycle of doubling coupling can be abbreviated 
by eliminating the intermittent i-PrOH washing step; this does not seem to affect the yield of 
the coupling reaction. 
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General Procedure G: resin “capping” with acetic anhydride 
Reagent grade DMF (8 mL), acetic anhydride (2 mL) and distilled DIPEA (160 μL) were 
added to a 15 mL polypropylene Falcon® tube.  The tube was capped and the solution was mixed 
using a bench-top vortex shaker.  A portion of this solution was applied to the resin after it had 
been washed in DMF (see General Procedure D).  After capping, the resin was usually washed 
with DMF, i-PrOH, and then DMF in the manner described in General Procedure D. 
 
General Procedure H: Fmoc group deprotection on solid-phase 
Reagent grade DMF (80 mL) was transferred into a 125 mL Erlenmeyer flask.  Piperidine 
(20 mL) was added to the flask.  The solution was mixed by gentle swirling, and the flask was 
capped with a polypropylene stopper (Note 1). 
To remove the Fmoc group from a resin-bound amine, freshly prepared 20% 
piperidine/DMF solution was measured into the reaction vessel containing the resin using an 
adjustable volume Eppendorf pipette (Note 2).  The resin-solution suspension was mixed using 
General Procedure B (mixing by argon bubbling) or General Procedure C (mixing by argon 
bubbling and magnetic stirring) for 40 minutes (Note 3).  After 40 minutes, the mixing was 
stopped, and the resin settled to the bottom of the solid-phase reaction vessel. 
An aliquot of the deprotection reaction mixture was taken from the top of the solution 
and added to 20% piperidine/DMF in a 1 cm UV-absorbance cell (Note 4).  The sample was 
mixed by pipetting the solution up and down several times using a 2 mL glass pipette with a 
rubber bulb.  The UV-absorbance spectrum of this solution was measured between 250 nm and 
350 nm.  The absorbance spectrum of the 20% piperidine/DMF solution was subtracted from the 
UV-absorbance spectrum of the sample.  The absorbance of the processed spectrum at 301 nm 
was recorded (Note 5). 
Following Fmoc deprotection, the resin was washed with DMF (~ 3 ×), i-PrOH (~ 3 ×) 
and DMF (~ 3 ×) using General Procedure E (Notes 6, 7).   
 
Notes on General Procedure H: 
1. The 20% piperidine/DMF solution was used for the removal of Fmoc groups during SPPS, 
and to dilute samples from the deprotection reaction solution (for quantifying coupling 
reaction yields by measuring the UV-absorbance of the released dibenzofulvene-piperidine 
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chromophore).  After 2 days, residual solution was discarded, and a fresh batch of 20% 
piperidine/DMF was prepared. 
2. 1 mL of 20% piperidine/DMF was typically used for small batches of resin (25 mg of resin or 
less).  2 mL to 5 mL of the 20% piperidine/DMF solution was typically used for larger batches 
of resin.  The volume was chosen such that the resin could tumble freely within the solution 
during the deprotection reaction. 
3. The reaction time for Fmoc deprotection has been abbreviated to 30 minutes without an 
appreciable effect on the reaction yields. 
4. Aliquot size was chosen based upon the theoretical loading of the resin, and upon the volume 
of 20% piperidine/DMF in the UV cell.  The dilution factor was chosen so that the absorbance 
of the solution in a 1 cm cell was roughly 1 AU (within the linear range of the 
spectrophotometer). 
5. ε = 7800 M-1 cm-1 for the dibenzofulvene-piperidine adduct in 20% piperidine/DMF at room 
temperature. 
6. Special care was taken to wash the inner walls of the solid-phase reaction vessel after Fmoc 
deprotection to remove all traces of residual piperidine solution. 
7. The resin was washed with either DMF or 20% CH2Cl2/DMF prior to the next coupling 
reaction. 
 
General Procedure I: resin washing and treatment prior to linker cleavage 
After completing SPPS, the solid-phase resin was generally washed with DMF, i-PrOH, 
DMF, CH2Cl2, MeOH, and finally CH2Cl2 as described in General Procedure E.  After the final 
wash with CH2Cl2, the reaction vessel was removed from the SPPS apparatus and the top was 
sealed with a polypropylene cap.  Residual solvent was removed from the resin under reduced 
pressure. 
3.7.2 Details for synthesis of trimer bis-peptide 44 and intermediates 
Compound 49 
Rink Amide AM Resin (72 mg resin, 46.1 μmol loading) was transferred into a 10 mL fritted 
polypropylene SPPS reaction vessel.  DMF (~ 5 mL) was added to the reaction vessel; the resin 
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was swollen in the DMF solution with argon bubbling (General Procedure B).  The Fmoc group 
was removed from the Rink Amide linker using 20% piperidine/DMF (General Procedure H).  
The resin was then washed with DMF, i-PrOH and 20% CH2Cl2/DMF (General Procedure E).  
Cbz-pro4(2S,4S) monomer 18 (50.2 mg, 92.2 μmol) and HATU (35.1 mg, 92.2 μmol) were 
measured into a 2.2 mL polypropylene microcentrifuge tube and dissolved in 20% CH2Cl2/DMF 
(460 μL).  DIPEA (32 μL, 184.4 μmol) was added to the tube, and the coupling solution was 
mixed briefly and transferred to the resin.  This coupling reaction was allowed to proceed for 60 
minutes at room temperature; the coupling solution was then removed from the resin by vacuum 
assisted filtration. The resin was washed with DMF (General Procedure B), and coupling with 18 
was repeated a second time (see General Procedure F).  The resin was washed with DMF 
(General Procedure E).  The Fmoc group of the Cbz-pro4(2S,4S) monomer residue was removed 
with 20% piperidine/DMF (General Procedure H).  UV-visible spectroscopic analysis of the 
dibenzofulvene-piperidine adduct in the solvent at 301 nm suggested nearly quantitative 
coupling, relative to the initial resin loading. The resin was washed with DMF, i-PrOH, and then 
20% CH2Cl2/DMF (General Procedure E).  Two additional Cbz-pro4(2S,4S) monomers (18) 
were coupled to the resin using the same sequence of procedures. 
 
N-α-Fmoc-O-tert-butyl-L-tyrosine (63.6 mg, 138.3 μmol) and HATU (52.6 mg, 138.3 μmol) 
were added to a 2.2 mL polypropylene microcentrifuge tube then dissolved in 20% CH2Cl2/DMF 
(690 μL).  DIPEA (48.1 μL) was added, and the solution was mixed then quickly transferred to 
the resin (General Procedure F).  After 60 minutes of mixing (General Procedure B), the 
coupling solution was removed by vacuum filtration and washed with DMF (General Procedure 
E).  The N-terminal Fmoc group of tyrosine was removed by treatment with 20% 
piperidine/DMF over 120 minutes.  The resin was thoroughly washed with DMF, methanol, and 
CH2Cl2 (General Procedure I).  Solvent was removed from the resin under reduced pressure.  
Cleavage of the product from the resin was affected by treatment with 3 mL of 95:2.5:2.5 
TFA/TIS/H2O for 120 minutes.  The resin was filtered from the cleavage solution, and then 
washed with additional TFA.  The TFA washes were combined with the cleavage solution, and 
the solvent was evaporated at room temperature under a stream of dry nitrogen.  Residual solvent 
was removed under reduced pressure, affording 49 as a yellow residue. 
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HPLC-MS: column, Waters XTerra MS C18, 4.6 × 100 mm; mobile phase, CH3CN / water (0.1% 
TFA), 5% to 95% CH3CN over 30 min; flow rate, 0.40 mL/min; UV detection at 274 nm; tR for 
49, 21.0 min; ESI-MS m/z (extracted ion) 1061.2 (M + H+). 
 
Compound 50 
49 was dissolved in 7:2:1 methanol/water/acetic acid (4 mL).  A small volume of this solution 
(50 μL) was removed for HPLC-MS analysis.  The remaining solution was transferred into a 10 
mL round bottom flask containing 10 wt. % Pd on activated carbon (~ 5 mg) and a magnetic stir 
bar.  The flask was evacuated under reduced pressure and backfilled with H2 gas.  The reaction 
mixture was stirred under H2 gas (balloon) for 60 minutes.  The reaction mixture was filtered 
through a centrifugal spin filter (0.2 μm nylon frit), and the activated carbon was washed with an 
additional portion of the reaction solvent (3 × 333 μL).  The filtered reaction mixture and washes 
were combined, and the solvent was removed at 40 °C for 5 hours under centrifugal evaporation.  
Residual solvent was removed under reduced pressure at room temperature overnight yielding 50 
as a foamy white solid. 
 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 100 mm; mobile phase, CH3CN / water (0.1% 
TFA), 5% to 95% CH3CN over 30 min; flow rate, 0.40 mL/min; UV detection at 274 nm; tR for 
50, 8.03 min; ESI-MS m/z (ion) 659.2 (100%, M + H+). 
 
Compound 44  
50 was dissolved in 1400 μL of 20% piperidine/DMF (anhydrous) and transferred to a 2.2 mL 
polypropylene microcentrifuge tube.  The tube was placed in a 4 °C refrigerator and stored for 24 
hours, then transferred to a 2 °C refrigerator where it was stored for an additional 24 hours.  An 
irregular, straw colored precipitate formed in the solution during this time.  The supernatant was 
filtered from the precipitate using a centrifugal spin filter (0.2 μm nylon frit).  The precipitate 
was washed with CHCl3 500 μL), dissolved in 60:40 MeCN/D2O with 0.1% TFA (5 mL); the 
resulting solution was transferred into a Falcon® tube.  The solution was frozen by immersing the 
tube into liquid nitrogen and rotating the tube so that a thin shell of frozen solvent covered the 
walls of the tube.  The frozen solution was lyophilized, yielding 44 (~ 5 mg, 8 μmol, 17% from 
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initial resin loading), as a fine white powder, analyzed by NMR without further purification.  
This product was contaminated with piperidine salt (~ 5.6 μmol, determined by NMR).  A small 
sample of 44 was dissolved in 0.1% TFA/H2O for HPLC-MS analysis.  1H chemical shifts are 
reported in ppm (δ) relative to the piperidine salt, which was calibrated under identical 
experimental conditions to the sodium salt of 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid.  13C 
chemical shifts are reported in ppm (δ) relative to the piperidine salt, which was calibrated under 
identical experimental conditions to dioxane. 
 
1H NMR (500 MHz, 10 °C, D2O): δ 7.05 (d, J = 4.9 Hz, 2H), 6.90 (d, J = 4.9 Hz, 2H), 4.84 (dd, 
J = 10.1, 7.9 Hz, 1H), 4.60 (dd, J = 10.0, 8.0 Hz, 1H), 4.53 (dd, J = 10.6, 6.9 Hz, 1H), 4.48 (t, J = 
3.2 Hz, 1H), 4.08 (d, J = 12.5 Hz, 1H), 4.06 (d, J = 12.4 Hz, 1H), 3.67 (d, J = 12.6 Hz, 1H), 3.53 
(d, J = 12.5 Hz, 1H), 3.22 (dd, J = 14.1, 1.9 Hz, 1H), 3.07 (dd, J = 13.7, 7.6 Hz, 1H), 2.95 (dd, J 
= 14.1, 4.5 Hz, 1H), 2.78 – 2.69 (m, 3H), 2.44 – 2.35 (m, 3H), 2.17 (dd, J = 13.0, 11.0 Hz, 1H); 
13C NMR (125 MHz, 10 °C, D2O) δ 171.3, 170.7, 170.5, 169.7, 167.2, 166.7, 156.2, 132.7 (2C), 
126.7, 118.2, 116.5 (2C), 115.9, 65.0, 62.4, 60.5, 59.4, 58.7, 57.7, 56.4, 55.2, 52.8, 51.2, 40.8, 
40.1, 38.6. 
 
1H NMR (500 MHz, 10 °C, 10% D2O/H2O, pH ≈ 0) δ 8.81 (s, 1H), 8.80 (s, 1H), 8.78 (s, 1H), 
8.71 (s, 1H), 7.99 (s, 1H), 7.54 (s, 1H), 7.05 (d, J = 8.04 Hz, 2H), 6.90 (d, J = 6.1 Hz, 2H), 4.81 
(t, J = 8.7 Hz, 1H), 4.60 (dd, J = 17.1, 8.3 Hz, 1H), 4.47 (br s, 1H), 4.08 (d, J = 12.2 Hz, 1H), .07 
(d, J = 12.1 Hz, 1H), 3.68 (d, J = 12.5 Hz, 1H), 3.54 (d, J = 12.5 Hz, 1H), 3.21 (d, J = 14.0 Hz, 
1H), 3.09 (dd, J = 13.7, 7.8 Hz, 1H), 2.94 (dd, J = 14.0, 3.5 Hz, 1H), 2.79 – 2.72 (m, 3H), 2.45 – 
2.36 (m, 3H), 2.16 (t, J = 12.0 Hz, 1H); 13C NMR (125 MHz, 10 °C, 10% D2O/H2O, pH ≈ 0) δ 
170.7, 170.2, 170.0, 169.1, 166.6, 166.1, 155.7, 132.2 (2C), 126.2, 117.7, 116.2 (2C), 115.4, 
64.8, 62.3, 60.4, 59.3, 58.5, 57.5, 56.2, 55.0, 39.9, 38.5. 
 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 100 mm; mobile phase, CH3CN / water (0.1% 
TFA), 5% to 20% CH3CN over 30 min; flow rate, 0.40 mL/min; UV detection at 274 nm; tR for 
44, 8.84 min; ESI-MS m/z (ion) 595.2 (100%, M + H+). 
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3.7.3 Details for synthesis of pentamer bis-peptide 53 
Compound 51  
Rink Amide AM Resin (49 mg resin, 31.4 μmol loading) was added to a 10 mL polypropylene 
SPPS reaction vessel and swollen overnight in DMF under argon.  The N-terminal Fmoc group 
was removed with 20% piperidine/DMF (General Procedure H).  The resin was washed with 
DMF, i-PrOH, and 20% CH2Cl2/DMF (General Procedure E).  N-α-Fmoc-O-tert-butyl-L-
tyrosine (46.5 mg, 101.2 μmol), HATU (38.5 mg, 101.2 μmol), and 20% CH2Cl2/DMF (690 μL) 
were added to a 2.2 mL polypropylene microcentrifuge tube.  DIPEA (48.1 μL) was added to the 
tube; the solution was mixed briefly, and was then transferred to the resin (General Procedure F).  
The coupling reaction was mixed for 60 minutes at room temperature.  The coupling solution 
was removed by vacuum filtration, and the resin was washed (General Procedure E). The N-
Fmoc group was removed with 20% piperidine/DMF (General Procedure H) 
 
18 (34.2 mg, 62.8 μmol), HATU (23.9 mg, 62.8 μmol) and 20% CH2Cl2/DMF (314 μL) were 
added to a 2.2 mL polypropylene tube.  DIPEA (22 μL, 126 μmol) was added; the coupling 
solution was mixed briefly then added to the resin (General Procedure F). The coupling reaction 
was mixed for 60 minutes at room temperature, and then the reaction mixture was removed from 
the resin by vacuum assisted filtration.  The resin was washed with DMF (General Procedure F).  
The coupling reaction was repeated a second time using identical conditions for an additional 60 
minutes. The resin was washed, and the terminal N-Fmoc group was removed using 20% 
piperidine/DMF (General Procedure H).  The UV-visible absorption spectrum of the piperidine-
dibenzofulvene adduct in the deprotection solution suggested nearly quantitative coupling, 
relative to the initial resin loading.  The resin was washed with DMF, i-PrOH, and 20% 
CH2Cl2/DMF (General Procedure E). Double coupling and deprotection of 18 was repeated 
sequentially four additional times.  The resin was washed with DMF, methanol, and then 
CH2Cl2; residual solvent was removed from the resin over 4 hours under reduced pressure 
(General Procedure I).  Product cleavage was affected by treating ~ 13 mg of the resin with 
95:2.5:2.5 TFA/H2O/TIS (2 mL) for 120 minutes.  The resin was filtered from the cleavage 
solution, and was washed with additional TFA (3 × 1 mL). The TFA washes were combined with 
the cleavage solution, and the solvent was evaporated at room temperature under a stream of dry 
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N2 gas.  Residual solvent was removed under reduced pressure affording crude 51 as a slightly 
yellow residue. 
 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 100 mm; mobile phase, CH3CN / water (0.1% 
TFA), 5% to 95% CH3CN over 30 min; flow rate, 0.40 mL/min; UV detection at 220 nm; tR for 
51, 22.90 min; ESI-MS m/z (relative intensity) 1701.4 (25%, M + H+). 
 
Compound 52  
Crude 51 was dissolved in 7:2:1 MeOH/H2O/AcOH (2 mL).  A small volume of this solution (50 
μL) was removed for HPLC-MS analysis.  The remaining solution was transferred to a 10 mL 
round bottom flask containing 10 wt. % Pd/C (~ 5 mg) and a magnetic stir bar.  The flask was 
evacuated under reduced pressure, and backfilled with H2 gas.  The reaction mixture was stirred 
under H2 gas (balloon) for 60 minutes. The reaction mixture was filtered through a centrifugal 
spin filter (0.2 μm nylon frit), and the activated carbon was washed with 7:2:1 
MeOH/H2O/AcOH (3 × 333 μL).  The solvent was removed by centrifugal evaporation at 40 °C, 
then under reduced pressure overnight yielding a yellow residue. HPLC-MS analysis indicated 
that the major component of this crude product was the compound 52 with one DKP closed. 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 100 mm; mobile phase, CH3CN / water (0.1% 
TFA), 5% to 20% CH3CN over 30 min; flow rate, 0.40 mL/min; UV detection at 274 nm; tR for 
major component, 15.3 min; ESI-MS m/z (relative intensity) 999.3 (13%, M52 – MeOH + H+), 
500.2 (80%). 
 
Compound 53  
The products of the catalytic hydrogenolysis of 51 were dissolved in 20% piperidine/DMF (1 
mL) and transferred to a 2.2 mL polypropylene tube.  After 24 hours at room temperature, the 
solution was added dropwise to ether (50 mL); the resulting fine, white precipitate was pelleted 
by centrifugation.  The pellet was dried overnight affording crude 53 (~ 3 mg, 3 μmol, 33% from 
initial resin loading) as a white solid.  Crude 53 was dissolved in 60:40:1 MeCN/H2O/TFA (200 
μL), and a portion of this solution (20 μL) was added to an additional volume of 60:40:1 
MeCN/H2O/TFA (180 μL) for HPLC analysis. 
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HPLC-MS: column, Waters XTerra MS C18, 4.6 × 100 mm; mobile phase, CH3CN / water (0.1% 
TFA), 5% to 20% CH3CN over 30 min; flow rate, 0.40 mL/min; UV detection at 274 nm; tR for 
53, 8.84 min; ESI-MS m/z (ion extracted) 903.3 (M + H+). 
3.7.4 Details for synthesis of compounds in model DKP closure study 
Compound 54, Compound 55, Compound 56 
Rink Amide AM Resin (20 mg, 12.8 μmol loading) was added to a 10 mL polypropylene SPPS 
reaction vessel and swollen in DMF.  N-α-Fmoc-O-tert-butyl-L-tyrosine, 18, 18, and 4-
nitrobenzoic acid were coupled sequentially to the resin using HATU with DIPEA in 20% 
CH2Cl2/DMF (coupling by General Procedure F, Fmoc deprotection by General Procedure H, 
and washing by General Procedure E).  The resin was washed with CH2Cl2, MeOH, and CH2Cl2, 
then dried under reduced pressure overnight (General Procedure I).  Thioanisole (50 μL), 
ethanedithiol (EDT, 25 μL), and TFA (500 μL) were added to the resin.  Triflic acid (50 μL) was 
added carefully to the solution; the cleavage cocktail and resin were agitated occasionally over 
90 minutes.  The cleavage solution was filtered from the resin, and added dropwise into ether (~ 
40 mL).  The resulting precipitate was formed into a pellet by centrifugation; the ether was 
decanted, and an additional portion of ether (40 mL) was added to the pellet.  The pellet was 
broken up, suspended in the ether, then reformed by centrifugation; the ether wash was decanted, 
affording the product 54 as a white solid.  This was dissolved in 1:1 H2O/ACN (0.1% TFA) and 
lyophilized, yielding a fluffy white solid that was dissolved in another portion of H2O/ACN and 
divided evenly into 1 mL polypropylene tubes.  The solvent was removed by centrifugal 
evaporation.  To analyze DKP formation, solvents (100 μL portions) were added to the tubes 
containing 54, mixed quickly with a pipette.  Each reaction was monitored by HPLC. 
HPLC: column, Microsorb 100 C18, 4.6 mm × 250 mm; mobile phase, CH3CN (0.05% TFA) / 
water (0.1% TFA), 28% to 35% CH3CN over 5 minutes; flow rate, 1.00 mL / min; UV detection 
at 274 nm; tR for 54, 4.88 min; tR for 55, 5.41 min; tR for 56, 3.51 min.  For 54: ESI-MS m/z (ion) 
670.2 (M + H+).  For 55: ESI-MS m/z (ion) 638.3 (M + H+).  For 56: ESI-MS m/z (ion) 624 (M + 
H+) 
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3.7.5 Details for the synthesis of 57 and 58, and preparation of NMR samples 
Compound 57, Compound 59 
100 mg of Rink Amide AM resin (0.63 mmol/gram substitution) were transferred to a solid 
phase reaction vessel and swollen in DMF for several hours.  The N-Fmoc protecting group of 
the resin was removed by treatment with a solution of 20% piperidine/DMF for 40 minutes 
(General Procedure H).  The resin was washed sequentially with DMF, CH2Cl2, i-PrOH, and 
DMF (General Procedure E).  (S)-N-Fmoc-2-naphthylalanine (56.4 mg, 128 μmol) and HATU 
(48.6 mg, 128 μmol) were added to a polypropylene microcentrifuge tube.  The protected amino 
acid and coupling reagent were dissolved in 640 μL of 20% CH2Cl2/DMF.  DIPEA (45.0 μL, 
256 μmol) was added to the coupling solution; the solution was mixed and added to the resin 
immediately (General Procedure F).  The resin and coupling solution were agitated for 1 hour 
and then washed.  The coupling reaction was repeated one additional time.  The resin was capped 
with a solution of 400:100:8 DMF/Ac2O/DIPEA (General Procedure G).  The naphthylalanine 
N-terminal Fmoc protecting group was removed using a solution of 20% piperidine/DMF over 
40 minutes (General Procedure H), and the resin was washed sequentially with DMF, CH2Cl2, i-
PrOH, and DMF (General Procedure E). 
 
Monomer 18 (70.0 mg, 128 μmol) was coupled to the resin using HATU in a similar fashion 
(General Procedure F).  Following coupling of the first monomer to the solid phase, the resin was 
capped (General Procedure G), the N-terminal Fmoc protecting group was removed (General 
Procedure H), and the resin was washed (General Procedure E).  Three additional monomers 
were coupled sequentially to the resin using similar procedures (monomers 18, 29, then 29).  The 
N-terminal Fmoc protecting group was removed (General Procedure H).  The resin was washed 
with CH2Cl2, MeOH, and CH2Cl2 then dried under reduced pressure overnight (General 
Procedure I). 
 
The resin was transferred to a 4 mL conical vial containing a magnetic spin vane.  
Triisopropylsilane (86 μL), water (86 μL), and trifluoroacetic acid (TFA, 3.25 mL) were added 
sequentially.  This cleavage solution was stirred for 2 hours, and then the resin was filtered from 
the solution and washed with an additional volume of TFA.  The filtrates were combined and 
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concentrated by centrifugal evaporation at room temperature.  Thioanisole (25 μL) and 
ethanedithiol (10 μl) were added to the resulting oily residue, followed by TFA (250 μL) and 
triflic acid (25 μL).  This solution was stirred for 15 minutes, then added slowly to diethyl ether 
(~ 80 mL); the precipitate (crude 59) was pelleted by centrifugation.  The ether was decanted 
from the pellet, and the pellet was dissolved in 20% piperidine/DMF (1.25 mL).  After 
approximately 48 hours at room temperature, the crude product was precipitated from ether.  The 
precipitate was dissolved in a 90:10:1 H2O/MeCN/TFA solution, and the product (57) was 
purified by preparative HPLC (C18 column; 30 mm × 300 mm; mobile phase, CH3CN (0.05% 
TFA) / water (0.1% TFA), 10% to 35% CH3CN over 30 min; flow rate, 43 mL/min).  The 
fractions containing the desired product were concentrated by lyophilization yielding 57 (10.3 
mg, 12.9 μmol, ~ 20% overall yield, based upon initial resin loading): HRESIQTOFMS calcd for 
C38H43N10O10 (M + H+) 799.3158, found 799.3251. 
 
 
HPLC: column, Microsorb 100 C18, 4.6 × 250 mm; mobile phase, CH3CN (0.05% TFA) / water (0.1% TFA), 5% to 
95% CH3CN over 30 min; flow rate, 1.00 mL/min; UV detection at 274 nm; tR for 57, 11.67 min. 
 
Figure 3-22: HPLC chromatogram of purified 57 
 
Compound 58, Compound 60 
58 was prepared using a procedure similar to the one described for the synthesis of 57.  (S)-N-
Fmoc-2-naphthylalanine, 18, 29, 18, and 29 were coupled sequentially to 100 mg of Rink Amide 
AM resin (coupling using General Procedure F, capping using General Procedure G, washing as 
described for 57, Fmoc deprotection using General Procedure H, and final resin wash using 
General Procedure I).  The resin was cleaved using TFA, and the Cbz groups of the crude 
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product were removed with exposure to triflic acid, affording compound 60.  This was treated 
with 20% piperidine/DMF for 48 hours, precipitated from ether, and purified by preparative 
HPLC.  Fractions containing the desired product were concentrated by lyophilization yielding 58 
(10.4 mg, 13.0 μmol, ~ 20% overall yield, based upon initial resin loading):  HRESIQTOFMS 
calcd for C38H43N10O10 (M + H+) 799.3158, found 799.3190. 
 
 
HPLC: column, Microsorb 100 C18, 4.6 × 250 mm; mobile phase, CH3CN (0.05% TFA) / water (0.1% TFA), 5% to 
95% CH3CN over 30 min; flow rate, 1.00 mL/min; UV detection at 274 nm; tR for 58, 10.69 min. 
 
Figure 3-23: HPLC chromatogram of 58 
 
NMR Analysis of 57 and 58 
The NMR samples of 57 and 58 were prepared by dissolving each in approximately 450 μL of 
degassed 9:1 H2O/D2O with 0.025 M ND4COOD:CD3COOD buffer (pH 4-5).  The samples were 
filtered through 0.2 μm Nylon frit centrifugal filters and transferred to a D2O matched Shigemi 
NMR tube.  Experiments were acquired on a 500 MHz spectrometer at 2 °C.  COSY, ROESY 
(mixing time of 300 ms), HMQC and HMBC experiments were performed.  Processed data sets 
were analyzed using Sparky.151  The chemical shift assignments are based upon the COSY, 
HMBC, and ROESY cross-peaks. 
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3.7.6 Details for the synthesis of 61, 62, and 63, and preparation of NMR samples 
Compound 61, Compound 62, Compound 63 
A 100 mg batch of Rink Amide AM resin (0.64 mmol/g loading) was transferred to a solid-phase 
reaction vessel containing a small magnetic stir bar.  The resin was swollen in DMF for several 
hours with gentle argon bubbling (General Procedure B).  The N-Fmoc group of the resin linker 
was removed using 20% piperidine/DMF for 40 minutes; the resin was washed sequentially with 
DMF, CH2Cl2, i-PrOH, and DMF (General Procedure E).  The desired monomer was coupled to 
the resin.  The coupling reaction mixture was prepared by measuring the desired monomer (193 
mg, 378 μmole) and HATU (143 mg, 378 μmole) into a 15 mL polypropylene centrifuge tube.  
Freshly prepared anhydrous 4:1 DMF/CH2Cl2 (1800 μL, 0.2 M in monomer) was added to the 
tube followed by DIPEA (131 μL, 756 μmole).  The coupling solution was mixed for about one 
minute, and then transferred to the resin.  The resin and coupling solution were mixed by slowly 
bubbling argon through the solution and by using a small magnetic stir bar (General Procedure 
C).  Coupling was allowed to proceed for 30 minutes, and the coupling solution was drained 
from the resin.  The resin was washed with DMF, i-PrOH, and DMF (General Procedure E).  The 
coupling and washing procedure was repeated one additional time with the same monomer.  
Unreacted amines were then capped with a solution of 50:12.5:1 DMF/Ac2O/DIPEA for 20 
minutes (General Procedure G).  The N-Fmoc group of the terminal amine was removed using 
20% piperidine/DMF solution for 40 minutes (General Procedure H), and the coupling yield was 
determined by measuring the concentration of the piperidine/dibenzofulvene adduct in the 
deprotection reaction solution. 
 
The coupling, capping, and deprotection sequence was repeated for each of the desired 
monomers on each batches of resin.  The sequence of monomers coupled to each batch of resin is 
shown in the following table (Table 3-2).  After the final monomer was coupled to the resin 
(General Procedure F) and the Fmoc group removed (General Procedure H), (S)-N-Fmoc-
tyrosine was coupled in a similar fashion using HATU and DIPEA.  The N-Fmoc group of the 
tyrosine residue was removed (General Procedure H), and the resin was washed sequentially 
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with DMF, CH2Cl2, MeOH, and CH2Cl2 (General Procedure I).  Residual solvent was removed 
from the resin under reduced pressure. 
Table 3-2: The coupling sequence for the solid phase synthesis of oligomers 61, 62, and 63 
 
 
70 mg of the resin was removed from each batch and transferred into a fritted polypropylene 
reaction vessel containing a small stir bar.  Ethanedithiol (100 μL) and thioanisole (200 μL) were 
added to the resin, and the reaction vessels were submerged in an ice bath.  TFA (2 mL) was 
added to the resin, followed by triflic acid (100 μL).  The cleavage solution was stirred for 2 
hours and then added dropwise to a stirred, room temperature Et2O (100 mL).  The resins were 
washed with TFA (1 mL); this was filtered into the ether as well.  The resulting precipitates were 
pelleted by centrifugation.  The pellets were washed with an additional volume of ether and then 
dried to a yellowish residue.  The product of each cleavage was dissolved in 20% 
piperidine/NMP (1.25 mL) and sealed in an HPLC vial for 48 hours.  Each solution was then 
slowly added to ether, the precipitate was isolated by centrifugation.  The products were purified 
by preparative HPLC (C18 column; mobile phase, CH3CN (0.05% TFA) / water (0.1% TFA), 0% 
to 20% CH3CN over 30 min; flow rate, 15 mL/min).  Desired fractions were concentrated by 
centrifugal evaporation. 
 
Preparing the NMR Samples of 61, 62, and 63 
Samples were each dissolved in 420 μL of a degassed 90:10 H2O/D2O solution buffered with 10 
mM CD3COOD/CD3COO-ND4+, pH 1.5.  The final solution was around pH 3.0.  A trace amount 
of the sodium salt of 3-(trimethylsilyl)propionic acid-d4 (TSP-d4) was added to the solution as an 
internal standard.  The solutions were filtered through 0.2 μm Nylon centrifugal filters.  50 μL of 
each sample was used for HPLC and for high resolution mass spec analysis; the remainder was 
transferred into the Shigemi NMR tubes for analysis by NMR.  Based upon the maximum 
tyrosine absorbance at 274 nm, it was determined by HPLC that the overall isolated yield (based 
on initial resin loading) was between 25% and 30%, and that the concentration of the NMR 
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samples was on the order of 10 mM.  The NMR samples of 61 and 62 were contaminated with a 
trace amount of NMP. 
 
Analytical data for bis-peptide 61: 
 
HPLC: C18 column; mobile phase, CH3CN (0.05% HCOOH) / water (0.1% HCOOH), 0% to 25% CH3CN over 30 
min; flow rate, 0.80 mL/min; UV detection at 274 nm; tR for 61, 9.03 min; HRESIQTOFMS calcd for C33H37N10O10 
(M + H+) 733.2689, found 733.2675. 
 
Figure 3-24: HPLC chromatogram and HRMS analysis of the NMR sample containing compound 61 
 
Analytical data for bis-peptide 62: 
 
HPLC: C18 column; mobile phase, CH3CN (0.05% HCOOH) / water (0.1% HCOOH), 0% to 25% CH3CN over 30 
min; flow rate, 0.80 mL/min; UV detection at 274 nm; tR for 62, 9.09 min; HRESIQTOFMS calcd for C33H37N10O10 
(M + H+) 733.2689, found 733.2653. 
 
Figure 3-25: HPLC chromatogram and HRMS analysis of the NMR sample containing compound 62 
 
 
 110 
Analytical data for oligomer 63: 
 
HPLC: C18 column; mobile phase, CH3CN (0.05% HCOOH) / water (0.1% HCOOH), 0% to 25% CH3CN over 30 
min; flow rate, 0.80 mL/min; UV detection at 274 nm; tR for 63, 8.06 min; HRESIQTOFMS calcd for C33H37N10O10 
(M + H+) 733.2689, found 733.2719. 
 
Figure 3-26: HPLC chromatogram and HRMS analysis of the NMR sample containing compound 63 
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4.0  FRET STUDY 
2D-NMR experiments have been used to determine the conformation and shape of bis-
peptide oligomers in solution.  Oligomers were modeled using molecular mechanics calculations, 
and the resulting conformers were evaluated by measuring the relative intensity of ROESY 
correlations across the pyrrolidine and DKP rings.  Measurable ROESY correlations can be 
detected between protons that are within 3 to 4 Å of one another.  Modeling suggests that 44, 
containing three pro4(2S,4S) monomer residues, is around 15 Å in length.  The ROESY 
correlations provided insight into the conformation of heterocycles within the oligomer, but 
predicting global structure from the sum of local interactions is error prone. 
Analysis of oligomer structure by 2D-NMR is non-trivial and time consuming.  Although 
multiple bis-peptide oligomers can be designed and synthesized in parallel within days, NMR 
structure determination requires weeks.  We envision a rapid cycle of design, synthesis, testing, 
and re-design; faster and more convenient methods for analyzing oligomer structure and function 
could enable this approach.  There is need to explore other methods for measuring the shape and 
structure of bis-peptide oligomers. 
We have attempted structure determination by X-ray diffraction, but growing suitable 
crystals is an extremely slow process.  Crystal-packing forces can elicit changes in molecular 
conformation;152 this effect has been observed in molecules containing DKPs.139  The 
conformation of an oligomer in solution is arguably more relevant than its crystal structure 
because the applications for the oligomers are primarily solution-based.  Although the size of 
larger oligomer structures might be determined using viscosity measurements, light scattering, 
and ultracentrifugal sedimentation, these methods are inappropriate for smaller oligomers.153  
Our first approach was to synthesize fluorophore end-labeled oligomers, and to evaluate the 
relative length of these oligomers by fluorescence resonance energy transfer (FRET). 
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FRET is technique used to measure the distance between a “donor” and an “acceptor” 
fluorophore.154  FRET is only possible when the fluorescence emission spectrum of the donor 
overlaps with the absorption spectrum of the acceptor (Figure 4-1).  Light energy excites the 
donor fluorophore; when the acceptor is absent, the donor fluoresces at a particular wavelength, 
λ1.155  If the acceptor is positioned near the donor, energy is transferred from the donor into the 
acceptor; the acceptor will then emit light at λ2 (a longer wavelength than λ1).  The energy 
transfer between the donor and acceptor (Förster energy transfer) is caused by resonance 
between the dipoles of the excited state of the donor and the excited state of the acceptor, and not 
by emission of a photon from the donor.156 
 
Figure 4-1: A schematic representation of fluorescence resonance energy transfer (illustration 
adapted from “Modern Physical Organic Chemistry”)155 
 
The efficiency of Förster energy transfer is proportional to (1 / r6), where r is the distance 
between the donor and acceptor.  The relationship between donor-acceptor distance and energy 
transfer efficiency was first exploited as a “spectroscopic ruler” by Stryer and Haugland;52 they 
measured the lengths of poly-L-proline oligomers by labeling the C-terminus of each oligomer 
with a naphthyl group and the N-terminus of each oligomer with a dansyl group.  FRET has 
since been used extensively to measure dimensions and dynamics of biological macromolecules 
and peptides.53,153,154,157 
We designed two pentamer oligomers based upon the conformational preferences 
described in the previous chapter.  The first (pentamer 69) was designed to be a helical rod, 
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whereas the second (pentamer 70) was designed to have a curved shape.  The pentamers were 
end-labeled with naphthyl (fluorescence donor) and dansyl (fluorescence acceptor) groups.  The 
design hypothesis was confirmed by measuring the efficiency of fluorescence resonance energy 
transfer between the naphthyl and dansyl pair. 
 
Figure 4-2: Theoretical FRET efficiency plotted as a function 
of the distance between a pair of fluorophores with a Förster 
distance of 22 Å. 
 
Modeling suggests that 69 and 70 are around 20 Å long; the dansyl-naphthyl pair was an 
appropriate choice for this system because their Förster distance is 22 Å.158  FRET active 
fluorophore pairs each have a characteristic Förster distance, where Förster energy transfer is 
50% efficient.  The greatest sensitivity for FRET distance measurements is achieved when the 
donor-acceptor pair is positioned at or near their characteristic Förster distance (Figure 4-2). 
The fluorescence excitation spectra and absorption spectra of the dansyl and naphthyl 
groups are illustrated in Figure 4-3.  The naphthyl chromophore absorbs strongly around 290 nm 
(Figure 4-3, solid line), and fluoresces at 350 nm (Figure 4-3, inset spectrum, solid line).  The 
dansyl group absorbs light at the frequency of dansyl emission (around 350 nm) and fluoresces at 
520 nm (Figure 4-3, inset, dashed line).  With this pair of fluorophores, the naphthyl group 
behaves as the energy donor, while the dansyl group behaves as the energy acceptor.  We 
planned to model our analysis of the fluorescence data based upon Stryer and Haugland’s 
original experiments with oligoproline.52 
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Figure 4-3: The fluorescence excitation and absorption spectra (inset spectra) of the naphthyl 
(donor) and dansyl (acceptor) groups.  The spectra were obtained in ethanol.  This illustration was 
adapted from Stryer and Haugland.52 
4.1 SYNTHESIS OF FLUOROPHORE LABELED SCAFFOLDS 
The structures of the compounds designed for the FRET study are illustrated in Figure 
4-4.  69 contains a sequence of 5 pro4(2S,4S) monomers.  On the basis of the conformational 
preferences determined for linear trimer bis-peptide 44 (3 pro4(2S,4S) monomers), 69 was 
expected to be a linear molecular rod.  70 is a pentamer bis-peptide of alternating pro4(2R,4R) 
and pro4(2S,4S) monomer residues.  On the basis of the conformational preferences determined 
for tetramer bis-peptide 58 (alternating pro4(2S,4S) and pro4(2R,4R) monomers), it was 
anticipated that 70 would adopt a curved shape.  We also synthesized 71, wherein the dansyl 
group is coupled through a short linker to naphthylalanine, and 72, labeled only with the dansyl 
group; these were used as controls for the FRET measurements. 
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Figure 4-4: Structure of the molecules used in the FRET study.  The stereochemistry has been labeled in 
red to highlight the differences between 69 and 70. 
 
The dansyl fluorophore was installed at the C-terminus of 69, 70, 71, and 72 by 
performing solid-phase synthesis on Dansyl NovaTag™ resin (Figure 4-5).159  This is 
polystyrene resin functionalized with a variation of the “PAL” linker used for the Fmoc-SPPS of 
C-terminal peptide amides.160  When the NovaTag linker is cleaved with TFA, the C-terminus of 
the peptide remains connected by a short linker to the dansyl sulfonamide. 
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Figure 4-5: Dansyl NovaTag resin 
 
We attempted to synthesize the oligomers for the FRET study using the Cbz-pro4 
monomers 18 and 29, but abandoned this approach because the dansyl labeled oligomers 
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decomposed when exposed to the conditions used for Cbz group removal (8% triflic acid in 
TFA).  Boc-pro4 monomers 19 and 30 were used instead.  The Boc groups are removed 
concurrently with resin cleavage, eliminating one post-cleavage transformation required when 
using the Cbz-pro4 monomers. 
 
Scheme 4-1: Synthesis of pentamer oligomers 69 and 70 
 
Synthesis of the labeled pentamer oligomers 69 and 70 is illustrated in Scheme 4-1.  Five 
Boc-pro4 monomers were coupled sequentially to Dansyl NovaTag™ resin, followed by Fmoc-
(S)-1-naphthylalanine.  The open-form oligomers 67 and 68 were obtained upon resin cleavage.  
DKP ring closure (rigidification) was achieved by dissolving the open-form oligomers in 20% 
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piperidine/DMF.  The rigidification reaction was complete after approximately 2 days, affording 
the desired products 69 (from 67) and 70 (from 68). 
The purpose of executing this experiment was to demonstrate that the shape of a bis-
peptide oligomer could be designed in a rational way by changing the stereochemistry of its 
monomers.  To draw legitimate conclusions from the FRET data regarding the relationship 
between monomer stereochemistry and oligomer shape, it was essential to avoid epimerization 
during DKP closure. 
Proving the stereochemical fidelity of 69 and 70 would require NMR experiments, but 
the oligomers were prepared on small scale, and overlap in the 1H spectra would likely prevent 
analysis.  The trimer 44, and tetramers 57, 58, 61, 62, and 63, were each the sole or major 
product of DKP closure; the stereochemistry of each was confirmed by NMR.  Experience with 
these compounds suggests that the rate of bis-peptide epimerization is considerably slower than 
the rate of DKP closure.  We partially addressed the epimerization issue by monitoring the DKP 
closing reactions as a function of time by HPLC-MS.  The progress of the DKP closing reaction 
of 67 (to 69) is illustrated in Figure 4-6.  After 3 hours, a large number of intermediates 
containing less than 5 DKP rings were observed (Figure 4-1, chromatogram B).  After 32 hours, 
however, the reaction is nearly complete (Figure 4-1, chromatogram C).  The intermediate 
compounds disappear and converge into a single major product, 69.  Two small peaks with 
longer retention times than 69 are visible in the HPLC chromatogram of the crude product 
(Figure 4-1, C).  These minor impurities are likely epimers of 69.  69 was purified easily by 
preparative HPLC.  Similar results were observed during the conversion of 68 to 70. 
There is mass spectral evidence that the intermediates are partially rigidified.  In Figure 
4-7, D is the HPLC chromatogram of the rigidification of 67 to 69 after 3 hours (identical to B, 
Figure 4-6).  E (Figure 4-7, right of D), is the total ion count from analysis of the effluent during 
the HPLC analysis at 3 hours. The signal peaks in the total ion count chromatogram coincide 
with the UV-absorbance peaks in chromatogram D.  The m/z ratios of each partially closed 
intermediate were extracted from the total ion count; these ion extractions are illustrated in 
chromatograms F1 through J1.  The ion extractions confirm that DKP closure is taking place, 
but that at 3 hours, there is little of the desired product 69 (note the small ion signal in J1).  
Averaged ESI-MS spectra for each ion extraction are shown (F2 through I2): these are consistent 
with the mixtures of intermediates.  The ESI-MS of purified 69 is shown (J2, Figure 4-7). 
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HPLC: column, Microsorb 100 C18, 4.6 × 250 mm; mobile phase, CH3CN (0.05% TFA) / water (0.1% TFA), 5% to 
95% CH3CN over 30 min; flow rate, 1.00 mL/min; UV detection at 274 nm. 
 
Figure 4-6: Progress of diketopiperazine formation as monitored by C18 reverse-phase HPLC.  A (top): crude resin 
cleavage product 67.  B (middle): after three hours dissolved in 20% piperidine/DMF.  C (bottom): after 32 hours in 
20% piperidine/DMF. 
 
 
 119 
 
Figure 4-7: ESI-MS analysis of the intermediate products during rigidification of open-form oligomer 67.  D (5% to 
95% CH3CN): HPLC of rigidification of 67 after 3 hours.  E: total ion count during ESI-MS analysis of effluent 
during analysis shown in D.  F1 through J1: computational extraction of the ions (from signal E) of the partially-
closed intermediates.  F2 through J2: ESI-MS averaged over the signal obtained from F2 through I2.  J2: ESI-MS 
of purified 69. 
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Synthesis of controls 71 and 72 was straightforward (Scheme 4-2).  Fmoc-(S)-1-
naphthylalanine was coupled to the NovaTag™ resin using HATU.  The terminal Fmoc group 
was removed, and the resin was cleaved with TFA affording 71.  72 was prepared by coupling 
one Boc-pro4(2S,4S) monomer then Fmoc-(S)-leucine to the Dansyl NovaTag resin; extended 
exposure to 20% piperidine/DMF quantitatively closed the terminal DKP, and the desired 
product was cleaved from the resin with TFA. 
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Scheme 4-2: Synthesis of 71 and 72, controls for the FRET study 
4.2 FLUORESCENCE MEASUREMENTS 
bis-Peptide 69 was designed to form a molecular rod about 20 Å long, while bis-peptide 
70 was designed to be curved, holding its two ends closer together.  Models of compound 69, 
calculated by molecular mechanics using the Amber89150 and Amber94138 force fields within 
MOE, predict that the distance from the pyrrolidine nitrogen of the first monomer to the 
quaternary center of the last monomer will be 19 Å and 21 Å, respectively.  Modeling compound 
70 using the Amber89 and Amber94 force fields predicts that the distance from the pyrrolidine 
nitrogen of the first monomer to the quaternary center of the last monomer will be 12 Å and 16 
Å, respectively. 
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The excitation spectra of all four molecules are shown in Figure 4-8.  Excitation at 293 
nm causes strong emission at 520 nm when the dansyl and naphthyl groups are in close 
proximity, as resonance energy transfer increases with decreasing donor-acceptor distance.52  
The excitation spectrum of 72 (black curve, Figure 4-8) is that of a dansyl group infinitely far 
away from a naphthyl donor.  The excitation spectrum of 72 represents the case of minimum 
energy transfer between donor and acceptor (0% energy transfer efficiency).  The excitation 
spectrum of 71 (green curve, Figure 4-8) indicates highly efficient resonance energy transfer 
from the naphthyl group to the dansyl group, as they are coupled through a short linker.  The 
excitation spectrum of 71 approaches the maximum possible energy transfer efficiency (100% 
energy transfer efficiency).  We assumed that the excitation spectra of 71 and 72 represented 
100% and 0% efficient energy transfer, respectively, based upon Stryer and Haugland’s original 
experiments using FRET as a molecular ruler.52  Relative to the excitation spectra of 71 and 72, 
the spectrum of 69 (blue curve, Figure 4-8), the oligomer designed to form the molecular rod, 
demonstrates resonance energy transfer that is approximately 50% efficient (at 293 nm).  This is 
reasonable, considering that the Förster distance of the dansyl/naphthyl pair is 22 Å.158  The 
excitation spectrum of the curved oligomer 70 (red curve, Figure 4-8) shows resonance energy 
transfer (at 293 nm excitation) that is about 72% efficient, suggesting that 70 has a curved shape, 
as designed. 
Interestingly, the excitation spectra of the open-form flexible precursors 67 and 68 
(Figure 4-8, purple dotted line and yellow dotted line, respectively) are indistinguishable from 
one another, and nearly identical to the excitation spectrum of curved compound 70  An 
explanation for this is that prior to rigidification, the open-form flexible oligomers 67 and 68 
exist as an ensemble of conformations where the dansyl and naphthyl groups are close enough to 
one another on average to permit efficient resonance energy transfer.  It is only after the 
molecules are rigidified that they exhibit the behavior inherent to their design. 
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Figure 4-8: Excitation spectra of the FRET oligomers: 71 (green, 1); 69 (red, 2); 70 (blue, 3); 72 
(black, 4); 67 (broken purple line); 68 (broken yellow line). 
 
The fractional efficiency of Förster energy transfer (E) is described by the following 
expression (equation 4-1)161 
 
where r is the distance between the donor and acceptor, and Ro is the Förster distance.  The 
Förster distance for a donor/acceptor pair depends on the spectral characteristics of the 
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fluorophores, the refractive index of the medium, and κ2, a function of the relative angular 
orientations of the donor and acceptor dipoles.154  κ2 averages to 2/3 when the donor and 
acceptor undergo sufficient re-orientation over the fluorescence lifetime. 
Calculating the distance between the naphthyl and dansyl groups with equation 4-1 
requires a number of assumptions.  For the Förster distance, Ro, we used a literature value of 22 
Å.158  This choice is legitimate only if the angular relationship between the dansyl and naphthyl 
groups is substantially randomized, such that the value κ2 is equal to 2/3.52  The values for E 
(percent energy transfer efficiency) for the excitation spectra of 69 and 70 were calculated 
relative to the normalized excitation spectra of controls 71 and 72, as described above (the 
efficiency of energy transfer was 50% for 69 and 72% for 70, relative to the assumed energy 
transfer efficiencies of 0% for 72 and 100% for 71).  Based on the preceding assumptions, the 
calculated distances between the donor acceptor pair are 22 Å for the rod-shaped compound 69, 
and 18.5 Å for the curved compound 70.  These values are more consistent with the predictions 
of the Amber94 force field.  Nonetheless, recent single-molecule fluorescence measurements 
reveal that distances measured using FRET tend to be overestimated when the donor and 
acceptor are closer to each other than the Förster distance.162  This suggests that the curved 
oligomer 70 may hold its donor-acceptor pair closer together than 18.5 Å.  It must also be 
considered that in 69 and 70, the naphthyl group might fold back across the neighboring DKP 
ring.15,117,139  This would impede dipole rotational averaging in this fluorophore, and might 
invalidate any quantitative analysis of end-to-end distance. 
4.3 EXPERIMENTAL DETAILS 
General procedures used for solid-phase peptide synthesis are described above (section 
3.7, page 91).  Fluorescence excitation spectra were obtained using a fluorescence 
spectrophotometer (Cary Eclipse).  The excitation and emission slits were both set to 5 nm.  
Excitation was monitored at 520 nm and samples were irradiated between 270 and 450 nm at a 
scan rate of 120 nm/min.  Samples were measured in a 1 cm quartz cell.  Fluorescence samples 
were prepared such that their concentrations were approximately 2 μM; this was determined 
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based upon theoretical yields from the solid phase resin.  Each sample was scanned ten times 
sequentially, and the ten scans were averaged.  The excitation spectra were normalized such that 
the emission maximum of the dansyl group (337 nm) was 100 arbitrary units for all samples. 
 
Compound 67 
10 mg of Dansyl NovaTag resin (Novabiochem, 0.51 mmol/gram substitution) were transferred 
to a solid phase reactor and swollen in DMF.  The N-terminal Fmoc protecting group was 
removed by mixing the resin with 20% piperidine/DMF for 40 minutes (General Procedure H).  
The resin was then washed with DMF, CH2Cl2, i-PrOH, CH2Cl2, and DMF.  19, 19, 19, 19, 19 
and (S)-N-Fmoc-1-naphthylalanine were coupled sequentially to the resin (2 equiv. of N-Fmoc 
protected amino acid, 2 equiv. of HATU, 4 equiv. of DIPEA, 0.2 M in 20% CH2Cl2/DMF, 30 
minutes reaction time)  Each coupling reaction was repeated an additional time (see General 
Procedure F), and was followed by washing (General Procedure E), resin capping with a 
400:100:8 DMF/Ac2O/DIPEA solution (General Procedure G), and deprotection of the terminal 
N-Fmoc group with 20% piperidine/DMF (General Procedure H).  After careful washing, 
residual solvent was removed from the resin overnight under reduced pressure (General 
Procedure I).  The resin was cleaved using 95% TFA, 2.5% triisopropylsilane, 2.5% water over 
two hours with stirring.  The cleavage solution was filtered, the resin washed with an additional 
volume of TFA, and the filtrates were combined and concentrated by centrifugal evaporation.  
One quarter of the resulting residue was purified by preparative HPLC (C18 column; mobile 
phase, CH3CN (0.05% TFA) / H2O (0.1% TFA), 5% to 95% CH3CN over 30 min; flow rate, 15 
mL/min, herein, the “standard method” for the purification of the oligomers in the FRET study).  
Fractions containing the desired product were pooled and concentrated to dryness by centrifugal 
evaporation yielding compound 67.  HRESIQTOFMS calcd for C61H77N14O17S (M + H+) 
1309.5312, found 1309.5281. 
 
This sample of 67 was dissolved in UV/VIS grade MeOH (1.5 mL) and filtered through a 0.2 μm 
Nylon frit.  A sample for fluorescence spectroscopy was prepared by diluting an aliquot (22.6 
μL) of this stock solution into MeOH (3 mL). 
 125 
 
HPLC-MS: C18 column; mobile phase, CH3CN (0.05% HCOOH) / water (0.1% HCOOH), 5% to 95% CH3CN over 
30 min; flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 67, 8.55 min; ESI-MS m/z (ion): 1309.0 (M + H+). 
 
Figure 4-9: HPLC chromatogram and ESI-MS analysis of the methanol stock solution of purified 67 
 
Compound 68  
19, 30, 19, 30, 19, and (S)-N-Fmoc-1-naphthylalanine were coupled sequentially to 10 mg of 
Dansyl NovaTag resin using the methods described for the synthesis of compound 67.  
Following removal of the terminal N-Fmoc group, the product was cleaved from the resin; the 
cleavage solution was filtered from the resin, and then concentrated by centrifugal evaporation.  
One quarter of the resulting residue was purified by preparative HPLC using the standard 
method.  Fractions containing the desired product were pooled and concentrated to dryness by 
centrifugal evaporation yielding compound 68.  HRESIQTOFMS calcd for C61H77N14O17S (M + 
H+) 1309.5312, found 1309.5237. 
 
This sample of 68 was dissolved in UV/VIS grade MeOH (1.5 mL) and filtered through a 0.2 μm 
Nylon frit.  A sample for fluorescence spectroscopy was prepared by diluting an aliquot (7.4 μL) 
of this stock solution into MeOH (3 mL). 
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HPLC-MS: C18 column; mobile phase, CH3CN (0.05% HCOOH) / water (0.1% HCOOH), 5% to 95% CH3CN over 
30 min; flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 68, 8.19 min; ESI-MS m/z (ion): 1309.0 (M + H+). 
 
Figure 4-10: HPLC chromatogram and ESI-MS analysis of the methanol stock solution of purified 68 
 
Compound 69  
The larger portion of the residue containing crude 67 was dissolved in 20% piperidine/DMF 
(1.25 mL) and transferred to a sealed, amber HPLC vial.  Diketopiperazine closure was 
monitored by analytical HPLC-MS.  After ~ 48 hours, the solution was added slowly to diethyl 
ether (45 mL); the resulting precipitate was pelleted by centrifugation.  After decanting the ether, 
the pellet was dissolved in a 50:50:1 H2O/MeCN/TFA, and the desired product was purified by 
preparative HPLC using the standard method.  The desired fractions were pooled and 
concentrated to dryness by centrifugal evaporation affording compound 69.  HRESIQTOFMS 
calcd for C57H61N14O13S (M + H+) 1181.4263, found 1181.4136. 
 
This sample of 69 was dissolved in UV/VIS grade MeOH (1.5 mL) and filtered through a 0.2 μm 
Nylon frit.  A sample for fluorescence spectroscopy was prepared by diluting an aliquot (10.0 
μL) of this stock solution into MeOH (3 mL). 
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HPLC-MS: C18 column; mobile phase, CH3CN (0.05% HCOOH) / water (0.1% HCOOH), 5% to 95% CH3CN over 
30 min; flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 69, 11.13 min; ESI-MS m/z (ion): 1181.0 (M + H+). 
 
Figure 4-11: HPLC chromatogram and ESI-MS analysis of the methanol stock solution of purified 69 
 
Compound 70  
The larger portion of the residue containing crude 68 was dissolved in 20% piperidine/DMF 
(1.25 mL) and transferred to a sealed amber HPLC vial.  After ~ 48 hours, the solution was 
added slowly to diethyl ether (45 mL); the resulting precipitate was pelleted by centrifugation.  
After decanting the ether, the pellet was dissolved in a 50:50:1 H2O/MeCN/TFA, and the desired 
product was purified by preparative HPLC using the standard method.  The desired fractions 
were pooled and concentrated to dryness by centrifugal evaporation affording compound 70.  
HRESIQTOFMS calcd for C57H61N14O13S (M + H+) 1181.4263, found 1181.4182. 
 
This sample of 70 was dissolved in UV/VIS grade MeOH (1.5 mL) and filtered through a 0.2 μm 
Nylon frit.  A sample for fluorescence spectroscopy was prepared by diluting an aliquot (150 μL) 
of this stock solution into MeOH (3 mL). 
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HPLC-MS: C18 column; mobile phase, CH3CN (0.05% HCOOH) / water (0.1% HCOOH), 5% to 95% CH3CN over 
30 min; flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 70, 11.49 min; ESI-MS m/z (ion): 1181.0 (M + H+). 
 
Figure 4-12: HPLC chromatogram and ESI-MS analysis of the methanol stock solution of purified 70 
 
Compound 71 
(S)-N-Fmoc-1-naphthylalanine was coupled to Dansyl NovaTag resin (10 mg) with HATU using 
the method described above.  Following removal of the N-Fmoc group of the naphthylalanine, 
resin cleavage and filtration of the resin, the cleavage solution was concentrated by centrifugal 
evaporation.  The resulting residue was dissolved in 40:60:0.1 MeCN/H2O/TFA (1 mL) and 
purified by preparative HPLC by the standard method.  The desired fractions were pooled and 
concentrated to dryness by centrifugal evaporation giving compound 71.  HRESIQTOFMS calcd 
for C27H31N4O3S (M + H+) 491.2117, found 491.2092. 
 
This sample of 71 was dissolved in UV/VIS grade MeOH (1.5 mL) and filtered through a 0.2 μm 
Nylon frit.  A sample for fluorescence spectroscopy was prepared by diluting an aliquot (2.5 μL) 
of the stock solution into MeOH (3 mL). 
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HPLC-MS: C18 column; mobile phase, CH3CN (0.05% TFA) / water (0.1% TFA), 5% to 95% CH3CN over 30 min; 
flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 71, 14.36 min; ESI-MS m/z (ion): 491.0 (M + H+). 
 
Figure 4-13: HPLC chromatogram and ESI-MS analysis of the methanol stock solution of purified 71 
 
Compound 72  
19 and then (S)-N-Fmoc-leucine were coupled to Dansyl NovaTag resin (10 mg) using the 
method described above.  The N-Fmoc group of leucine was removed using 20% 
piperidine/DMF; the resin was treated an additional time with the same solution to ensure that 
the diketopiperazine between the monomer residue and the leucine had completely formed.  
After resin cleavage, the cleavage solution was removed from the resin by filtration and 
concentrated by centrifugal evaporation.  The resulting residue was dissolved in 40:60:0.1 
MeCN/H2O/TFA (1 mL) and purified by preparative HPLC by the standard method.  The desired 
fractions were pooled and concentrated to dryness by centrifugal evaporation giving compound 
72.  HRESIQTOFMS calcd for C26H37N6O5S (M + H+) 545.2546, found 545.2516. 
 
This sample of 72 was dissolved in UV/VIS grade MeOH (1.5 mL) and filtered through a 0.2 μm 
Nylon frit.  A sample for fluorescence spectroscopy was prepared by diluting an aliquot (15 μL) 
of this stock solution into MeOH (3 mL). 
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HPLC-MS: C18 column; mobile phase, CH3CN (0.05% TFA) / water (0.1% TFA), 5% to 95% CH3CN over 30 min; 
flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 72, 11.70 min; ESI-MS m/z (ion): 545.2 (M + H+). 
 
Figure 4-14: HPLC chromatogram and ESI-MS analysis of the methanol stock solution of purified 72 
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5.0  PROGRESS IN OLIGOMER LIGATION 
Many biologically active natural products are macrocycles.163,164  The activity of a 
compound is related to how efficiently it can bind to a receptor; macrocyclization is believed to 
lower the entropic penalty of binding by providing some conformational pre-organization, but 
allows enough flexibility in the compound to achieve the best fit.164  A modular approach to the 
synthesis of non-natural macrocycles would enable convergent synthesis of diverse structures for 
nanotechnology and bio-mimetic applications, and allow fine-tuning of the structures to optimize 
their properties.165  A number of modular approaches toward non-natural cyclic macromolecules 
have been reported; many generate symmetrical macrocycles.166-168 
From the outset, we have been interested in using bis-peptide oligomers to construct 
cavity-like receptors for sensors169,170 and catalysts.34,171  All four pro4 monomers have been 
incorporated into oligomers of varying length.  Data from NMR,15,100,117 ESR,118 and FRET100 
experiments suggest that the bis-peptides made exclusively from pro4 monomers have linear or 
slightly curved topology; they resemble “twisted sticks”.  It is not likely that a small pocket or 
cavity could be fashioned from a single bis-peptide oligomer containing only the pro4 
monomers. 
This has led us to consider a different strategy for assembling nanoscale cavities: using 
individual bis-peptide oligomers as construction elements for large macrocyclic structures 
(Figure 5-1).4  This is a modular approach toward the design of macrocycles.  The 
macromolecules would be composed of interchangeable bis-peptide oligomers; the rigid bis-
peptide oligomers are composed of interchangeable monomers.  The resulting macrocycles 
would have large, extended structures with hydrogen bonding groups around the perimeter.  
Probes that have been designed to investigate protein-protein interactions share these 
characteristics.165 
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Figure 5-1: Figurative representation of modular, asymmetric macrocycle synthesis using bis-peptide 
oligomers as construction elements 
 
The crux of this approach is selecting the methods used to connect the ends of the bis-
peptide oligomers.  Many types of chemistry have been used to cyclize peptides, including 
amidation, esterification, and olefin methathesis.163  All of these might be considered for 
oligomer macrocyclization; the bis-peptide oligomers are peptide-like, and tolerate similar 
conditions as peptides.13-15,100,117-119  For a preliminary study of oligomer macrocyclization, we 
selected the copper-assisted alkyne/azide cycloaddition (CuAAC) reaction.  This reaction is 
high-yielding, regioselective, and is performed under mild conditions.  It provides considerable 
latitude for designing a strategy for cyclization, as it is compatible with aqueous and organic 
solvents.  Adding additional functional groups to bis-amino acid oligomers requires careful 
consideration of protecting group chemistry; one benefit of the CuAAC reaction is that alkynes 
and azides do not require protecting groups during Fmoc-SPPS. 
The thermal 1,3-dipolar cycloaddition reaction between alkynes and azides (Huisgen’s 
cyclization) is relatively slow; it requires high temperatures and long reaction times, and 
generates two triazole regioisomers (Scheme 5-1, reaction A).169,172,173  1,4-triazoles are very 
stable; they resist hydrolysis, oxidation, and reduction, and have been used as restrained 
analogues of amide bonds.174,175  The copper-assisted variation of Huisgen’s cycloaddition was 
reported independently by the Sharpless176 and Meldal177 groups (Scheme 5-1, reaction B).  CuI 
salts dramatically increase the rate of the reaction between terminal alkynes and azides at room 
temperature.  The 1,4-triazole is generated exclusively with the copper-assisted cyclization. 
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Scheme 5-1: Huisgen’s thermal, 1,3-dipolar cycloaddition (A) and the copper catalyzed alkyne-
azide cycloaddition reaction (B) 
 
CuAAC has been used for diverse applications, including bioconjugation,178 for 
generating libraries of compounds during drug discovery,174 in materials chemistry,179 dendrimer 
synthesis,180 and for the conjugation of peptides181 and carbohydrates.182  CuAAC has been used 
primarily in an intermolecular fashion,173 but there are increasingly more examples of the 
CuAAC reaction being used for intramolecular macrocyclization. 
Gin reported the synthesis of the C2 symmetric β-cyclodextrin analogue 74 (Scheme 5-2) 
using CuAAC to perform tandem dimerization/macrocylization.179  An alkyne/azide 
functionalized, benzyl ether protected mannose trisaccharide (73, Scheme 5-2) was subjected to 
CuAAC conditions for 16 hours in toluene.  The major product of the cycloaddition reaction was 
the cyclic dimer 74; the reaction also generated trace amounts of cyclic trimer and higher order 
oligomers.  Like β-cyclodextrin, 74 formed inclusion complexes with small, hydrophobic 
molecules. 
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Scheme 5-2: Synthesis of cyclodextrin analogue 74 by CuAAC 
 
Billing used a similar method to synthesize a C2 symmetric dimer from a 
carbohydrate/peptide conjugate (Scheme 5-3).183  The alkyne/azide functionalized monomer 75 
(Scheme 5-3) polymerized unless the CuAAC reaction was performed under very dilute 
conditions.  Dynamics simulations suggest that the product, macrocycle 76, forms a relatively 
rigid cavity in water. 
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Scheme 5-3: Synthesis of a peptide/carbohydrate cyclic dimer by CuAAC 
 
Several examples of peptide cyclization with CuAAC have been reported.184-187  Ghadiri 
reported cyclodimerizaton of the short peptide 77 (Scheme 5-4)186 in 12 hours to 78 with 80% 
recovered yield at room temperature using excess CuI in CH3CN.  van Maarseveen reported the 
cyclization of short peptide 79 (Scheme 5-4),185 which could only be achieved under reflux in 
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toluene; the cyclic monomer 80 was the exclusive product.  These examples illustrate the 
potential difficulties in anticipating the cyclic monomer / cyclic dimer product distribution. 
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Scheme 5-4: Examples of short-peptide cyclization by CuAAC 
5.1 CHOOSING A MACROCYCLIZATION STRATEGY 
Having selected CuAAC as the vehicle for macrocyclization, we needed to design a 
synthetic strategy for oligomer ligation.  Four possible cyclization strategies are illustrated in 
Figure 5-2; each route has certain advantages and disadvantages.  For route B and route C, the 
cyclic dimer is the expected product; the rigidified oligomer between the terminal alkyne and 
azide would likely prevent self-cyclization.  For routes A and D, where the CuAAC reaction is 
performed before DKP formation, it was difficult to predict the cyclic monomer / cyclic dimer 
distribution.  We were concerned that macrocyclization would preclude complete DKP formation 
by preventing the inter-monomer amide bonds from making the required trans-cis isomerization 
for DKP formation.  Cyclization is performed on solid phase for routes C and D, which would 
allow easy removal of the copper salts from the reaction.  It is more complicated to monitor the 
reaction progress on solid support, however.  The CuAAC substrates for A and D are non-polar, 
and the reaction could be tested in acetonitrile.177  The substrates for B and C are very polar, so 
the reaction would need to be performed under aqueous or mixed solvent conditions.176 
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Figure 5-2: Diagram illustrating possible synthetic routes to bis-peptide macrocyclization 
 
We chose to start with route A for several reasons.  This is the most diagnostic approach; 
the reaction would be performed in solution, and could be monitored in real-time by HPLC-MS.  
In solution, it would be straightforward to change the monomer concentration, and if necessary, 
the reaction could be performed under very dilute conditions.  On solid-phase, the concentration 
of the starting material is a function of resin loading, and cannot be manipulated to the same 
extent or as accurately as in solution.  Ghadiri’s cyclizations of side-chain protected peptides in 
acetonitrile186 were high-yielding and were performed at room temperature; the same reaction 
conditions could be applied to the non-polar, Boc-protected open-form oligomers.  Acetonitrile is 
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an excellent solvent for the reaction because it coordinates CuI, preventing oxidation by 
dissolved oxygen.183 
5.2 AZIDE SYNTHESIS 
Azides and terminal alkynes are stable to the conditions used for Fmoc-SPPS, as well as 
typical resin cleavage conditions, and have been introduced into peptides using a number of 
methods.187,188  Propargylglycine is commercially available, and was the most convenient way to 
introduce the alkyne.  We wanted to install the azide at the N-terminus of the oligomer on the 
side-chain of an amino acid.  This would permit DKP formation between the azide-
functionalized amino acid and the preceding pro4 monomer, reducing the number of rotatable 
bonds between the azide and the oligomer, and converting the methyl ester (which slowly 
hydrolyzes under aqueous acidic conditions) to an amide.  Fmoc-protected amino acids with a 
side-chain azide are not commercially available, so it was necessary to synthesize one. 
The initial synthetic target was azide 81 (Fmoc-Dap-N3, Figure 5-3), which we had 
originally intended to synthesize from Fmoc-serine (82). 
FmocHN O
OHHO
FmocHN O
OHN3
81 82  
Figure 5-3: Fmoc-Dap-N3 (81), and expected precursor Fmoc-serine (82) 
 
The attempts to synthesize azide 81 from Fmoc-serine were unsuccessful (Scheme 5-5).  
The Weinreb amide189 of Fmoc-serine was prepared.  We tried to generate the mesylate from the 
Weinreb amide, then displace the mesylate by azide in DMF;190 no product could be isolated.  
Similar results were obtained using Mitsunobu conditions191 and TMS-N3 as the nucleophile.  
We also tried to make the lactone from Fmoc-serine, and then open the heterocycle with 
NaN3.192,193  The recovered yield of 81 using this method was poor. 
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Scheme 5-5: Initial attempts to synthesize azide 81 from Fmoc-serine (82) 
 
We obtained significantly better results using diazo transfer to Fmoc-protected 
diaminopropionic acid (83) with triflic azide194 (Scheme 5-6) in the presence of a catalytic 
amount of CuII salt.195  This method has been used extensively,188,196,197 though not with Fmoc-
protected amino acids.  Triflic azide is explosive when concentrated,194 but the reagent is 
prepared as a solution in dichloromethane, and added directly to reaction mixture.  Clean 
conversion of 83 to azide 81 was achieved with good yield using this method. 
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Scheme 5-6: Synthesis of azide 81 from Fmoc-diaminopropionic acid using triflic azide 
 
With Fmoc-Dap-N3 (81) and Fmoc-propargylglycine in hand, we tried to synthesize an 
alkyne/azide labeled bis-peptide oligomer.  The “route A” approach to cyclization (Figure 5-2) 
requires that the oligomer be cleaved from the resin without removal of the Boc groups.  2-
chlorotrityl chloride resin198,199 was selected for oligomer synthesis.  Peptides may be cleaved 
from this linker using very dilute TFA (1% TFA in CH2Cl2), which does not remove Boc groups. 
The solid-phase syntheses of trimer and pentamer oligomers were performed as described 
in Scheme 5-7.  Fmoc-(S)-propargylglycine was coupled to the resin in dichloroethane with 
DIPEA.  After removing the Fmoc group from the propargylglycine, 3 or 5 Boc-pro4(2S,4S) 
monomers (19) were coupled sequentially to the propargylglycine with HATU.  Finally, Fmoc-
Dap-N3 (81) was coupled to the resin.  The final Fmoc deprotection was extended to allow 
complete DKP formation between the Dap-N3 residue and the preceding pro4(2S,4S) monomer.  
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Analytical samples of both resins were then cleaved with 95% TFA.  HPLC-MS analysis of the 
crude cleavage products indicated a single product from each resin that did not have the expected 
mass.  Rather, the ESI mass spectra of the products were consistent with compounds 84 and 85 
(Scheme 5-7); these appeared to have eliminated the azide anion. 
 
Scheme 5-7: Synthesis of and proposed structure for 84 and 85; these compounds suffered 
elimination of the azide anion during diketopiperazine closure (see below) 
 
This result was unexpected; alkyl azides are stable to peptide coupling with 
DCC/HOBt188 and HATU.186  Fmoc-Dap-N3 (81) has been used during Fmoc-SPPS and is stable 
to treatment with 20% piperidine/DMF.200  Elimination may have occurred as illustrated in 
Figure 5-4.  Removing the Fmoc group from Dap-N3 initiated DKP formation between this 
residue and the preceding monomer.  The α-proton of Dap, in the context of the DKP, is more 
acidic; piperidine could then abstract the proton, causing E2 elimination of the azide anion.  This 
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result underscores the sensitivity of DKPs to basic conditions.  Such elimination by loss of the 
azide anion usually requires a very strong base, such as DBU.201 
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Figure 5-4: The mechanism likely responsible for the undesired azide elimination 
leading to 84 and 85 
 
To circumvent elimination, an analogous azide with an additional methylene group 
between the azide and α-proton (Scheme 5-8) was prepared.  Commercially available N-α-
Fmoc-N′-Boc-(S)-2,4-diaminobutanoic acid (86) was treated with TFA in CH2Cl2 to remove the 
Boc group from the side chain amine.  The TFA salt 87 was subjected to the diazo-transfer 
conditions described for the synthesis of 81, affording the desired azide 88 (Fmoc-Dab-N3) in 
excellent yield.  We found (see below) that the elimination reaction that occurred with Fmoc-
Dap-N3, 81, did not occur with extended chain Fmoc-Dab-N3, 88. 
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Scheme 5-8: Synthesis of azide 87 
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5.3 MODEL SYSTEM 1 
A trimer oligomer functionalized with propargylglycine, Dab-N3, and naphthylalanine 
was synthesized (Scheme 5-9) as a model system for developing CuAAC reaction conditions.  
Fmoc-(S)-1-naphthylalanine, Fmoc-(S)-propargylglycine, three Boc-pro4(2S,4S) monomers (19) 
and Fmoc-Dab-N3 (88) were coupled in sequence to 2-chlorotritylchloride resin.  Cleavage with 
1% TFA in CH2Cl2 afforded the desired product 89 in excellent purity and yield.  89 is non-
polar, and soluble in acetonitrile. 
 
Scheme 5-9: Synthesis of 89, model system for CuAAC macrocyclization 
 
Ghadiri’s conditions for CuAAC186 were used for the first attempted cyclization with this 
model system.  Compound 89 was dissolved in degassed acetonitrile; 2,6-lutidine and DIPEA 
were added to the solution, followed by CuI.  Within 2 hours, HPLC-MS analysis indicated that 
the starting material 89 was being consumed, and three products, 90, 91, and 92 were forming 
(Figure 5-5).  At 20 hours, the starting material had been entirely consumed.  After the starting 
material had disappeared, subsequent HPLC analysis of the solution indicated no change over a 
period of days. 
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HPLC-MS: Column, Waters XTerra C18, 4.6 × 150 mm; mobile phase, CH3CN (0.05% HCOOH) / water (0.1% 
HCOOH), 5% to 95% CH3CN over 30 min; flow rate, 0.80 mL/min; UV detection at 274 nm; tR for 90, 21.42 min; 
tR for 89, 22.30 min; tR for 91, 25.40 min; tR for 92, 28.43 min. 
 
Figure 5-5: HPLC chromatograms that track the progress of the CuI catalyzed alkyne/azide cycloaddition of 89.  A 
(top): before addition of copper.  B (middle): two hours after addition of copper.  C (bottom): after reaction had 
stirred overnight. 
 
Each of the three products has the characteristic absorption spectrum of naphthylalanine; 
this suggests that the starting material had been incorporated into each of these products.  We 
tentatively assigned the structure of these products based upon the polarity of each compound.  
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We hypothesized that 90 (Figure 5-5, chromatogram C, peak at 21.42 min) was cyclic monomer; 
the cyclic monomer was expected to become more polar because it would have a triazole, but no 
additional hydrophobic groups (1,2,3-triazoles have very large dipole moments).174  91 (Figure 
5-5, chromatogram C, peak at 25.40 min) was assigned as the cyclic dimer.  The cyclic dimer 
has twice as many Boc and naphthyl groups as the starting material, so would likely be less polar 
than the starting material.  By the same reasoning, 92 (Figure 5-5, chromatogram C, peak at 
28.43 min) was cyclic trimer.  We assumed that the products were cyclic oligomers, rather than 
linear oligomers, because there was no change in the concentration or distribution of the products 
once the starting material had been consumed. 
The three products were easily separated by preparative HPLC, and the putative structure 
assignments were confirmed by detailed analysis of the electrospray mass spectrum of each 
compound.  In the ESI mass spectrum of cyclic monomer 90 (spectrum A, Figure 5-6, top) the 
base m/z peak is 1215.4, which corresponds to [Mcyclic monomer + H+].  A simulated mass 
spectrum202 of 90 has a similar distribution of isotope peaks above the base peak (the peak ratio 
of M + 1 to M + 2 to M + 3, etc.).  A small peak at m/z 2430.6 corresponds to [2Mcyclic monomer + 
H+]; the ratio of the intensity of the base peak to this smaller peak is about 20:1. 
In the ESI mass spectrum of cyclic dimer 91 (spectrum B, Figure 5-6, middle) the base 
peak is 1215.8, which corresponds to [Mcyclic dimer + 2H+]; the distribution of isotope peaks 
around this m/z ratio is different from that observed with the cyclic monomer.  The peak at 
2430.6, [Mcyclic dimer + H+], is noticeably larger for the cyclic dimer than for the cyclic monomer; 
for the cyclic dimer, the ratio of the intensity of the base peak to this peak is about 5:1.  The mass 
spectrum of 92 (spectrum C, Figure 5-6, bottom) provides strong evidence for the proposed 
structure.  The base peak is 1823.4, an ion unique to the cyclic trimer.  It corresponds with 
[Mcyclic trimer + 2H+]. 
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Figure 5-6: ESI mass spectra of the cyclic monomer 90 (A, top), cyclic 
dimer 91 (B, middle) and cyclic trimer 92 (C, bottom) 
 
Having confirmed the identity of each product, we considered the yield and product 
distribution for the reaction; the analysis is summarized in Scheme 5-10.  Based on the integrated 
areas under the peaks in the HPLC chromatogram, 76% of the alkyne/azide functionalized 
oligomer 89 was incorporated into the cyclic monomer, cyclic dimer, and cyclic trimer.  The 
remaining 24% of the starting material may have been incorporated into trace amounts of higher 
order oligomers that were not detected by HPLC.  The molar product distribution was 100:33:4 
cyclic monomer / cyclic dimer / cyclic trimer. 
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Scheme 5-10: The CuAAC macrocyclization of 89 in solution 
 
To study the effects of macrocyclization on DKP closure, we performed the usual 
sequence of manipulations for bis-peptide preparation on the cyclic monomer 90, cyclic dimer 
91, and cyclic trimer 92.  First, the purified samples of the three products were dissolved in 
TFA/CH2Cl2 to remove the Boc groups (Scheme 5-11).  The products of Boc cleavage, 93 (from 
90), 94 (from 91), and 95 (from 92) were analyzed by HPLC-MS and found to be very clean. 
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Scheme 5-11: Removing the Boc groups from 90, 91, and 92, affording 
93, 94, and 95, respectively; the structure of 93 is illustrated  
 
Removing the Boc groups exposes the ionizable secondary amines of the pyrrolidine 
rings; increasing the number of ionizable groups of macromolecules can improve the quality 
their ESI mass specta.203  The intensity of the ESI mass spectra of the Boc-deprotected open-
form cyclic monomer (93) and cyclic dimer (94) improved considerably after Boc removal.  [M 
+ 1H+], [M + 2H+], and [M + 3H+] mass peaks were identified for both compounds (Figure 5-7).  
The 610.7 [M + 3H+] m/z peak in the mass spectrum of 94 is characteristic of the cyclic dimer, 
and is not observed for the cyclic monomer.  There was only a trace amount of Boc-deprotected 
cyclic trimer (95), and so this material was taken into the DKP closing reaction without 
preparing an analytical sample. 
 
Figure 5-7: The ESI mass spectra of cyclic monomer 93 (left) and cyclic dimer 94 (right) 
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The Boc-deprotected macrocycles were dissolved in 20% piperidine/DMF, and the DKP 
closing reaction was monitored by HPLC-MS (Scheme 5-12).  DKP closure for the open-form 
cyclic dimer was clean; 94 was converted to the expected product 97 within 12 hours (Scheme 
5-12).  There was trace evidence that complete DKP closure occurred in the cyclic trimer; though 
the absorbance signal in the HPLC chromatogram is barely above baseline, the ESI mass 
spectrum of what appears to be the major product is consistent with the expected product, 98 (see 
experimental details, Figure 5-16). 
In less than 6 hours, the cyclic monomer 90 was converted to 96 (Scheme 5-12), which is 
not the desired product.  In 96, 2 of the 3 DKP rings have closed (the desired product has 3 
closed DKP rings).  96 was incubated in the 20% piperidine/DMF solution for several days, but 
the HPLC chromatogram of the mixture did not change; DKP formation was stalled.  The open-
form Boc-deprotected cyclic monomer 90 is a relatively small macrocycle.  In its preferred 
conformation, there may be a low-energy trajectory for the formation of one of the two DKP 
rings (either between monomer resides 1 and 2, or between residues 2 and 3); when this DKP 
ring closes, the macrocycle becomes even more constrained, perhaps locking the amide bond 
between the remaining two monomers resides into the trans conformation, preventing the closure 
of the final DKP ring. 
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Scheme 5-12: DKP closing reaction for 90 and 91; the inset HPLC chromatograms are of the crude DKP closing 
reaction in 20% piperidine/DMF at the times indicated.  HPLC-MS: Column, Waters XTerra C18, 4.6 × 150 mm; 
mobile phase, CH3CN (0.05% HCOOH) / water (0.1% HCOOH), 0% to 50% CH3CN over 30 min; flow rate, 0.80 
mL/min; UV detection at 274 nm. 
5.4 EXPLORING OTHER CONDITIONS 
The major product from the CuAAC macrocyclization reaction with model compound 89 
was cyclic monomer 90.  DKP formation was incomplete for the cyclic monomer, likely because 
the macrocycle was too strained to permit every DKP ring to form.  While the DKP closing 
reaction for the cyclic monomer stalled, complete DKP formation was achieved for the cyclic 
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dimer.  Because it was possible to rigidify the cyclic dimer and obtain a well-defined product, it 
seemed like the more interesting macrocycle. 
To determine if it was possible to increase selectivity for the cyclic dimer during 
macrocyclization, we explored the effects of oligomer and copper concentration on the product 
ratios (Table 5-1).  Either 0.3 or 2.0 equivalents of CuI were added to the reaction, with either 1 
mM or 5 mM oligomer concentration.  At oligomer concentrations greater than 5 mM, a 
gelatinous precipitate would appear almost immediately in the reaction mixture, probably the 
result of oligomer polymerization. 
The concentration of open-form oligomer 89 had a large effect upon the ratio of the three 
major products.  Increasing the concentration of 89 did increase the ratio of cyclic dimer to 
cyclic monomer; unfortunately, this also increased the ratio of cyclic trimer to cyclic dimer.  It 
was possible to increase the proportion of cyclic dimer relative to the cyclic monomer, but not 
the overall yield of cyclic dimer.  Using sub-stoichiometric amounts of copper did not have a 
significant effect on yield or product distribution. 
 
Table 5-1: Summary of the results obtained by performing the CuAAC macrocyclization of model compound 
89 under different conditions 
 
 
5.5 EFFECT OF OLIGOMER LENGTH UPON PRODUCT DISTRIBUTION 
We also explored the effect of oligomer length on the product distribution obtained from 
CuAAC macrocyclization.  A series of 7 oligomers were prepared (Scheme 5-13).  These 
oligomers contain between 3 and 9 pro4(2S,4S) monomer residues; each oligomer is 
functionalized with an alkyne and azide.  The methods used to synthesize these oligomers are 
similar to those used to prepare model oligomer 89 (Scheme 5-9). 
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Scheme 5-13: Synthesis of the series of alkyne/azide functionalized oligomers 
 
After cleaving each of the alkyne/azide functionalized oligomers from the 2-
chlorotritylchloride resin, the products were purified, then subjected to the same CuAAC 
conditions used for the model system (2 equivalents CuI, 2 equivalents of DIPEA and 2,6-
lutidine, 1 mM in ACN).  The CuAAC reactions were monitored by HPLC-MS; the results of the 
macrocyclizations are summarized in Table 5-2.  The macrocyclization yield was similar for 
each Boc-protected oligomer.  As the length of the oligomers increased, the proportion of cyclic 
dimer decreased.  Excluding the results from the 5-mer oligomer 100 and the 7-mer oligomer 
102, the ratio of cyclic dimer to cyclic monomer is nearly proportional to 1/n, n being the 
number of pro4 monomer residues in the oligomer.  The chances that the two ends of a Boc-
protected open-form oligomer encounter one other must increase as the oligomers becomes 
longer.  The increased proportion of cyclic dimer for the CuAAC macrocyclizations of 100 and 
102 may be due to slightly higher oligomer concentration during the CuAAC reaction, caused by 
better than average cleavage yield or purification recovery. 
Table 5-2: Product distribution and yields for the CuAAC macrocyclization for the alkyne/azide 
functionalized Boc-protected oligomers of varying length 
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The Boc groups were cleaved from all of the cyclized products as shown in Scheme 5-14.  
The products from Boc group cleavage were each dissolved in 20% piperidine/NMP, and the 
DKP closing reaction was monitored by HPLC. 
 
Scheme 5-14: Removing the Boc groups from the series of cyclic monomers and cyclic dimers 
 
When the model system cyclic monomer 93 was dissolved in 20% piperidine, the 
reaction stalled after one DKP ring had closed.  The cyclic monomers containing between 4 and 
9 pro4(2S,4S) monomer resides behaved in a similar way during DKP formation.  When 
dissolved in 20% piperidine/NMP, the open-form cyclic monomers were converted to mixtures 
of products; these products (by mass) had 1 or 2 DKP rings fewer than the expected product.  
After 24 hours, there was little change in the HPLC chromatograms of the reaction mixtures.  
DKP formation in the 7-mer cyclic monomer 123 is representative of the results obtained with 
the other cyclic monomers.  Two HPLC chromatograms of this reaction are illustrated in Figure 
5-8.  After removing the Boc groups, the 7-mer cyclic monomer appears to be a single compound 
(Figure 5-8, top).  After 48 hours in 20% piperidine/NMP, the 7-mer cyclic monomer had been 
converted into a mixture of products (Figure 5-8, bottom).  The compounds with earlier retention 
time had masses consistent with oligomers that had closed 5 DKP rings; compounds which 
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eluted later had masses consistent with oligomers that had closed 6 DKP rings (7 DKP rings 
were expected to close). 
 
HPLC-MS: Column, Waters XTerra C18, 4.6 × 150 mm; mobile phase, CH3CN (0.05% HCOOH) / water (0.1% 
HCOOH), 0% to 50% CH3CN over 30 min; flow rate, 0.80 mL/min; UV detection at 274 nm. 
 
Figure 5-8: HPLC chromatograms of the DKP closing reaction for the 7-mer cyclic monomer 123: starting material 
(top) and the DKP closing reaction after ~ 48 hours (bottom) 
 
The products obtained when the cyclic monomers were dissolved in 20% 
piperidine/NMP are summarized in Table 5-3.  In each case, it was possible to close one less 
than the expected number of DKP rings. 
Table 5-3: A summary of the products obtained when each of the cyclic monomers in the series 
were dissolved in 20% piperidine/NMP (as determined by HPLC-MS) 
 
 
Conversion of the open-form 3-mer cyclic dimer 94 to the desired product 96 was clean.  
DKP formation for the open-form 4-mer and 5-mer cyclic dimers (118 and 120) was relatively 
clean; the bis-peptide cyclic dimers 129 and 130 were purified by preparative HPLC (Figure 
5-9), and analyzed by HRMS.  There was evidence of complete DKP closure for the longer 
cyclic dimers (6-mer through 9-mer open-form cyclic dimers).  Unfortunately, substantial 
epimerization occurred while these samples were dissolved in 20% piperidine/NMP.  The Boc-
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deprotected open-form oligomers were dissolved in water in order to obtain samples for HPLC-
MS analysis.  The aqueous samples were concentrated by centrifugal evaporation (SpeedVac); 
the epimerization may have been caused by residual water content. 
 
HPLC-MS: Column, Waters XTerra C18, 4.6 × 150 mm; mobile phase, CH3CN (0.05% HCOOH) / water (0.1% 
HCOOH), 0% to 50% CH3CN over 30 min; flow rate, 0.80 mL/min; UV detection at 274 nm. 
 
Figure 5-9: HPLC chromatograms of purified bis-peptide cyclic dimers: 97 (3-mer cyclic dimer), 129 (4-mer cyclic 
dimer), 130 (5-mer cyclic dimer) 
5.6 ROD-HINGE-ROD MOTIF 
The cyclic dimers generated in the model systems described above are large macrocycles.  
Nonetheless, the synthetic route favors cyclic monomers, which cannot undergo complete DKP 
closure.  Although the dimers can be isolated and their bis-peptide oligomer components can be 
rigidified, these macrocycles are C2 symmetric.  To create cavities that are bio-mimetic, 
asymmetry is essential; asymmetry is intimately associated with biological sensing and 
molecular recognition. 
The results from the model systems inspired us to pursue a different strategy: connecting 
two oligomers with a flexible hinge during solid-phase synthesis (Figure 5-10).  This approach 
would exploit the cyclic monomer selectivity of the CuAAC macrocyclization reaction with 
lengthy Boc-protected oligomers.  The expected major product was the cyclic monomer, which 
 154 
would be composed of two bis-peptide oligomers connected through a 1,4-triazole and a flexible 
hinge.  Once the DKP rings between the monomers have been closed, the macrocycle will 
resemble the cyclic dimers (or incompletely rigidified cyclic monomers).  The linker should 
provide flexibility in the backbone, allowing complete rigidification of the bis-peptide oligomer 
segments. 
 
Figure 5-10: Schematic representation of a “rod-hinge-rod” approach toward asymmetrical bis-
peptide oligomer based macrocycles 
 
For the initial test of this strategy, we prepared 131, the precursor of a “3-hinge-3” 
macrocycle (Scheme 5-15).  The naphthylalanine, propargylglycine, and the first three Boc-
pro4(2S,4S) monomers (19) were coupled to 2-chlorotritylchloride resin as described for the 
model system (above).  The “hinge”, N-Fmoc-N’-ivDde-(S)-diaminobutanoic acid (Fmoc-Dab-
(ivDde)), was coupled to the third monomer using HATU.  The Fmoc group was removed for an 
extended time to quantitatively close the DKP between the Dab and the preceding monomer.  
The ivDde group204,205was removed from the side chain amine of the residue using hydrazine; 
allyl alcohol was added to the reaction mixture to scavenge diimide, an impurity which 
accumulates in hydrazine solutions, and which could reduce the propargyl group.206  Three 
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additional Boc-pro4(2S,4S) were coupled to the resin, followed by Fmoc-Dab-N3 (88).  131 was 
isolated by resin cleavage with 1% TFA. 
 
Scheme 5-15: Synthesis of 131, the precursor of a “3-hinge-3” macrocycle 
 
Because of the relationship between oligomer length and the cyclic monomer / cyclic 
dimer ratio during macrocyclization, 131 was expected to cyclize to the cyclic monomer under 
the CuAAC reaction conditions.  The selectivity for the cyclic monomer was excellent; the ratio 
of cyclic monomer 132 to cyclic dimer 133 was 100:7 (Scheme 5-16).  The combined yield of 
cyclic monomer and cyclic dimer was 89%.  The Boc groups were removed using TFA, 
affording the Boc-deprotected open-form cyclic monomer, 134. 
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Scheme 5-16: CuAAC reaction of 131, generating the major product, cyclic monomer 132; the Boc groups were 
removed from 132, forming 134. 
 
Finally, the Boc-deprotected open-form cyclic monomer was dissolved in 20% 
piperidine/NMP (Scheme 5-17); DKP occurred in the usual fashion.  HPLC chromatograms of 
the crude reaction mixture for each step in the synthesis of 135 are illustrated in Figure 5-11. 
 
Scheme 5-17: DKP closure for the 3-hinge-3 macrocycle 
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Figure 5-11: HPLC chromatograms of the intermediates and final product of the synthesis of the 3-hinge-3 cyclic 
bis-peptide oligomer: A (5% to 95% CH3CN): 131 after resin cleavage,  B (5 to 95% CH3CN): 132 and 133 after the 
CuAAC reaction, C (0 to 50% CH3CN): 134 after treating purified 132 with TFA, D (0 to 50% CH3CN): the crude 
DKP closing reaction after ~ 24 hours 
 
To test the generality of the “hinged” approach to bis-peptide macrocycles, a 6-hinge-6 
macrocycle was prepared (6 pro4(2S,4S) monomers before and after the hinge).  The complete 
synthesis of the 6-hinge-6 macrocycle 139 is illustrated in Scheme 5-18.  136 was synthesized on 
solid phase using the methods described for the synthesis of the 3-hinge-3 precursor 131.  
Following resin cleavage, 136 was found to be contaminated by a small amount of a compound 
that resulted from incomplete coupling of the Fmoc-Dab-(ivDde) amino acid (Figure 5-12, 
HPLC chromatogram A1). 
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Scheme 5-18: Synthesis of the 6-hinge-6 cyclic monomer, 139 
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After the resin cleavage product 136 was dissolved in the cycloaddition reaction solution 
(2 equivalents of CuI, DIPEA, and 2,6,-lutidine, ~ 1 mM in 136), there was no apparent change 
in the HPLC chromatogram.  As the number of Boc-pro4 monomers increased, there was a 
corresponding decrease in the difference in retention time between the of the Boc-protected 
cyclic monomers and the starting material.  This result was disappointing; unlike the previous 
CuAAC reactions, there was no immediate evidence that the starting material had undergone any 
chemical transformation. 
Nonetheless, the ESI mass spectrum of the reaction mixture provides evidence for 
macrocyclization.  In the ESI mass spectrum of the starting material 136, there is a strong peak 
that corresponds to [M – 2Boc + 2H+] (Figure 5-16, ESI-MS A2).  Following CuAAC, the 
intensity of this peak decreases.  Also, the base peak in the mass spectrum becomes [M – Boc + 
2H+] (Figure 5-16, ESI-MS B2a).  There were similar differences between the ESI mass spectra 
of 3-hinge-3 precursor 131 and its cyclic monomer 132. 
To obtain addition proof that cyclization had occurred, a simple chemical test was 
performed to determine if the compound was functionalized with an azide.  After removing the 
residual copper, a small amount of tris(2-carboxyethyl)phosphine (TCEP)207 was added to a 
solution containing an analytical portion of the alleged cyclic monomer, 137.  TCEP is a strong, 
water-soluble reducing agent, typically used for the cleavage of disulfide bonds.  Triazoles do 
not react with TCEP, but azides are rapidly reduced to amines; reduction elicits a change in the 
mass spectrum of compounds labeled with azides.208  This test provides a means to distinguish 
between linear monomer and cyclic monomer.  There was no change in the diagnostic ESI-MS 
peaks of 137 following treatment with TCEP (Figure 5-16, ESI-MS B2b).  This suggests that the 
compound with the same retention time as 136 is not an azide; this also supports the proposed 
cyclization from 136 to 137. 
The residual copper was removed by adsorbing 137 upon C18 silica, washing the silica 
with water, and then eluting 137 with CH3CN.  Treatment of the concentrated eluent with TFA in 
dichloromethane afforded 138, which has an exceptionally clean and characteristic ESI mass 
spectrum (Figure 5-12, ESI-MS C2) because of its numerous ionizable amines. 
After Boc deprotection, crude 138 was dissolved in 20% piperidine/NMP.  Within 12 
hours (Figure 5-16, HPLC chromatogram D1) a single major product began to accumulate in 
solution.  Considering the number of transformations that had been performed prior to DKP 
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formation, the major product of DKP closure, 139, was remarkably clean, especially considering 
that none the intermediates had been rigorously purified (removal of the CuI from 137 on C18 
silica was not performed with gradient elution).  The product was isolated by preparative HPLC; 
HPLC-MS analysis of the purified product indicated that the mass of product 139 is consistent 
with the structure illustrated in Scheme 5-18 (Figure 5-16, HPLC chromatogram E1 and ESI-MS 
E2). 
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Figure 5-12: HPLC and ESI-MS analysis of the intermediates produced during the synthesis of 139.  A1 (5% to 
95% CH3CN): HPLC of crude cleavage product 136.  A2: ESI-MS of 136.  B1 (5% to 95% CH3CN): HPLC of 137.  
B2a: ESI-MS of crude 137 before treatment with TCEP.  B2b: ESI-MS of crude 137 after TCEP treatment.  C1 (0% 
to 50% CH3CN): 138.  C2: ESI-MS of crude 138.  D1 (0% to 50% CH3CN): DKP closing reaction at 12 hours.  E1 
(0% to 50% CH3CN): HPLC of purified 139.  E2: ESI-MS of 139. 
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5.7 CONCLUSIONS  
The CuAAC “click” reaction209 has been used to create macrocycles from bis-peptide 
oligomers.  The reaction was performed with the Boc-protected, open-form oligomers in 
acetonitrile.  The macrocyclization reaction is very clean; the starting material was converted 
into recoverable macrocycles with good yields (> 70%).  The reaction generates two major 
products; the cyclic monomer and cyclic dimer.  In the model system (an alkyne/azide 
functionalized oligomer containing 3 Boc-pro4 monomers) the cyclic monomer was the 
preferred product; selectivity for the cyclic monomer improved with increasing length of the 
open-form oligomers.  This relationship was exploited for efficient preparation of “rod-hinge-
rod” macrocycles.  It was possible to rigidify the open-form bis-peptides in the context of the 
cyclic dimers and the rod-hinge-rod macrocycles; DKP formation was incomplete for the cyclic 
monomers without a hinge.  These experiments have barely scratched the surface of using bis-
peptide oligomers as building blocks for macromolecular construction. 
5.7.1 Extending the rod-hinge-rod approach 
The success of the approach toward the 3-hinge-3 and 6-hinge-6 macrocycles warrants 
further investigation; this method may be limited only by the practical constraints of SPPS.  
Introducing multiple hinges and bis-peptide oligomer subunits would allow access to 
macrocycles of tailored size and shape (Figure 5-13). 
 
Figure 5-13: Incorporating multiple hinges and bis-peptide oligomer segments 
should allow control over the shape and size of the resulting macrocycles. 
 
Consider Kimura’s “helix-triangle” illustrated in Figure 5-14, which represents the state-
of-the-art in large, covalently assembled, shaped macrocycles.168  Three poly-aromatic amino 
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acids are used as the vertices of the triangle; assembly of the macrocycle is dictated by the 60° 
angle defined at each vertex.  The sides of the helix triangle are rigid α-helical peptides.  It is 
possible change the size of the triangle by increasing the length of the peptides.  Creating 
different shapes, however, would be challenging; every shape would require molecules at the 
vertices which display co-planar functional groups in precise, geometric orientations.  Certain 
shapes would likely be impossible (a heptagon, for instance).  An almost limitless variety of 
macrocycle shapes and sizes could be synthesized using the rod-hinge-rod bis-peptide 
macrocyclization approach. 
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Figure 5-14: A “helix-triangle”168 
5.7.2 Exploring solution and solid phase routes toward macrocyclization 
Occasionally, exploring new bis-peptide chemistry on solid phase has led to intractable, 
inseparable mixtures following resin cleavage.  It is difficult to identify the source of the problem 
in these cases; these circumstances usually require that the synthesis be repeated from the 
beginning.  To avoid this situation, model CuAAC bis-peptide macrocyclization reactions were 
performed in solution.  The progress of each reaction was monitored in (almost) real-time; 
products and side products were identified almost immediately. 
Dealing with the residual copper in the product was irksome, and led to difficulties with 
NMR experiments and with purification.  During the synthesis of the 6-hinge-6 oligomer, the 
crude CuAAC reaction was loaded onto a disposable C18 silica gel cartridge and washed 
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extensively with water; the desired product was eluted with acetonitrile.  This method effectively 
removed residual copper from the product, but extensive product manipulation after resin 
cleavage leads to loss of material. 
The CuAAC reaction of long, Boc-protected, open-form oligomers was extremely 
selective for the cyclic monomer.  It might be possible to perform cyclization of the rod-hinge-
rod oligomers on solid phase (see “Route D”, Figure 5-2); the residual copper could be removed 
from the resin with chelating reagents, and the Boc groups could be removed upon resin 
cleavage, leaving only DKP formation.  Resin loading is critically important for this approach.  
Selectivity for the cyclic monomer was possible under dilute conditions; when the CuAAC 
reaction was performed in more concentrated solutions, the proportion of cyclic dimer (and 
cyclic trimer) increased significantly.  The reaction was performed at 1 mM concentration.  The 
concentration of oligomer attached to 1% cross-linked polystyrene Rink Amide resin is 
considerably higher.  The diffusion of the oligomers is inhibited because they are “anchored” to 
the solid support.  Nonetheless, Rebek and Trend’s study210 on the interactions between short 
peptides anchored to solid support suggests that when the resin is solvated, peptides anchored to 
the resin can encounter and react with adjacent anchored peptides.  Finn reported a dramatic 
example of tandem dimerization/macrocyclization between adjacent peptides on solid support 
using CuAAC.187 
A number of questions remain about bis-peptide macrocyclization.  The effect of 
macrocyclization upon the rigidity of the bis-peptides is unknown; bundling rod-like molecules 
can create macromolecules with increased rigidty.2  It would also be interesting to develop 
conditions that caused macrocyclization after DKP closure; it is expected that the rigidified 
oligomers would undergo dimerization because the alkyne and azide are held apart.  Sequences 
of alternating pro4(2S,4S) and pro4(2R,4R) monomers seem to impart curvature to pro4 bis-
peptides, but the exact amount of curvature is not known.  If enough alternating monomers are 
incorporated into an oligomer, modeling suggests that the two ends of the bis-peptide will 
eventually meet.  A series of alkyne-azide oligomers of increasing length could be synthesized, 
but with the alternating pro4(2S,4S)–pro4 (2R,4R) motif (similar to the experiment described in 
section 0 above).  DKP formation would be attempted before and after macrocyclization: such an 
experiment might provide good evidence about the degree of curvature imparted by this 
sequence motif.  The CuAAC reaction could also be combined with other cyclization methods to 
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create 3-dimensional polyhedra from rigidified bis-peptide oligomers; these would be a 
spectacular demonstration of modular design and synthesis of nanoscale structures.  
5.8 EXPERIMENTAL DETAILS 
5.8.1 Fmoc-Dap-N3 synthesis and incorporation into oligomers 84 and 85 
(S)-3-Azido-2-(9H-fluoren-9-ylmethoxycarbonylamino)-propionic acid (Fmoc-Dap-N3, 81) 
NaN3 (597 mg, 9.19 mmol), water (1.6 mL) and CH2Cl2 (3.12 mL) were added to a conical vial 
containing a magnetic stir bar.  The vial was immersed in an ice bath.  Triflic anhydride (Tf2O, 
310 μL, 1.8 mmol, used as received from Acros) was added to the stirred reaction mixture very 
slowly by syringe.  The mixture was stirred for 2 additional hours while warming to room 
temperature.  The solution separated into two layers; the bottom organic layer was removed.  The 
remaining aqueous layer was washed with CH2Cl2 (2 × ~ 1 mL).  All of the CH2Cl2 layers were 
combined and washed with saturated aqueous K2CO3 (2 × 1 mL).  The resulting solution of 
triflic azide (TfN3) in CH2Cl2 was covered and set aside (CAUTION: TfN3 is explosive when 
dry, and so the solution should not be concentrated, nor should the CH2Cl2 be allowed to 
evaporate).  (S)-3-Amino-2-(9H-fluoren-9-ylmethoxycarbonylamino)-propionic acid (Fmoc-Dap, 
83, 300 mg, 0.92 mmol), potassium carbonate (190 mg, 1.4 mmol), and CuSO4·5H2O (2.3 mg, 
9.2 μmol) were transferred to a 10 mL round bottom flask containing a magnetic stir bar.  
Methanol (4.7 mL) and water (3.1 mL) were added to the flask.  The solution of TfN3 in CH2Cl2 
was added dropwise to the stirred reaction mixture, which became cloudy.  By TLC (5:1 
CHCl3/MeOH), the starting material 83 (Rf = 0.1) was completely consumed within 1 hour; the 
product (81, Rf = 0.2) stained bright orange-yellow with anisaldehyde.  The reaction mixture was 
distributed between EtOAc (50 mL) and pH 2 aqueous HCl (75 mL).  After separating the two 
layers, the aqueous layer was extracted with additional EtOAc (3 × ~ 25 mL); the EtOAc layers 
were combined, washed with brine, dried over MgSO4, filtered, then concentrated by rotary 
evaporation.  The product was purified using gradient elution flash chromatography on silica 
(CHCl3 (0.1% AcOH) to 10% MeOH/CHCl3 (0.1% AcOH)).  Fractions containing the product 
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were pooled and concentrated by rotary evaporation.  Residual acetic acid was removed by 
repeatedly dissolving the product in 1:1 CH2Cl2/hexanes, then re-concentrating the solution.  
Solvent was removed overnight under reduced pressure affording 81 (244 mg, 69.2 mmol, 
75.4%) as a white foam.  The 1H NMR spectrum of 81 was consistent with literature data.200  1H 
NMR (300 MHz, CDCl3): δ 7.78 (d, J = 7.5 Hz, 2H), 7.61 (d, J = 7.3 Hz, 2H), 7.42 (t, J = 7.2 
Hz, 2H), 7.34 (t, J = 7.4 Hz, 2H), 5.61 (d, J = 7.9 Hz, 1H), 4.62 (m, 1H), 4.46 (d, J = 7.0 Hz, 
2H), 4.25 (t, J = 6.7 Hz, 1H), 3.83 (m, 2H). 
 
Compound 84: alkyne functionalized, 3-mer open-form oligomer (elimination product) 
N-Fmoc-(S)-propargylglycine (22.1 mg, 66 μmol) and DIPEA (46 μL, 264 μmol) were dissolved 
in dichloroethane (330 μL); the solution was transferred into a 4 mL conical vial containing 15 
mg of 2-chlorotritylchloride resin (1.1 mmol/gram loading) and a magnetic spin vane.  The vial 
was capped, and the suspension was stirred under nitrogen for 5 hours.  The resin was transferred 
to a solid phase reaction vessel, capped with methanol and DIPEA, and washed.  The N-Fmoc 
group was removed from the propargylglycine with 20% piperidine/DMF, and the resin was 
washed thoroughly.  19, 19, 19, and 81 were coupled sequentially to the resin with HATU (2 
equiv of N-Fmoc protected amino acid, 2 equiv of HATU, 4 equiv of DIPEA, 0.2 M in 20% 
CH2Cl2 in DMF, 30 minute couplings).  Every coupling was repeated an additional time to 
assure quantitative coupling, and following each coupling the resin was capped with 400:100:8 
DMF/Ac2O/DIPEA.  The N-terminal Fmoc groups were removed by treatment with 20% 
piperidine/DMF for 40 minutes; Fmoc removal from 81 was extended to 2 hours, allowing the 
DKP to close.  The resin was split into two portions.  One half of the resin was treated with an 
8:2:1 CH3CN/DMSO/H2O solution (231 μL) containing CuSO4·5H2O (0.6 mg, 2.3 μmol, 0.3 
equiv relative to initial resin loading) and sodium ascorbate (1.5 mg, 7.7 μmol, 1 equiv relative 
to initial resin loading) overnight under argon.  The CuI treated and untreated portions were 
washed thoroughly, and residual solvent was removed under reduced pressure.  The products 
were cleaved from the resins using 95:2.5:2.5 TFA/TIS/H2O.  By HPLC-MS analysis, there was 
a single major product generated upon cleavage of both resin portions with identical retention 
times and ESI mass spectra.  The mass spectra were consistent with the proposed structure of 84.  
The yield of 84 from both resin portions was similar (based upon the relative area under the 220 
nm absorbance peaks in their respective HPLC chromatograms). 
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HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 25% CH3CN over 30 min; flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 84, 3.92 min; ESI-MS m/z (ion) 660.6 (100%, M + H+, expected 
661.3), 331.0 (92%, [M +2H+]/2, expected 331.1). 
 
Compound 85: alkyne functionalized, 5-mer open-form oligomer (elimination product) 
N-Fmoc-(S)-propargylglycine, 19, 30, 19, 30, 19, and 81 were coupled sequentially to 15 mg of 
2-chlorotritylchloride resin in the manner described for the synthesis of 84.  The resin was split 
into two portions; one half of the resin was treated with copper sulfate as described for 84.  Both 
the treated and untreated resin portions were washed thoroughly and residual solvent was 
removed under reduced pressure.  The products were cleaved from the resins using 95:2.5:2.5 
TFA/TIS/H2O.  By HPLC-MS analysis, there was a single major product generated upon 
cleavage of both resin portions with identical retention times and ESI mass spectra.  The mass 
spectra were consistent with the proposed structure of 85.  The yield of 85 from both portions 
was very similar, based upon the relative HPLC chromatogram peak areas. 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 25% CH3CN over 30 min; flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 85, 6.28 min; ESI-MS m/z (ion) 1000.4 (23%, M + H+, expected 
1001.4), 500.8 (100%, [M +2H+]/2, expected 501.2). 
5.8.2 Fmoc-Dab-N3 and CuAAC model system 89 
(S)-4-Azido-2-(9H-fluoren-9-yloxycarbonylamino)-butyric acid (Fmoc-Dab-N3, 88) 
NaN3 (1.52 g, 23.4 mmol), water (4 mL) and CH2Cl2 (8.7 mL) were added to a 25 mL round 
bottom flask containing a magnetic stir bar.  The flask was immersed in an ice bath.  Tf2O (790 
μL, 4.68 mmol) was added to the stirred reaction mixture very slowly by syringe.  The mixture 
was stirred for an additional 2 hours while warming to room temperature.  The organic layer was 
removed, and the aqueous layer was washed with CH2Cl2 (2 ×).  The portions of CH2Cl2 were 
combined and washed with saturated aqueous K2CO3 (2 ×).  This TfN3 solution was covered and 
set aside (see the caution above regarding TfN3, which is explosive). 
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(S)-4-tert-Butoxycarbonylamino-2-(9H-fluoren-9-ylmethoxycarbonylamino)-butyric acid (86, 
1000 mg, 2.34 mmol) was added to a 25 mL round bottom flask containing a magnetic stir bar, 
then dissolved in 1:1 TFA/CH2Cl2 (~ 12 mL).  The reaction mixture was stirred until TLC 
analysis revealed that the starting material had been entirely consumed.  The mixture was 
concentrated by rotary evaporation, and residual solvent was removed overnight under reduced 
pressure affording compound 87, used without further purification. 
 
Methanol (12 mL), water (8 mL) and a stir bar were added to the 25 mL round bottom flask 
containing 87.  Potassium carbonate (808 mg, 5.85 mmol) and CuSO4·5H2O (5.8 mg, 23.4 μmol) 
were transferred into the solution.  The solution of TfN3 in CH2Cl2 was added dropwise to the 
stirred reaction mixture, which became cloudy.  The reaction mixture was concentrated, worked-
up, and purified (as described for compound 81), affording Fmoc-Dab-N3 (88, 745 mg, 2.03 
mmol, 87%) was a white foam.  1H NMR (300 MHz, CDCl3): δ 7.78 (d, J = 7.5 Hz, 2H), 7.60 (d, 
J = 7.2 Hz, 2H), 7.42 (t, J = 7.4 Hz, 2H), 7.33 (t, J = 7.4 Hz, 2H), 5.46 (d, J = 5.5 Hz, 1H), 4.59 – 
4.46 (m, 3H), 4.24 (apparent t, J = 6.5 Hz, 1H), 3.43 (apparent t, J = 6.1 Hz, 2H), 2.20 (m, 1H), 
2.03 (m, 1H); 13C NMR (75.4 MHz, CDCl3) mixture of rotamers δ 176.1 and 175.3, 156.8 and 
156.0, 143.7 and 143.5, 141.3, 127.8 (CH), 127.1 (CH), 125.0 (CH), 120.0 (CH), 67.2 (CH2), 
51.6 (CH), 47.6 (CH2), 47.1 (CH), 31.3 (CH2); IR (neat film) 3306, 3066, 2929, 2102 (–N3 
stretch), 1720, 1524, 1478, 1450, 1337, 1250, 1154, 1104, 1059 cm-1; [α]D 21.5° (c 0.4, CH3Cl); 
ES-MS m/z (relative intensity) 1121.5 (7%, 3M + Na+), 909.3 (32%), 755.3 (48%, 2M + Na+), 
389.1 (100%, M + Na+); HRESIQTOFMS calcd for C19H18N4O4Na (M + Na+) 389.1226, found 
389.1227. 
 
Compound 89: alkyne/azide functionalized Boc-protected open-form 3-mer oligomer 
N-Fmoc-1-(S)-naphthylalanine (57.8 mg, 132 μmol), CH2Cl2 (660 μL) and DIPEA (92 μL, 527 
μmol) were added to a 4 mL conical vial containing 2-chlorotritylchloride resin (30 mg, 1.1 
mmol/gram substitution) and a magnetic spin vane.  The vial was sealed and the reaction mixture 
was stirred for 3 hours.  The resin was transferred into a SPPS reaction vessel, washed, and then 
capped using 17:2:1 CH2Cl2/MeOH/DIPEA.  The N-Fmoc group was removed from the 
naphthylalanine using 20% piperidine/DMF for 40 minutes.  N-Fmoc-(S)-propargylglycine, 19, 
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19, 19, and 88 were coupled sequentially to the resin with HATU as described above.  The resin 
was stirred in 20% piperidine/DMF for 2 hours during the final Fmoc deprotection to ensure 
quantitative DKP formation between the last two residues.  The resin was washed, and residual 
solvent was removed under reduced pressure. 
 
The resin was re-swollen in CH2Cl2; the solvent was filtered away.  Aliquots (~ 2 mL) of 1% 
TFA/CH2Cl2 were transferred to the resin, which immediately turned from pale yellow to 
maroon.  The suspension was stirred with gentle argon bubbling for 2 minutes, and then the 
solution was siphoned from the resin into a receiving flask containing 20% pyridine/MeOH (4 
mL).  This procedure was repeated 10 times.  The resin was washed with several portions of 
CH2Cl2 and MeOH; these were also transferred into the receiving flask.  The solution was 
concentrated by centrifugal evaporation; hexanes and MeOH were added periodically to help 
remove residual solvent.  One-half of the resulting fluffy powder was purified by 
chromatography on C18 silica (4 gram column, gradient elution from H2O (0.1% HCOOH) to 
CH3CN (0.05% HCOOH) over 14 column volumes).  Fractions containing the desired product 
were pooled and concentrated by centrifugal evaporation, affording 89 (8.6 μmol, ~ 52% 
recovery relative initial resin loading, determined by HPLC calibration with naphthylalanine). 
 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / CH3CN (0.05% 
HCOOH), 5% to 95% CH3CN over 30 min; flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 89, 22.30 min; 
ESI-MS m/z (ion) 1115.3 (100%, M – Boc + H+), 1215.4 (30%, M + H+), 1283.4 (45%), 1300.4 (18%), 2330.6 (5%, 
2M – Boc + H+). 
 
Figure 5-15: HPLC chromatogram of purified 89 
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Compound 90, Compound 91, Compound 92: cyclic monomer, cyclic dimer and cyclic 
(respectively) from CuAAC reaction of Boc-protected oligomer 89  
Anhydrous CH3CN was degassed by sparging with argon for 30 minutes.  89 (~ 8.6 μmol) was 
dissolved in the degassed CH3CN (16.5 mL); the solution was transferred into a 25 mL round 
bottom flask containing a magnetic stir bar.  DIPEA (5.7 μL, 33 μmol), 2,6-lutidine (3.8 μL, 33 
μmol) and CuI (6.3 mg, 33 μmol) were added to the solution.  The flask was sealed with a rubber 
stopper and the reaction mixture was stirred overnight.  The solution was concentrated by 
centrifugal evaporation, and the three products (90, 91, and 92) were isolated by preparative 
HPLC (XTerra C18, 10 × 100 mm; mobile phase, H2O (0.l% HCOOH) / CH3CN (0.05% 
HCOOH), 5% to 95% CH3CN over 30 min; flow rate, 6.5 mL/min).  By integrated area under 
peaks in the HPLC chromatogram of the reaction mixture, 76% of the starting material 89 was 
converted into one of the three major products, in the molar ratio 100:33:4 cyclic monomer 90 / 
cyclic dimer 91 / cyclic trimer 92. 
 
Compound 90: 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min; flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 90, 21.42 min; ESI-MS m/z (ion) 1215.4 (100%, M + H+), 2430.6 
(5%, 2M + H+);  HRESIQTOFMS calcd for C57H74N12O18Na (M + Na+) 1237.5142, found 
1237.5171. 
 
Compound 91: 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min; flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 91, 25.40 min; ESI-MS m/z (ion) 1215.8 (100%, [M + 2H+]/2), 
2430.6 (20%, M + H+); HRESIQTOFMS calcd for C114H148N24O36Na (M + Na+) 2452.0386, 
found 2451.9990. 
 
Compound 92: 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min; flow rate, 0.80 mL/min; UV 
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detection at 220 nm; tR for 92, 28.41 min; ESI-MS m/z (ion) 1215.8 (65%, [M + 3H+]/3), 1823.4 
(100%, [M + 2H+]/2), 2430.5 (7%, [2M + 3H+]/3); HRESIQTOFMS calcd for 
C171H222N36O54Na2 / 2 ([M + 2Na+]/2) 1844.7759, found 1844.7683. 
 
Compound 93, Compound 94, Compound 95: Boc-deprotected open-form cyclic monomer, 
cyclic dimer, and cyclic trimer (respectively) 
The Boc-protected cyclic monomer 90, cyclic dimer 91, and cyclic trimer 92 were each dissolved 
in TFA (~ 4 mL).  The solutions were mixed by swirling, allowed to stand for 1 hour, and then 
concentrated by centrifugal evaporation overnight.  Analytical samples of 93 and 94 were 
prepared by dissolving a portion of the crude product in 1:1 CH3CN/H2O. 
 
Compound 93: 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min; flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 93, 12.81 min; ESI-MS m/z (ion) 915.2 (15% M + H+), 458.2 (100%, 
[M + 2H+]/2); HRESIQTOFMS calcd for C42H51N12O12 (M + H+) 915.3749, found 915.3744 
 
Compound 94: 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min; flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 94, 14.41 min; ESI-MS m/z (ion) 915.4 (8%, [M + 2H+]/2), 610.7 
(43%, [M + 3H+]/3), 458.4 (100%, [M + 4H+]/4); HRESIQTOFMS calcd for C84H102N24O24 / 2 
([M + 2H+]/2) 915.3750, found 915.3774. 
 
Compound 96, Compound 97, Compound 98: cyclic monomer, cyclic dimer, and cyclic trimer 
following DKP formation reaction 
The residues containing Boc-deprotected cyclic monomer 93, cyclic dimer 94, and cyclic trimer 
95 were each dissolved in 20% piperidine/DMF (1.25 mL) and transferred to HPLC vials.  The 
progress of the DKP closing reactions were monitored by HPLC.  After three days, each solution 
was added dropwise to stirred Et2O; the resulting precipitates were pelleted by centrifugation.  It 
was possible to isolate pellets containing 96 and 97.  These were dried, dissolved in 1:1 
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CH3CN/H2O, and found to be remarkably pure by analytical HPLC-MS; the samples were 
analyzed by HRMS.  There was insufficient rigidified cyclic trimer 98 for HRMS analysis. 
 
Compound 96: 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min; flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 96, 12.29 min; ESI-MS m/z (ion) 883.2 (100%, M + H+), 1766.4 
(12%, 2M + H+); HRESIQTOFMS calcd for C41H47N12O11 (M + H+) 883.3487, found 883.3477. 
 
Compound 97: 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min; flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 97, 11.27 min; ESI-MS m/z (ion) 1702.3 (15%, M + H+), 1277.0 ([3M 
+ 4H+]/4), 1135.1 (20%, [2M + 3H+]/3), 851.2 (100%, [M + 2H+]/2), 568.0 (15%, [M + 3H+]/3); 
HRESIQTOFMS calcd for C80H85N24O20 (M + H+) 1701.6372, found 1701.6433. 
 
Compound 98: (not isolated: see the analytical HPLC of the crude DKP closure reaction 
mixture in Figure 5-16) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min; flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 98, 11.31 min; ESI-MS m/z (ion) 1276.6 (85%, [M + 2H+]/2), 851.0 
(33%, [M + 3H+]/3). 
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HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / CH3CN (0.05% 
HCOOH), 5% to 95% CH3CN over 30 min; flow rate, 0.80 mL/min. 
 
Figure 5-16: HPLC chromatogram of crude 98 in 20% piperidine/DMF 
5.8.3 Alkyne/azide functionalized oligomers of increasing length 
N-Fmoc-1-(S)-naphthylalanine and N-Fmoc-(S)-propargylglycine were coupled sequentially to 
2-chlorotritylchloride resin (100 mg, 1.1 mmol/gram substitution) using the methods described 
above.  Boc-pro4(2S,4S) (19) was coupled to the resin with HATU, and the N-Fmoc group was 
removed from the monomer.  ~ 10 mg of the resin was removed (based on initial resin weight; 
this was determined by suspending the resin in 10 mL of DMF, mixing the suspension 
thoroughly, and removing 1 mL of the suspension).  The resin sample was transferred into a 
second SPPS vessel.  Fmoc-(S)-Dab-N3 (88) was coupled to the resin sample, and monomer 19 
was coupled to the main batch.  This procedure was repeated as described in Scheme 5-13.  
When SPPS was complete, the 7 resins were washed, and residual solvent was removed from 
each under reduced pressure.  The products were cleaved from each resin using 1% TFA/CH2Cl2 
as described above.  The cleavage products were purified by flash chromatography on C18 silica 
(4 gram column, gradient elution over 14 column volumes from H2O (0.1% HCOOH) to CH3CN 
(0.05% HCOOH)).  Fractions containing the desired products were concentrated by centrifugal 
evaporation.  The yield of the cleavage reactions were typically around 70%.  This was 
determined by HPLC analysis of the cycloaddition reactions before adding the CuI and 2,6-
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lutidine; the HPLC calibration curve was generated by injecting various amounts of (S)-
naphthylalanine under the same column conditions and flow rate. 
 
Compound 99: alkyne/azide functionalized 4-mer oligomer (resin cleavage product) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 99, 23.37 min; ESI-MS m/z 
(ion) 1553.4 (7%), 1507.3 (10%), 1485.4 (25%, M + H+), 1385.4 (100%, M – Boc + H+); 
HRESIQTOFMS calcd for C69H92N14O23Na (M + Na+) 1507.6357, found 1507.6334. 
 
Compound 100: alkyne/azide functionalized 5-mer oligomer (resin cleavage product) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 100, 23.31 min; ESI-MS m/z 
(ion) 1823.4 (7%), 1778.4 (12%), 1655.4 (100%, M – Boc + H+); HRESIQTOFMS calcd for 
C81H110N16O28Na (M + Na+) 1777.7573, found 1777.7577. 
 
Compound 101: alkyne/azide functionalized 6-mer oligomer (resin cleavage product) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 101, 24.95 min; ESI-MS m/z 
(ion) 1926.6 (100%, M – Boc + H+), 913.2 (48%, [M – 2Boc + 2H+]/2), 885.2 (20%). 
 
Compound 102: alkyne/azide functionalized 7-mer oligomer (resin cleavage product) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 102, 25.51 min; ESI-MS m/z 
(ion) 2196.4 (20%, M – Boc + H+), 1048.4 (100%, [M – 2Boc + 2H+]/2). 
 
Compound 103: alkyne/azide functionalized 8-mer oligomer (resin cleavage product) 
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HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 103, 26.01 min; ESI-MS m/z 
(ion) 1183.3 (100%, [M – 2Boc + 2H+]/2). 
 
Compound 104: alkyne/azide functionalized 9-mer oligomer (resin cleavage product) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 104, 26.47 min; ESI-MS m/z 
(ion) 1318.3 (100%, [M – 2Boc + 2H+]/2). 
 
General procedure for the CuAAC macrocyclizations of 99 through 104: 
Anhydrous CH3CN was degassed by sparging with argon for 30 minutes.  The resin cleavage 
product (the Boc-protected alkyne-azide functionalized oligomer) was dissolved in CH3CN such 
that oligomer concentration was ~ 1 mM (estimated; based upon the theoretical yield from resin 
cleavage).  The solution was transferred into a round bottom flask containing a magnetic stir bar.  
DIPEA (2 equivalents, relative to the theoretical cleavage yield), 2,6-lutidine (2 equivalents) and 
CuI (2 equivalents) were added to the solution.  The flask was sealed with a rubber stopper, and 
the mixture was stirred overnight.  The reaction mixture was concentrated by centrifugal 
evaporation, affording a bluish residue that was dissolved in 1:1 CH3CN/H2O.  The cyclic 
monomer and cyclic dimer were isolated by preparative HPLC (XTerra C18, 10 × 100 mm; 
mobile phase, H2O (0.l% HCOOH) / CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 
min; flow rate, 6.5 mL/min).  Fractions containing the desired products were concentrated. 
 
Compound 105: Boc-protected 4-mer cyclic monomer 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 105, 22.61 min; ESI-MS m/z 
(ion) 1485.4 (100%, M + H+). 
 
Compound 106: Boc-protected 4-mer cyclic dimer 
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HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 106, 26.91 min; ESI-MS m/z 
(ion) 1485.9 (72%, [M + 2H+]/2); HRESIQTOFMS calcd for C69H92N14O23Na (M + Na+) 
1507.6357, found 1507.6339. 
 
Compound 107: Boc-protected 5-mer cyclic monomer 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 107, 23.65 min; ESI-MS m/z 
(ion) 1755.6 (100%, M + H+), 828.6 (20%, M – Boc + H+). 
 
Compound 108: Boc-protected 5-mer cyclic dimer 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 108, 28.48 min; ESI-MS m/z 
(ion) 1756.4 (10%, [M + 2H+]/2); HRESIQTOFMS calcd for C81H110N16NaO28 (M + Na+) 
1777.7573, found 1777.7533. 
 
Compound 109: Boc-protected 6-mer cyclic monomer 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 109, 24.47 min; ESI-MS m/z 
(ion) 2026.8 (100%, M + H+), 963.8 (50%, M – Boc + H+). 
 
Compound 110: Boc-protected 6-mer cyclic dimer 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 110, 28.52 min; ESI-MS m/z 
(ion) 2026.8 (15%, [M + 2H+]/2). 
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Compound 111: Boc-protected 7-mer cyclic monomer 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 111, 25.35 min; ESI-MS m/z 
(ion) 2296.5 (100%, M + H+), 1098.8 (60%, M – Boc + H+). 
 
Compound 112: Boc-protected 7-mer cyclic dimer 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 112, 29.42 min; ESI-MS m/z 
(ion) 2296.3 (50%, [M + 2H+]/2), 1497.7 (22%). 
 
Compound 113: Boc-protected 8-mer cyclic monomer 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 113, 25.93 min; ESI-MS m/z 
(ion) 2566.3 (20%, M + H+), 1233.8 (100%, M – Boc + H+). 
 
Compound 114: Boc-protected 8-mer cyclic dimer 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 114, 29.79 min; ESI-MS m/z 
(ion) 2566.6 (15%, [M + 2H+]/2), 1677.5 (12%). 
 
Compound 115: Boc-protected 9-mer cyclic monomer 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 115, 26.48 min; ESI-MS m/z 
(ion) 2835.9 (5%, M + H+), 1368.4 (100%, M – Boc + H+). 
 
Compound 116: Boc-protected 9-mer cyclic dimer 
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HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 116, 30.28 min; ESI-MS m/z 
(ion) 1857.6 (14%, [M + 3H+]/3). 
 
Removing the Boc groups from the series of cyclic monomers and dimers: 
After purification of the cyclization products, each (106 through 116) was dissolved in 50% 
TFA/CH2Cl2.  The solution was concentrated after ~ 30 minutes by centrifugal evaporation. 
 
Compound 117: Boc-deprotected 4-mer cyclic monomer (open-form oligomer) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 117, 10.42 min; ESI-MS m/z (ion) 1085.2 (15%, M + H+), 543.2 
(90%, [M + 2H+]/2), 362.6 (100%, [M + 3H+]/3). 
 
Compound 118: Boc-deprotected 4-mer cyclic dimer (open-form oligomer) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 118, 12.58 min; ESI-MS m/z (ion) 724.2 (8%, [M + 3H+]/3), 543.3 
(100%, [M + 4H+]/4), 435.0 (13%, [M + 5H+]/5). 
 
Compound 119: Boc-deprotected 5-mer cyclic monomer (open-form oligomer) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 119, 10.03 min; ESI-MS m/z (ion) 1255.2 (3%, M + H+), 628.3 (10%, 
[M + 2H+]/2), 419.3 (100%, [M + 3H+]/3). 
 
Compound 120: Boc-deprotected 5-mer cyclic dimer (open-form oligomer) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
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detection at 220 nm; tR for 120, 11.28 min; ESI-MS m/z (ion) 837.7 (7%, [M + 3H+]/3), 628.5 
(55%, [M + 4H+]/4), 502.9 (100%, [M + 5H+]/5). 
 
Compound 121: Boc-deprotected 6-mer cyclic monomer (open-form oligomer) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 121, 9.29 min; ESI-MS m/z (ion) 1425.2 (2%, M + H+), 476.0 (100%, 
[M + 3H+]/3). 
 
Compound 122: Boc-deprotected 6-mer cyclic dimer (open-form oligomer) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 122, 10.44 min; ESI-MS m/z (ion) 951.0 (5%, [M + 3H+]/3), 713.6 
(25%, [M + 4H+]/4), 571.0 (100%, [M + 5H+]/5), 475.9 (15%, [M + 6H+]/6). 
 
Compound 123: Boc-deprotected 7-mer cyclic monomer (open-form oligomer) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 123, 8.63 min; ESI-MS m/z (ion) 1595.3 (7%, M + H+), 789.2 (23%, 
[M + 2H+]/2), 532.6 (100%, [M + 3H+]/3), 399.8 (65%, [M + 4H+]/4). 
 
Compound 124: Boc-deprotected 7-mer cyclic dimer (open-form oligomer) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 124, 10.09 min; ESI-MS m/z (ion) 1595.8 (6%, [M + 2H+]/2), 1064.1 
(8%, [M + 3H+]/3), 798.5 (43%, [M + 4H+]/4), 639.1 (100%, [M + 5H+]/5), 532.8 (40%, [M + 
6H+]/6). 
 
Compound 125: Boc-deprotected 8-mer cyclic monomer (open-form oligomer)  
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
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detection at 220 nm; tR for 125, 8.27 min; ESI-MS m/z (ion) 1765.0 (5%, M + H+), 883.3 (10%, 
[M + 2H+]/2), 589.4 (70%, [M + 3H+]/3), 442.4 (100%, [M + 4H+]/4). 
 
Compound 126: Boc-deprotected 8-mer cyclic dimer (open-form oligomer) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 126, 9.76 min; ESI-MS m/z (ion) 883.6 (17%, [M + 4H+]/4), 707.2 
(100%, [M + 5H+]/5), 589.5 (80%, [M + 6H+]/6), 505.5 (5%, [M + 7H+]/7). 
 
Compound 127: Boc-deprotected 9-mer cyclic monomer (open-form oligomer) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 127, 8.04 min; ESI-MS m/z (ion) 968.2 (8%, [M + 2H+]/2), 646.1 
(43%, [M + 3H+]/3), 485.0 (100%, [M + 4H+]/4). 
 
Compound 128: Boc-deprotected 9-mer cyclic dimer (open-form oligomer) 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 128, 9.52 min; ESI-MS m/z (ion) 968.7 (10%, [M + 4H+]/4), 775.2 
(60%, [M + 5H+]/5), 646.2 (100%, [M + 6H+]/6), 554.1 (15%, [M + 7H+]/7). 
 
After removing the Boc groups from the cyclic monomers and dimers, each was dissolved in 
anhydrous 20% piperidine/NMP (1.25 mL) and transferred into an HPLC vial.  The DKP closing 
reactions were monitored by HPLC-MS.  The cyclic monomers produced mixtures of 
incompletely closed products, whereas the cyclic dimers appeared to close completely.  The 
rigidified cyclic dimer of the tetramer (129) and pentamer (130) oligomers were clean enough to 
purify by preparative HPLC and analyze by HRMS; there was extensive epimerization for the 
longer oligomers, and no major product of DKP formation was identified (probably due to water 
contamination; monitoring the DKP closure for the longer cyclic dimers was also complicated 
due to the incredibly small sample sizes).  The analytical data for the rigidified cyclic dimer of 
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the trimer oligomer (97) is described above.  The analytical data for the rigidified 4-mer and 5-
mer cyclic dimers is provided here. 
 
Compound 129: cyclic dimer of the tetramer oligomer, following DKP closure 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 129, 18.20 min; ESI-MS m/z (ion) 989.2 (95%, [M + 2H+]/2), 659.8 
(100%, [M + 3H+]/3); HRESIQTOFMS calcd for C92H98N28O24 / 2 ([M + 2H+]/2) 988.3649, 
found 988.3644. 
 
Compound 130: cyclic dimer of the pentamer oligomer, following DKP closure.  
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 130, 17.44 min; ESI-MS m/z (ion) 1127.7 (100%, [M + 2H+]/2), 
752.0 (22%, [M + 3H+]/3), 564.3 (34%, [M + 4H+]/4); HRESIQTOFMS calcd for 
C104H110N32O28 / 2 ([M + 2H+]/2) 1127.4078, found 1127.4070. 
5.8.4 Rod-hinge-rod motif 
Compound 135: 3-hinge-3 bis-peptide cyclic monomer 
N-Fmoc-1-(S)-naphthylalanine and N-Fmoc-(S)-propargylglycine were coupled sequentially to 
2-chlorotritylchloride resin (30 mg, 1.1 mmol/gram substitution) using the methods described 
above.  3 Boc-pro4(2S,4S) monomers (19) were coupled to the resin sequentially with HATU.  
N-Fmoc-N’-ivDde-(S)-diaminobutanoic acid (Fmoc-Dab-(ivDde)) was coupled to the resin with 
HATU.  The N-Fmoc group was removed using 20% piperidine/DMF; the deprotection was 
extended to 2 hours to ensure quantitative DKP formation.  The resin was capped with acetic 
anhydride.  The side-chain ivDde group was removed by soaking the resin in aliquots (2 mL) of 
a solution of hydrazine dihydrate and allyl alcohol in DMF (10 mL hydrazine dihydrate, 45 mL 
allyl alcohol, to 100 mL with DMF); the deprotection was monitored by measuring the UV 
absorbance of the deprotection solution at 280 nm.  When no more chromophore was detected in 
the deprotection solution, the resin was washed thoroughly.  3 additional Boc-pro4(2S,4S) 
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monomers (19) were coupled to the resin using HATU, followed by Fmoc-(S)-Dab-N3 (88).  The 
Fmoc group was removed from the N-terminus by treatment with 20% piperidine/DMF for 2 
hours (to ensure complete DKP formation between the last two residues).  After washing and 
drying the resin, the desired product was obtained by treating the resin multiple times with a 
solution of 1% TFA in CH2Cl2, as described above.  The cleavage product was purified by flash 
chromatography on C18 silica (4 gram column, gradient elution over 14 column volumes from 
H2O (0.1% HCOOH) to CH3CN (0.05% HCOOH)).  Fractions containing the desired product 
were concentrated by centrifugal evaporation.  The yield of 131, based upon the initial resin 
loading, was approximately 65% (based upon HPLC analysis of the purified cleavage product). 
 
131 (~ 21 μmol) was dissolved in degassed CH3CN (33 mL) and transferred to a 50 mL round 
bottom flask containing a magnetic stir bar.  DIPEA (11.5 μL, 66 μmol), 2,6-lutidine (7.6 μL, 66 
μmol) and CuI (12.5 mg, 66 μmol) were added to the solution, and the flask was sealed with a 
rubber stopper.  The mixture was stirred overnight, and analyzed the following morning by 
HPLC-MS.  89% of the starting material 131 had been converted to a mixture of cyclic monomer 
132, and cyclic dimer 133; the monomer/dimer ratio was 100:7.  Cyclic monomer 132 was 
isolated from the cyclic dimer 133 by flash chromatography on C18 silica (4 gram column, 
gradient elution over 14 column volumes from H2O (0.1% HCOOH) to CH3CN (0.05% 
HCOOH)). 
 
All of the purified cyclic monomer 132 was dissolved in 50:50 TFA/CH2Cl2; after 30 minutes, 
the solution was concentrated by centrifugal evaporation (a large portion of the material was lost, 
likely due to bumping during concentration).  Concentration afforded a residue that was 
determined to be 133 (cyclic monomer, open-form oligomer) by HPLC-MS.  This residue was 
dissolved in 20% piperidine/NMP (4 mL) and the solution was transferred to a conical vial 
containing a magnetic spin vane; the solution was stirred for ~ 24 hours under nitrogen, and 
monitored by HPLC-MS.  The product, 135 (3-hinge-3 bis-peptide cyclic monomer), was 
precipitated from ether, and purified by preparative HPLC.  The fractions containing 135 were 
treated with neutralized Chelex Resin (Bio-Rad) to remove residual copper; unfortunately, the 
purified material was lost, probably because it bound to the resin. 
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Compound 131: 3-hinge-3 Boc-protected resin cleavage product 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 131, 23.92 min; ESI-MS m/z (ion) 2180.5 (10%), 2093.4 (10%, M + 
H+), 1993.6 (50%, M – Boc + H+), 947.8 (100%, [M – 2Boc + 2H+]/2). 
 
Compound 132: 3-hinge-3 cyclic monomer, Boc-protected open-form oligomer  
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 132, 23.65 min; ESI-MS m/z 
(ion) 2094.5 (100%, M + H+), 997.2 (50%, [M – Boc + 2H+]/2). 
 
Compound 134: 3-hinge-3 cyclic monomer, open-form oligomer  
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 134, 9.09 min; ESI-MS m/z (ion) 1493.2 (75%, M + H+), 747.3 
(100%, [M + 2H+]/2). 
 
Compound 135: 3-hinge-3 bis-peptide cyclic monomer 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 135, 12.19 min; ESI-MS m/z (ion) 1365.0 (100%, M + H+), 683.3 
(50%, [M + 2H+]/2), 456.2 (70%, [M + 3H+]/3). 
 
Synthesis of 139: 6-hinge-6 bis-peptide cyclic monomer 
N-Fmoc-1-(S)-naphthylalanine and N-Fmoc-(S)-propargylglycine were coupled sequentially to 
2-chlorotritylchloride resin (25 mg, 1.1 mmol/gram substitution) using the methods described 
above.  6 Boc-pro4(2S,4S) monomers (19) and then N-Fmoc-N’-ivDde-(S)-diaminobutanoic acid 
(Fmoc-Dab-(ivDde)) were coupled sequentially to the resin as described.  The N-Fmoc group 
from the Dab was removed (2 hours) with 20% piperidine, the resin was capped with acetic 
anhydride, and the ivDde group was removed with hydrazine (see details for the synthesis of 3-
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hinge-3 bis-peptide cyclic monomer, 131).  6 additional 3 Boc-pro4(2S,4S) monomers were 
coupled to the resin, followed by Fmoc-(S)-Dab-N3 (88).  The Fmoc group was removed, the 
resin was washed, and the desired product 136 (Boc-protected open-form oligomer prior to 
CuAAC macrocyclization) was cleaved from the resin with a solution of 1% TFA in CH2Cl2, as 
described above.  The cleavage solution aliquots were combined and concentrated by rotary 
evaporation, and the residue was dissolved in EtOAc.  This solution was transferred into a 125 
mL separatory funnel and washed with pH 3.4 aqueous HCl (2 ×) and with brine (1 ×) to remove 
pyridine.  The EtOAc solution was concentrated, affording a residue that was purified by 
preparative HPLC.  The purified material was contaminated with some oligomer that ESI-MS 
suggested was the result of a partially failed coupling after installing the Dab hinge. 
 
An analytical portion of the cleavage product (~ 1.5 μmol, by HPLC) was dissolved in CH3CN 
(1.48 mL) and transferred into a conical vial containing a magnetic spin vane.  CuI (0.5 mg, ~ 3 
μmol), DIPEA (0.5 μL, ~ 3 μmol) and 2,6-lutidine (0.3 μL, ~ 3 μmol) were added to the 
solution.   The vial was sealed with a rubber stopper, and the solution was stirred overnight.  The 
solution was concentrated by rotary evaporation, dissolved in CH3CN (500 μL) and transferred 
to the top of a short column containing 500 mg of C18 silica, pre-equilibrated with H2O (0.1% 
HCOOH).  The CH3CN was evaporated under a stream of nitrogen.  The column was flushed 
with 0.1% HCOOH/H2O (12 ×) to remove copper, and then with CH3CN (10 mL) to elute the 
desired product.  A small portion (~ 300 μL) of the CH3CN eluate was transferred into an HPLC 
vial.  TCEP (~ 1 mg) was added to the solution; the vial was capped, then inverted several times 
to mix.  This solution was analyzed by HPLC-MS to test for the presence of azide.  The 
remaining CH3CN eluate was concentrated by rotary evaporation affording crude 137; the water 
washes were lyophilized and analyzed by HPLC to confirm that no product had been lost during 
the water wash. 
 
Crude 137 was dissolved in 50% TFA/CH2Cl2 and stirred for 2 hours.  The solvent was 
evaporated under a stream of nitrogen, and residual solvent was removed under reduced pressure 
overnight.  An analytical sample of 138, the product of Boc-cleavage, was dissolved in 
H2O/ACN and analyzed by HPLC-MS.  The remaining residue was dissolved in anhydrous 20% 
piperidine/NMP (800 μL); this solution was monitored by HPLC over the next 30 hours.  The 
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solution was then purified by preparative HPLC; the desired fractions were concentrated by 
lyophilization.  The resulting white powder was dissolved in 1:1 CH3CN/H2O, and was 
determined to be nearly pure 139 by HPLC-MS. 
 
Compound 136: 6-hinge-6, Boc-protected resin cleavage product  
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min, then 95% CH3CN for 5 additional 
minutes); flow rate, 0.80 mL/min; UV detection at 220 nm; tR for 136, 26.72 min; ESI-MS m/z 
(ion) 1757.1 (36%, [M – 2Boc + 2H+]/2), 1139.2 (10%, [M – 3Boc + 3H+]/3), 600.3 (50%), 
515.4 (100%). 
 
Compound 137: 6-hinge-6 cyclic monomer, Boc-protected open-form oligomer 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 5% to 95% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 137, 26.85 min; ESI-MS m/z (ion) 1899.4 (15%), 1867.1 (25%), 
1806.9 (100%, [M – Boc + 2H+]/2), 1756.4 (15%), 1171.3 (15%), 1138.3 (21%), 1119.3 
(12.5%), 599.9 (45%). 
 
Compound 138: 6-hinge-6 cyclic monomer, open-form oligomer 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 138, 6.96 min; ESI-MS m/z (ion) 1257.7 (30%, [M + 2H+]/2), 838.7 
(100%, [M + 3H+]/3), 629.3 (23%, [M + 4H+]/4). 
 
Compound 139: 6-hinge-6 bis-peptide cyclic monomer, all DKP rings closed 
HPLC-MS: column, Waters XTerra MS C18, 4.6 × 150 mm; mobile phase, H2O (0.l% HCOOH) / 
CH3CN (0.05% HCOOH), 0% to 50% CH3CN over 30 min); flow rate, 0.80 mL/min; UV 
detection at 220 nm; tR for 139, 14.19 min; ESI-MS m/z (ion) 1464.3 (15%, [2M + 3H+]/3), 
1097.6 (100%, [M + 2H+]/2), 731.8 (82%, [M + 3H+]/3). 
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APPENDIX A 
REPRESENTATIVE 1D-NMR SPECTRA 
The spectra illustrated in this appendix are representative 1D NMR spectra of the pro4 
monomers and their intermediates.  For each pair of enantiomers, one spectra is shown. 
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Supplemental Figure 1: 1H NMR spectrum of 20, 300 MHz, DMSO-d6, 350 K 
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Supplemental Figure 2: 1H decoupled 13C spectrum of 20, 75.4 MHz, DMSO-d6 
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Supplemental Figure 3: 1H NMR spectrum of 21, 300 MHz, DMSO-d6, 350 K 
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Supplemental Figure 4: 1H decoupled 13C spectrum of 21, 75.4 MHz, DMSO-d6, 350 K 
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Supplemental Figure 5: dept135 spectrum of 21, 75.4 MHz, DMSO-d6, 350 K 
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Supplemental Figure 6: 1H spectrum of 22, 300 MHz, DMSO-d6, 350 K 
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Supplemental Figure 7: 1H decoupled 13C spectrum of 22, 75.4 MHz, DMSO-d6 
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Supplemental Figure 8: 1H NMR spectrum of 23, 300 MHz, DMSO-d6, 350 K 
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Supplemental Figure 9: 1H decoupled 13C NMR of 23, 75.4 MHz, DMSO-d6, 350 K 
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Supplemental Figure 10: 1H NMR of 24, 300 MHz, DMSO-d6, 350 K 
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Supplemental Figure 11: 1H decoupled 13C spectrum of 24, 75.4 MHz, DMSO-d6 
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Supplemental Figure 12: dept135 spectrum of 24, 75.4 MHz, DMSO-d6 
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Supplemental Figure 13: 1H NMR spectrum of 26, 300 MHz, CD3COOD 
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Supplemental Figure 14: 1H decoupled 13C spectrum of 26, 75.4 MHz, CD3COOD 
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Supplemental Figure 15: dept135 spectrum of 26, 75.4 MHz, CD3COOD 
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Supplemental Figure 16: 1H NMR spectrum of 27, 300 MHz, DMSO-d6, 350 K 
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Supplemental Figure 17: 1H decoupled 13C spectrum of 27, 75.4 MHz, DMSO-d6 
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Supplemental Figure 18: dept135 spectrum of 27, 75.4 MHz, DMSO-d6 
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Supplemental Figure 19: 1H NMR spectrum of 28, 300 MHz, DMSO-d6 
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Supplemental Figure 20: 1H decoupled 13C spectrum of 28, 75.4 MHz, DMSO-d6 
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Supplemental Figure 21: dept135 spectrum of 28, 75.4 MHz, DMSO-d6 
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Supplemental Figure 22: 1H NMR spectrum of 29, 300 MHz, DMSO-d6, 350 K 
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Supplemental Figure 23: 1H decoupled 13C spectrum of 29, 75.4 MHz, DMSO-d6 
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Supplemental Figure 24: dept 135 spectrum of 29, 75.4 MHz, DMSO-d6 
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Supplemental Figure 25: 1H NMR spectrum of 30, 300 MHz, DMSO-d6 
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Supplemental Figure 26: 1H decoupled 13C spectrum of 30, 75.4 MHz, DMSO-d6 
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Supplemental Figure 27: dept 135 spectrum of 30, 75.4 MHz, DMSO-d6 
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Supplemental Figure 28: 1H NMR spectrum of 34, 300 MHz, CD3COOD 
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Supplemental Figure 29: 1H decoupled 13C spectrum of 34, 75.4 MHz, CD3COOD 
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Supplemental Figure 30: dept135 spectrum of 34, 75.4 MHz, CD3COOD 
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Supplemental Figure 31: 1H NMR spectrum of 35, 300 MHz, DMSO-d6, 350 K 
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Supplemental Figure 32: 1H decoupled 13C spectrum of 35, 75.4 MHz, DMSO-d6 
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Supplemental Figure 33: dept135 spectrum of 35, 75.4 MHz, DMSO-d6 
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Supplemental Figure 34: 1H NMR spectrum of 36, 300 MHz, DMSO-d6, 350 K 
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Supplemental Figure 35: 1H decoupled 13C spectrum of 36, 75.4 MHz, DMSO-d6 
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Supplemental Figure 36: dept135 spectrum of 36, 75.4 MHz, DMSO-d6 
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Supplemental Figure 37: 1H NMR spectrum of 37, 300 MHz, DMSO-d6 
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Supplemental Figure 38: 1H decoupled 13C spectrum of 37, 75.4 MHz, DMSO-d6 
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Supplemental Figure 39: dept135 spectrum of 37, 75.4 MHz, DMSO-d6 
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APPENDIX B 
 
RESONANCE ASSIGNMENTS FOR TETRAMER OLIGOMERS 
The NMR resonances derived from the 2D-NMR spectra of the tetramer oligomers are displayed 
in the following tables. 
Group: the number corresponding to the place of the residue in the sequence 
Heavy atom number: the numerical designation of the atoms in the structures shown in the text. 
Atom:  the first letter (C or H) designates the nucleus.  The following letters are coded as 
follows; 
A = alpha 
B = beta 
C = gamma 
D = delta 
AC = carbonyl carbon adjacent to alpha carbon 
GC = carbonyl carbon adjacent to gamma carbon 
N = amide nitrogen 
Shift: chemical shift (on the δ scale) 
#: number of cross-peaks in the COSY/ROESY/HMBC/HMQC spectra used to determine the 
resonance 
StDev: the standard deviation of the mean chemical shift for each resonance 
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Supplemental Table 1: Nuclear resonance assignments of 57 based upon the 2D-NMR spectra 
 
Group Heavy Atom Atom Nuc Shift SDev # Group 
Heavy 
Atom Atom Nuc Shift SDev #
1  HB1 1H 2.86 0.004 7 1 2 CA 13C 55.4 0.010 3
1  HB2 1H 2.92 0.004 6 1 1 CAC 13C 175.5 0.021 4
1 2 HA 1H 4.22 0.007 3 2 6 CB 13C 40.1 0.041 4
1 3 HN 1H 8.52 0.009 9 2 5 CA 13C 59.1 0.064 4
2 6 HB2 1H 1.48 0.018 10 2 7 CG 13C 64.4 0.050 4
2 6 HB1 1H 2.10 0.005 7 2 17 CGC 13C 166.0 0.049 5
2 8 HD2 1H 3.00 0.006 6 2 4 CAC 13C 167.8 0.046 4
2 8 HD1 1H 3.53 0.002 6 3 13 CB 13C 37.1 0.000 1
2 5 HA 1H 3.92 0.003 7 3 12 CA 13C 58.5 0.024 6
2 10 HN 1H 8.34 0.011 7 3 14 CG 13C 62.0 0.019 4
3 13 HB2 1H 1.88 0.006 8 3 25 CGC 13C 167.4 0.025 4
3 13 HB1 1H 2.50 0.005 5 3 11 CAC 13C 170.1 0.030 3
3 15 HD2 1H 3.37 0.003 6 4 20 CA 13C 57.5 0.051 5
3 15 HD1 1H 3.56 0.008 5 4 22 CG 13C 62.5 0.021 5
3 12 HA 1H 4.18 0.004 8 4 33 CGC 13C 166.9 0.015 4
3 18 HN 1H 8.44 0.011 7 4 19 CAC 13C 170.2 0.028 4
4 21 HB2 1H 2.03 0.008 8 5 29 CB 13C 37.0 0.023 2
4 21 HB1 1H 2.45 0.011 6 5 28 CA 13C 52.9 0.131 2
4 23 HD2 1H 3.34 0.005 5 5 30 CG 13C 60.4 0.008 3
4 23 HD1 1H 3.71 0.008 6 5 27 CAC 13C 169.6 0.071 2
4 20 HA 1H 4.23 0.004 7        
4 26 HN 1H 8.65 0.011 7        
5 29 HB2 1H 2.13 0.006 5        
5 29 HB1 1H 2.62 0.007 4        
5 31 HD2 1H 3.69 0.003 2        
5 28 HA 1H 4.54 0.013 6        
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Supplemental Table 2: Crosspeaks on the ROESY spectrum of 57 
 
Resonance 1 Shift Resonance 2 Shift Integrated Volume 
01HB1 2.85 HN 8.52 3.39E+06 
01HB2 2.91 HN 8.52 1.89E+06 
02HA 3.92 01HN 8.52 1.24E+07 
02HB1 2.11 01HN 8.52 1.57E+06 
02HB1 2.11 03HA 4.18 6.72E+06 
02HB2 1.48 01HN 8.52 1.37E+06 
02HB2 1.48 HD2 2.99 2.17E+07 
02HB2 1.48 HN 8.33 2.94E+06 
02HD1 3.53 HA 3.91 4.18E+06 
02HD2 3.00 HN 8.33 1.10E+07 
03HA 4.18 02HN 8.33 8.61E+05 
03HB2 1.88 HD2 3.36 6.10E+06 
03HB2 1.88 HN 8.43 1.53E+07 
03HD1 3.55 HA 4.17 4.42E+06 
03HD1 3.56 04HA 4.23 1.25E+07 
03HD2 3.37 HN 8.43 4.13E+06 
03HD2 3.37 04HA 4.23 4.49E+06 
04HA 4.23 03HN 8.43 1.30E+06 
04HB1 2.48 05HA 4.56 1.01E+08 
04HB2 2.02 HD2 3.35 8.88E+06 
04HB2 2.03 HN 8.64 3.88E+06 
04HD1 3.70 HA 4.23 6.47E+06 
04HD2 3.34 HN 8.64 1.56E+07 
05HA 4.54 04HN 8.64 4.51E+05 
05HB2 2.14 HD2 3.69 4.01E+06 
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Supplemental Table 3: Nuclear resonance assignments of 58 based upon the 2D-NMR spectra 
 
Group Heavy Atom Atom Nuc Shift SDev # Group 
Heavy 
Atom Atom Nuc Shift SDev # 
1  HB1 1H 2.779 0.013 8 1  CB 13C 36.8 0.019 3 
1  HB2 1H 2.837 0.012 5 1 2 CA 13C 55.0 0.043 5 
1 2 HA 1H 4.24 0.01 10 1 1 CAC 13C 175.0 0.049 4 
1 3 HN 1H 8.601 0.002 9 2 6 CB 13C 38.0 0.051 5 
2 6 HB2 1H 1.69 0.004 9 2 8 CD 13C 52.9 0.023 4 
2 6 HB1 1H 2.648 0.005 7 2 5 CA 13C 59.1 0.008 4 
2 8 HD2 1H 3.071 0.005 9 2 7 CG 13C 63.8 0.016 6 
2 8 HD1 1H 3.356 0.003 8 2 17 CGC 13C 165.0 0.014 5 
2 5 HA 1H 4.187 0.007 8 2 4 CAC 13C 167.9 0.029 5 
2 10 HN 1H 8.28 0.001 8 3 13 CB 13C 36.9 0.026 2 
3 13 HB2 1H 1.864 0.012 10 3 15 CD 13C 55.0 0.000 1 
3 13 HB1 1H 2.491 0.004 5 3 12 CA 13C 57.9 0.050 2 
3 15 HD2 1H 3.402 0.012 7 3 14 CG 13C 61.6 0.081 3 
3 15 HD1 1H 3.487 0.006 3 3 25 CGC 13C 166.7 0.019 3 
3 12 HA 1H 4.401 0.003 7 3 11 CAC 13C 169.7 0.019 3 
3 18 HN 1H 8.428 0.001 8 4 21 CB 13C 37.3 0.029 2 
4 21 HB2 1H 1.91 0.009 9 4 23 CD 13C 55.1 0.000 1 
4 21 HB1 1H 2.533 0.004 5 4 20 CA 13C 57.7 0.099 3 
4 23 HD2 1H 3.456 0.008 4 4 22 CG 13C 61.7 0.094 4 
4 23 HD1 1H 3.52 0.006 3 4 33 CGC 13C 166.6 0.067 3 
4 20 HA 1H 4.479 0.007 6 4 19 CAC 13C 169.9 0.019 3 
4 26 HN 1H 8.542 0 9 5 29 CB 13C 36.4 0.000 1 
5 29 HB2 1H 2.083 0.012 8 5 31 CD 13C 52.1 0.000 1 
5 29 HB1 1H 2.575 0.001 6 5 28 CA 13C 56.9 0.012 4 
5 36 HME 1H 3.447 0 1 5 30 CG 13C 59.8 0.006 3 
5 31 HD1 1H 3.646 0.003 4 5 27 CAC 13C 168.7 0.036 3 
5 28 HA 1H 4.453 0.006 7 5 34 CGC 13C 169.6 0.015 4 
5 37 HN 1H 8.575 0 1        
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Supplemental Table 4: Crosspeaks on the ROESY spectrum of 58 
 
Resonance 1 Shift Resonance 2 Shift Integrated Volume 
01H1 7.31 HN 8.60 2.15E+06 
01H3 7.00 HN 8.60 1.76E+06 
01HA 4.24 H1 7.31 1.22E+07 
01HA 4.24 H3 6.99 3.55E+07 
01HA 4.24 H4 7.40 2.39E+07 
01HB1 2.80 H1 7.31 3.42E+07 
01HB1 2.80 H3 6.98 4.31E+07 
01HB1 2.79 HN 8.60 1.51E+07 
02HB1 2.64 01HN 8.60 3.24E+06 
02HB2 1.68 HD2 3.07 4.78E+07 
02HB2 1.69 HN 8.28 2.18E+07 
02HD1 3.35 HA 4.18 8.53E+06 
02HD1 3.35 03HA 4.40 2.22E+07 
02HD2 3.07 HN 8.28 5.99E+06 
02HD2 3.07 03HA 4.40 1.14E+07 
03HA 4.41 02HN 8.28 2.03E+06 
03HB2 1.85 HD2 3.39 1.10E+07 
03HB2 1.87 HN 8.43 2.24E+07 
03HD1 3.49 HA 4.40  
03HD1 3.49 04HA 4.49  
03HD2 3.40 HB2 1.88 6.41E+07 
03HD2 3.40 HN 8.43 5.45E+06 
03HD2 3.40 04HA 4.47  
04HA 4.47 03HN 8.43 3.83E+06 
04HB2 1.90 HN 8.54 2.18E+07 
04HD1 3.52 HN 8.54 1.51E+06 
04HD1 3.52 05HA 4.46  
04HD2 3.47 HB2 1.91 2.11E+08 
04HD2 3.45 HN 8.54 5.85E+06 
04HD2 3.46 05HA 4.46  
05HA 4.46 04HN 8.54 1.86E+06 
05HB2 2.06 HN 8.58 2.58E+06 
05HD1 3.64 HA 4.45 2.28E+07 
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Supplemental Table 5: Nuclear resonance assignments of 61 based upon the 2D-NMR spectra 
 
Group Atom 
Heavy 
Atom 
# 
Nuc Shift SDev # Group Atom 
Heavy 
Atom 
# 
Nuc Shift SDev # 
2 CA 3 13C 58.73 0.033 4 1 H2NA 1 1H 8.04 0.003 4 
2 CAC 2 13C 169.68 0.037 5 1 H2NB 1 1H 7.59 0.002 3 
2 CB 4 13C 39.49 0.056 2 2 HA 3 1H 4.64 0.009 8 
2 CD 6 13C 50.68 0.002 3 2 HB1 4 1H 3.11 0.012 8 
2 CG 5 13C 64.26 0.006 4 2 HB2 4 1H 2.51 0.017 5 
2 CGC 15 13C 165.64 0.058 4 2 HD1 6 1H 4.10 0.015 8 
3 CA 10 13C 57.04 0.041 4 2 HD2 6 1H 3.57 0.012 6 
3 CAC 9 13C 169.61 0.01 3 2 HN 8 1H 8.92 0.004 7 
3 CB 11 13C 38.71 0.049 3 3 HA 10 1H 4.85 0.015 7 
3 CD 13 13C 53.40 0.008 2 3 HB1 11 1H 2.74 0.008 9 
3 CG 12 13C 61.83 0.017 4 3 HB2 11 1H 2.58 0.011 4 
3 CGC 23 13C 165.32 0.014 4 3 HD1 13 1H 3.64 0.011 7 
4 CA 18 13C 56.61 0.026 4 3 HD2 13 1H 4.48 0.011 6 
4 CAC 17 13C 170.09 0.012 3 3 HN 16 1H 9.18 0.006 8 
4 CB 19 13C 35.65 0.038 3 4 HA 18 1H 4.87 0.011 6 
4 CD 21 13C 54.19 0 1 4 HB1 19 1H 2.49 0.012 6 
4 CG 20 13C 61.08 0.036 5 4 HB2 19 1H 3.06 0.008 8 
4 CGC 31 13C 166.04 0.047 4 4 HD1 21 1H 3.52 0.006 8 
5 CA 26 13C 57.60 0.02 6 4 HD2 21 1H 4.34 0.006 7 
5 CAC 25 13C 169.57 0.101 3 4 HN 24 1H 8.82 0.005 7 
5 CB 27 13C 39.73 0.007 2 5 HA 26 1H 4.51 0.016 9 
5 CD 29 13C 55.37 0.017 2 5 HB1 27 1H 1.03 0.019 9 
5 CG 28 13C 59.84 0.026 5 5 HB2 27 1H 1.50 0.013 9 
5 CGC 28 13C   0 5 HD1 29 1H 3.83 0.012 8 
6 C1 38 13C 125.79 0 1 5 HD2 29 1H 3.60 0.015 5 
6 C2 39 13C 131.55 0.01 2 5 HN 32 1H 8.86 0.004 3 
6 C3 40 13C 115.56 0.005 2 6 H2 39 1H 7.10 0.014 7 
6 C4 41 13C 155.12 0.01 2 6 H2' 39 1H 7.12 0.001 3 
6 CA 34 13C 55.81 0.005 3 6 H3 40 1H 6.92 0.015 6 
6 CAC 33 13C 168.54 0.021 2 6 H3' 40 1H 6.94 0 1 
6 CB 37 13C 37.85 0.038 2 6 HA 34 1H 4.47 0.002 4 
       6 HB1 37 1H 3.25 0.016 4 
       6 HB2 37 1H 2.97 0.012 6 
       6 HN 35 1H 8.87 0.004 4 
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Supplemental Table 6: Nuclear resonance assignments of 62 based upon the 2D-NMR spectra 
 
Group Atom Heavy Atom # Nuc Shift SDev # Group Atom 
Heavy 
Atom # Nuc Shift SDev # 
2 CA 3 13C 59.34 0.026 6 1 H2NA 1 1H 8.18 0.015 2 
2 CAC 2 13C 170.25 0.01 5 1 H2NB 1 1H 7.89 0.297 4 
2 CB 4 13C 37.78 0.009 5 2 HA 3 1H 4.78 0.005 8 
2 CD 6 13C 52.89 0.01 2 2 HB1 4 1H 3.06 0.378 10 
2 CG 5 13C 64.06 0.013 6 2 HB2 4 1H 2.40 0.279 10 
2 CGC 15 13C 165.38 0.014 5 2 HD1 6 1H 3.91 0.087 9 
3 CA 10 13C 57.11 0.036 6 2 HD2 6 1H 3.70 0.089 8 
3 CAC 9 13C 169.70 0.008 2 2 HN 8 1H 8.87 0.02 7 
3 CB 11 13C 38.55 0 1 3 HA 10 1H 4.80 0.01 9 
3 CD 13 13C 53.41 0.01 3 3 HB1 11 1H 2.74 0.004 9 
3 CG 12 13C 62.26 0.021 4 3 HB2 11 1H 2.59 0.003 7 
3 CGC 23 13C 165.55 0.023 4 3 HD1 13 1H 3.64 0.01 8 
4 CA 18 13C 57.19 0.013 3 3 HD2 13 1H 4.50 0.006 8 
4 CAC 17 13C 169.75 0.055 4 3 HN 16 1H 9.18 0.02 10 
4 CB 19 13C 38.70 0.03 2 4 HA 18 1H 4.82 0.007 7 
4 CD 21 13C 53.81 0.002 3 4 HB1 19 1H 2.67 0.006 11 
4 CG 20 13C 62.37 0.007 4 4 HB2 19 1H 2.49 0.005 9 
4 CGC 31 13C 165.11 0.018 4 4 HD1 21 1H 3.59 0.005 5 
5 CA 26 13C 57.70 0.027 6 4 HD2 21 1H 4.41 0.003 7 
5 CAC 25 13C 169.62 0.154 7 4 HN 24 1H 9.10 0.021 10 
5 CB 27 13C 39.56 0.004 3 5 HA 26 1H 4.55 0.005 10 
5 CD 29 13C 55.50 0.008 2 5 HB1 27 1H 1.05 0.007 9 
5 CG 28 13C 59.85 0.028 5 5 HB2 27 1H 1.51 0.003 11 
5 CGC 28 13C   0 5 HD1 29 1H 3.89 0.007 9 
6 C1 38 13C 125.81 0.012 3 5 HD2 29 1H 3.62 0.004 10 
6 C2 39 13C 131.58 0.016 3 5 HN 32 1H 8.83 0.018 6 
6 C3 40 13C 115.56 0 1 6 H2 39 1H 7.09 0.006 10 
6 C4 41 13C 155.12 0.014 2 6 H2' 39 1H 7.09 0.002 2 
6 CA 34 13C 55.86 0.039 3 6 H3 40 1H 6.91 0.006 5 
6 CAC 33 13C 168.60 0.016 3 6 H3' 40 1H 6.90 0 1 
6 CB 37 13C 37.85 0.013 2 6 HA 34 1H 4.47 0.006 6 
       6 HB1 37 1H 3.16 0.133 7 
       6 HB2 37 1H 2.99 0.087 9 
       6 HN 35 1H 8.86 0.025 7 
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Supplemental Table 7: Nuclear resonance assignments for 63 based upon the 2D-NMR spectra 
 
Group Atom Heavy Atom # Nuc Shift SDev # Group Atom 
Heavy 
Atom # Nuc Shift SDev # 
2 CA 3 13C 59.37 0.047 5 1 H2NA 1 1H 7.57 0.001 2 
2 CAC 2 13C 170.36 0.016 5 1 H2NB 1 1H 8.13 0.016 3 
2 CB 4 13C 38.00 0.041 5 2 HA 3 1H 4.74 0.008 10 
2 CD 6 13C 52.98 0.054 3 2 HB1 4 1H 3.16 0.002 10 
2 CG 5 13C 63.84 0.019 5 2 HB2 4 1H 2.28 0.004 11 
2 CGC 15 13C 165.33 0.025 5 2 HD1 6 1H 3.91 0.006 12 
3 CA 10 13C 56.64 0.037 4 2 HD2 6 1H 3.64 0.008 13 
3 CAC 9 13C 170.05 0.032 4 2 HN 8 1H 8.80 0.019 10 
3 CB 11 13C 35.92 0.05 6 3 HA 10 1H 4.81 0.008 15 
3 CD 13 13C 54.17 0.031 3 3 HB1 11 1H 2.51 0.003 11 
3 CG 12 13C 61.21 0.028 5 3 HB2 11 1H 3.05 0.005 10 
3 CGC 23 13C 166.36 0.034 5 3 HD1 13 1H 3.57 0.006 14 
4 CA 18 13C 58.10 0.053 5 3 HD2 13 1H 4.39 0.006 8 
4 CAC 17 13C 168.73 0 1 3 HN 16 1H 8.91 0.018 10 
4 CB 19 13C 36.98 0.069 5 4 HA 18 1H 4.92 0.012 5 
4 CD 21 13C 55.06 0.075 3 4 HB1 19 1H 2.95 0.004 10 
4 CG 20 13C 61.31 0.02 5 4 HB2 19 1H 2.34 0.005 10 
4 CGC 31 13C 166.79 0.035 5 4 HD1 21 1H 3.91 0.012 10 
5 CA 26 13C 56.60 0.028 4 4 HD2 21 1H 3.81 0.007 12 
5 CAC 25 13C 166.85 0.015 2 4 HN 24 1H 8.73 0.019 8 
5 CB 27 13C 38.99 0.01 2 5 HA 26 1H 4.48 0.009 10 
5 CD 29 13C 55.62 0.077 4 5 HB1 27 1H 1.23 0.007 14 
5 CG 28 13C 59.21 0.03 6 5 HB2 27 1H 1.61 0.007 12 
5 CGC 28 13C 169.60 0.084 6 5 HD1 29 1H 3.29 0.005 10 
6 C1 38 13C 125.77 0.025 3 5 HD2 29 1H 4.29 0.004 9 
6 C2 39 13C 131.65 0.018 3 5 HN 32 1H 8.84 0.018 9 
6 C3 40 13C 115.66 0 1 6 H2 39 1H 7.07 0.004 11 
6 C4 41 13C 155.11 0.013 2 6 H2' 39 1H 7.06 0.002 2 
6 CA 34 13C 55.89 0.069 3 6 H3 40 1H 6.90 0.006 7 
6 CAC 33 13C   0 6 H3' 40 1H    
6 CB 37 13C 37.96 0.019 3 6 HA 34 1H 4.47 0.004 7 
       6 HB1 37 1H 3.23 0.005 9 
       6 HB2 37 1H 2.95 0.007 10 
       6 HN 35 1H 8.70 0.022 8 
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Supplemental Table 8: ROESY crosspeaks for 61, 62, and 63 
 
61 62 63 
Assignment w1 w2 Volume Assignment w1 w2 Volume Assignment w1 w2 Volume 
2HA-
1H2NA 4.65 8.04 1.57E+06 
2HA-
1H2NA 4.78 8.16 5.11E+06 
2HA-
1H2NB 4.74 8.12 4.34E+06 
2HA-
1H2NB 4.65 7.60 4.31E+04 2HB1-HD1 3.25 3.94 1.39E+06 
2HB1-
1H2NB 3.16 8.12 7.37E+05 
2HB1-
1H2NA 3.13 8.03 5.08E+05 2HB2-HD2 2.30 3.67 3.41E+06 2HB2-HN 2.29 8.79 2.63E+06 
2HB1-HD1 3.12 4.14 2.93E+05 2HB2-HN 2.30 8.84 6.00E+06 2HD1-HA 3.90 4.72 2.25E+06 
2HB1-3HA 3.14 4.85 1.90E+06 2HD1-3HA 3.94 4.78 1.37E+07 2HD1-HB1 3.90 3.16 1.16E+06 
2HB2-
1H2NA 2.52 8.04 1.01E+05 2HD2-HN 3.67 8.84 2.23E+06 2HD1-3HA 3.92 4.81 6.94E+06 
2HB2-HD2 2.52 3.59 1.60E+06 3HA-HN 4.80 9.15 3.16E+06 2HD2-HA 3.63 4.74 1.05E+06 
2HB2-HN 2.52 8.91 7.20E+05 3HB1-HD1 2.75 3.64 1.23E+06 2HD2-HB2 3.66 2.28 2.45E+06 
2HD1-HA 4.12 4.65 6.14E+05 3HB1-HN 2.74 9.16 9.56E+05 2HD2-HN 3.63 8.78 2.18E+06 
2HD2-HN 3.59 8.92 1.81E+06 3HB2-HD2 2.59 4.49 5.33E+06 2HD2-3HA 3.64 4.81 1.52E+06 
3HA-HN 4.87 9.17 9.96E+05 3HD1-HA 3.66 4.78 8.99E+06 3HA-HN 4.81 8.89 1.32E+06 
3HB1-HD1 2.75 3.67 2.42E+05 3HD1-HN 3.64 9.15 7.80E+06 3HB1-HN 2.52 8.89 3.79E+06 
3HB1-HN 2.75 9.17 3.32E+05 4HA-HN 4.82 9.07 2.50E+06 3HD1-HA 3.57 4.80 2.92E+06 
3HB2-HD2 2.59 4.50 1.32E+06 4HB1-HD1 2.67 3.59 1.03E+06 3HD1-HB1 3.56 2.51 2.49E+06 
3HD1-HA 3.64 4.87 8.36E+05 4HB1-HN 2.67 9.07 5.14E+05 3HD1-HN 3.56 8.90 2.53E+06 
3HD1-HN 3.65 9.17 2.66E+06 4HB1-5HA 2.66 4.55 1.32E+07 3HD2-HB2 4.40 3.04 1.60E+06 
4HA-HN 4.88 8.81 4.26E+05 4HB2-HD2 2.49 4.40 4.85E+06 4HA-3HD1 4.91 3.57 2.53E+05 
4HB1-HD1 2.51 3.52 8.49E+05 4HB2-5HA 2.50 4.55 1.28E+06 4HA-3HD2 4.90 4.38 2.17E+06 
4HB1-HN 2.51 8.81 2.70E+06 4HD1-HA 3.58 4.82 4.24E+06 4HB2-HN 2.33 8.71 3.43E+06 
4HB2-HD2 3.08 4.35 4.72E+05 4HD1-HN 3.59 9.08 7.80E+06 4HD1-HB1 3.91 2.95 8.70E+05 
4HD1-HA 3.52 4.89 7.28E+05 5HB1-HD1 1.05 3.89 8.23E+05 4HD1-5HA 3.90 4.46 9.24E+06 
4HD1-HN 3.52 8.81 1.01E+06 5HB1-6H2' 1.06 7.09 2.84E+06 4HD2-HB2 3.82 2.34 1.65E+06 
4HD1-5HA 3.52 4.53 6.43E+05 5HB1-6H3' 1.06 6.90 3.43E+06 4HD2-HN 3.81 8.72 2.21E+06 
4HD2-5HA 4.35 4.53 2.60E+06 5HB2-HD2 1.51 3.62 3.32E+06 4HD2-5HA 3.81 4.49 5.58E+06 
5HA-6H2' 4.50 7.12 5.79E+05 5HB2-HN 1.50 8.81 2.05E+06 5HA-HN 4.47 8.83 8.83E+05 
5HB1-HD1 1.05 3.86 1.45E+05 5HB2-6H2 1.51 7.09 1.47E+06 5HB1-HD1 1.24 3.29 1.83E+06 
5HB1-6H2' 1.06 7.12 4.57E+05 5HB2-6H3 1.51 6.90 2.18E+06 5HB1-HN 1.23 8.84 5.76E+05 
5HB1-6H3' 1.06 6.94 3.20E+05 5HD1-HA 3.88 4.55 4.64E+06 5HB1-6H2' 1.24 7.06 1.62E+06 
5HB2-HD2 1.52 3.62 5.67E+05 5HD2-HN 3.62 8.81 4.53E+06 5HB1-6H3 1.25 6.89 2.62E+06 
5HB2-HN 1.51 8.86 9.93E+05 6H2-HN 7.09 8.82 2.75E+06 5HB2-HD2 1.60 4.29 2.45E+06 
5HB2-6H2 1.51 7.13 2.35E+05 6HB1-H2' 3.25 7.09 1.36E+07 5HB2-6H2 1.61 7.06 2.41E+06 
5HB2-6H3 1.51 6.95 1.94E+05 6HB2-H2 2.96 7.09 1.24E+07 5HB2-6H3 1.62 6.89 3.20E+06 
5HD1-HA 3.84 4.53 1.52E+06 6HB2-HN 2.96 8.82 5.53E+06 5HD1-HN 3.30 8.83 1.84E+06 
5HD2-HN 3.62 8.85 2.42E+06     6H2-HN 7.06 8.68 2.22E+06 
6HB1-H2' 3.28 7.12 4.00E+06     6HA-HN 4.46 8.68 7.99E+06 
6HB2-5HN 2.98 8.86 1.83E+06     6HB1-H2' 3.24 7.05 1.30E+07 
6HB2-H2 2.99 7.12 2.75E+06     6HB2-H2 2.95 7.05 6.11E+06 
        6HB2-HN 2.94 8.69 9.75E+05 
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APPENDIX C 
2D-NMR SPECTRA 
 
 
Supplemental Figure 40. 500 MHz NOESY spectrum of 12, DMSO-d6 
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Supplemental Figure 41. 500 MHz COSY spectrum of 12, DMSO-d6 
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Supplemental Figure 42: 500 MHz NOESY spectrum of 13, DMSO-d6 
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Supplemental Figure 43. 500 MHz COSY spectrum of 13, DMSO-d6 
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Supplemental Figure 44. 500 MHz COSY spectrum of 44, 10 °C, D2O 
 240 
 
Supplemental Figure 45. 500 MHz HMBC spectrum (expansion 1 of 2) of 44, 10 °C, D2O 
 241 
 
Supplemental Figure 46. 500 MHz HMBC spectrum (expansion 2 of 2) of 44, 10 °C, D2O 
 242 
 
Supplemental Figure 47. 500 MHz ROESY spectrum of 44, 10 °C, D2O 
 243 
 
Supplemental Figure 48. 500 MHz COSY spectrum of 44, 10 °C, 10% D2O/H2O, pH ~ 0 
 244 
 
Supplemental Figure 49. 500 MHz HMBC spectrum (expansion 1 of 4) of 44, 10 °C, 10% D2O/H2O, pH ~ 0 
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Supplemental Figure 50. 500 MHz HMBC spectrum (expansion 2 of 4) of 44, 10 °C, 10% D2O/H2O, pH ~ 0 
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Supplemental Figure 51. 500 MHz HMBC spectrum (expansion 3 of 4) of 44, 10 °C, 10% D2O/H2O, pH ~ 0 
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Supplemental Figure 52. 500 MHz HMBC spectrum (expansion 4 of 4) of 44, 10 °C, 10% D2O/H2O, pH ~ 0 
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Supplemental Figure 53. 500 MHz HMQC spectrum of 44, 10 °C, 10% D2O/H2O, pH ~ 0 
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Supplemental Figure 54. 500 MHz ROESY spectrum of 44, 10 °C, 10% D2O/H2O, pH ~ 0 
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Supplemental Figure 55. 500 MHz COSY spectrum of compound 57, 2 °C, 9:1 H2O/D2O with 0.025 M 
ND4COOD:CD3COOD buffer (pH 4-5) 
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Supplemental Figure 56. 500 MHz ROESY spectrum (expansion 1 of 2) of compound 57, 2 °C, 9:1 H2O/D2O with 
0.025 M ND4COOD:CD3COOD buffer (pH 4-5) 
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Supplemental Figure 57. 500 MHz ROESY spectrum (expansion 2 of 2) of compound 57, 2 °C, 9:1 H2O/D2O with 
0.025 M ND4COOD:CD3COOD buffer (pH 4-5) 
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Supplemental Figure 58. 500 MHz HMQC spectrum of compound 57, 2 °C, 9:1 H2O/D2O with 0.025 M 
ND4COOD:CD3COOD buffer (pH 4-5) 
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Supplemental Figure 59. 500 MHz HMBC spectrum (expansion 1 of 4) of compound 57, 2 °C, 9:1 H2O/D2O with 
0.025 M ND4COOD:CD3COOD buffer (pH 4-5) 
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Supplemental Figure 60. 500 MHz HMBC spectrum (expansion 2 of 4) of compound 57, 2 °C, 9:1 H2O/D2O with 
0.025 M ND4COOD:CD3COOD buffer (pH 4-5) 
 256 
 
Supplemental Figure 61. 500 MHz HMBC spectrum (expansion 3 of 4) of compound 57, 2 °C, 9:1 H2O/D2O with 
0.025 M ND4COOD:CD3COOD buffer (pH 4-5) 
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Supplemental Figure 62. 500 MHz HMBC spectrum (expansion 4 of 4) of compound 57, 2 °C, 9:1 H2O/D2O with 
0.025 M ND4COOD:CD3COOD buffer (pH 4-5) 
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Supplemental Figure 63. 500 MHz COSY spectrum of compound 58, 2 °C, 9:1 H2O/D2O with 0.025 M 
ND4COOD:CD3COOD buffer (pH 4-5) 
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Supplemental Figure 64. 500 MHz ROESY spectrum (expansion 1 of 3) of compound 58, 2 °C, 9:1 H2O/D2O with 
0.025 M ND4COOD:CD3COOD buffer (pH 4-5) 
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Supplemental Figure 65. 500 MHz ROESY spectrum (expansion 2 of 3) of compound 58, 2 °C, 9:1 H2O/D2O with 
0.025 M ND4COOD:CD3COOD buffer (pH 4-5) 
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Supplemental Figure 66. 500 MHz ROESY spectrum (expansion 3 of 3) of compound 58, 2 °C, 9:1 H2O/D2O with 
0.025 M ND4COOD:CD3COOD buffer (pH 4-5) 
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Supplemental Figure 67. 500 MHz HMQC spectrum  of compound 58, 2 °C, 9:1 H2O/D2O with 0.025 M 
ND4COOD:CD3COOD buffer (pH 4-5) 
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Supplemental Figure 68. 500 MHz HMBC spectrum (expansion 1 of 4) of compound 58, 2 °C, 9:1 H2O/D2O with 
0.025 M ND4COOD:CD3COOD buffer (pH 4-5) 
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Supplemental Figure 69. 500 MHz HMBC spectrum (expansion 2 of 4) of compound 58, 2 °C, 9:1 H2O/D2O with 
0.025 M ND4COOD:CD3COOD buffer (pH 4-5) 
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Supplemental Figure 70. 500 MHz HMBC spectrum (expansion 3 of 4) of compound 58, 2 °C, 9:1 H2O/D2O with 
0.025 M ND4COOD:CD3COOD buffer (pH 4-5) 
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Supplemental Figure 71. 500 MHz HMBC spectrum (expansion 4 of 4) of compound 58, 2 °C, 9:1 H2O/D2O with 
0.025 M ND4COOD:CD3COOD buffer (pH 4-5) 
 267 
 
Supplemental Figure 72. Oligomer 61, 500 MHz COSY spectrum 
 268 
 
Supplemental Figure 73: Oligomer 61, 600 MHz ROESY spectrum (1 of 2) 
 269 
 
Supplemental Figure 74: Oligomer 61, 600 MHz ROESY spectrum (2 of 2) 
 270 
 
Supplemental Figure 75: Oligomer 61, 500 MHz HMQC spectrum 
 271 
 
Supplemental Figure 76. Oligomer 61, 500 MHz HMBC spectrum (1 of 4) 
 272 
 
Supplemental Figure 77. Oligomer 61, 500 MHz HMBC spectrum (2 of 4) 
 273 
 
Supplemental Figure 78: Oligomer 61, 500 MHz HMBC spectrum (3 of 4) 
 274 
 
Supplemental Figure 79: Oligomer 61, 500 MHz HMBC spectrum (4 of 4) 
 275 
 
Supplemental Figure 80. Oligomer 62, 500 MHz COSY spectrum 
 276 
 
Supplemental Figure 81. Oligomer 62, 600 MHz ROESY spectrum (1 of 2) 
 277 
 
Supplemental Figure 82: Oligomer 62, 600 MHz ROESY spectrum (2 of 2) 
 278 
 
Supplemental Figure 83: Oligomer 62, 500 MHz HMQC spectrum 
 279 
 
Supplemental Figure 84. Oligomer 62, 500 MHz HMBC spectrum (1 of 4) 
 280 
 
Supplemental Figure 85. Oligomer 62, 500 MHz HMBC spectrum (2 of 4) 
 281 
 
Supplemental Figure 86. Oligomer 62, 500 MHz HMBC spectrum (3 of 4) 
 282 
 
Supplemental Figure 87. Oligomer 62, 500 MHz HMBC spectrum (4 of 4) 
 283 
 
Supplemental Figure 88. Oligomer 63, 500 MHz COSY spectrum 
 284 
 
Supplemental Figure 89. Oligomer 63, 600 MHz ROESY spectrum (1 of 2) 
 285 
 
Supplemental Figure 90. Oligomer 63, 600 MHz ROESY spectrum (2 of 2) 
 286 
 
Supplemental Figure 91. Oligomer 63, 500 MHz HMQC spectrum 
 287 
 
Supplemental Figure 92. Oligomer 63, 500 MHz HMBC spectrum (1 of 4) 
 288 
 
Supplemental Figure 93. Oligomer 63, 500 MHz HMBC spectrum (2 of 4) 
 289 
 
Supplemental Figure 94. Oligomer 63, 500 MHz HMBC spectrum (3 of 4) 
 290 
 
Supplemental Figure 95. Oligomer 63, 500 MHz HMBC spectrum (4 of 4) 
 291 
APPENDIX D 
SCHEMATIC OF MANUAL SPPS APPARATUS 
The schematic diagram on the following page illustrates the type of solid-phase reaction 
apparatus constructed for the SPPS reactions described above.  The commercial source and part 
number for all components are indicated. 
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Supplemental Figure 96: A schematic diagram illustrating the construction of 
the reactors for solid-phase peptide synthesis 
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